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CHAPTER 1. INTRODUCTION 
 
Problem Statement 
 Plants with bioactive specialized metabolites, also referred to as medicinal plants, have 
been used by human, and other primates for thousands of years.  These bioactive compounds are 
known to affect humans and cultures cells in many ways including but not limited to anti-viral, 
anti-oxidant, anti-depressant, anti-cancer, anti-bacteria, and anti-fungal.  The accumulation levels 
of these compounds inside the plant are highly influenced by genotype, and by biotic and abiotic 
cues.  Because of the importance of these compounds in pharmaceutical production, I worked to 
understand the metabolism of acylphloroglucinols, dianthrones, and flavonoids produced in 
Hypericum gentianoides and H. perforatum. To accomplish this goal, this research consisted of 
several components: 
 Identify previously unknown acylphloroglucinols and their predicted intermediates to 
establish a acylphloroglucinol biosynthetic pathway by using MS techniques in H. 
gentianoides 
 Identify where acylphloroglucinols and acylphloroglucinol intermediates accumulate in 
H. gentianoides by using MS techniques 
 Identify putative biosynthetic genes by using methods to correlate metabolite shifts to 
shifts in transcripts 
 Validate polyketide biosynthetic genes with in vitro expression studies in E. coli 
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Overview 
 This dissertation is organized as follows: 
 Chapter 2, modified from chapter 17 in the textbook Biotechnology for Medicinal Plants, 
focuses on approaches and assumptions used to identify transcripts involved in the 
biosynthesis and regulation of bioactive active compounds.  The methods of identifying 
distinct metabolite profiles necessary for production of diverse transcriptomic profiles 
were based on methods used for transcriptomic analyses in H. gentianoides and H. 
perforatum. 
 Chapter 3, modified from a publication in Physiologia Plantarum, is split into two 
sections:the first addresses the chemical characterization of the six previously 
unidentified acylphloroglucinol major acylphloroglucinols in H. gentianoides by 
comparison of the six LC/ESI-MS/MS spectra to that of the three NMR identified major 
acylphloroglucinols also present in H. gentianoides; and the second section discusses 
utilization of Q-TOF-MS to identify and validate the identity of eight decorated 
phlorisobutyrophenone molecules that are part of a ―monomer pool‖.  We hypothesized 
this ―monomer pool‖ is sufficient for the production of the nine major 
acylphloroglucinols observed in H. gentianoides.   
 Chapter 4, modified from a publication to be submitted to Plant Physiology, focuses on 
two related research areas: 1) discrete localization of the metabolites identified in chapter 
3 using Fourier Transform/Ion Cyclotron Resonance-Mass Spectroscopy (FTICR-MS) 
and Laser Desorption Ionization Mass Spectroscopy (LDI-MS), and 2) characterization 
of the development of, and organelles present in the translucent glands in H. 
gentianoides.  Through our mass spectral analyses, we observed that the entire set of 
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predicted acylphloroglucinol pathway metabolitesin H. gentianoidesexists exclusively in 
the translucent glands.  Furthermore, we used electron microscopyto document the 
development of the translucent glands over time, revealing the presence and timing of 
active mitochondria, ribosomes, and plastids.  These results together led us to 
hypothesize that the entire biosynthesis of acylphloroglucinols in H. gentianoides is 
completely sequestered within these translucent glands.   
 Chapter 5, modified from a publication to be submitted to Plant Physiology, focuses on 
our efforts to identify transcripts related to specialized polyketide metabolism, more 
specifically acylphloroglucinol biosynthesis.  We developed transcriptomic profiles from 
UV-B treated and untreated H. gentianoides seedlings.  Through metabolomic assays, we 
found that UV-B treated H. gentianoides seedlings accumulated acylphloroglucinols up 
to 5 fold higher than did H. gentianoides seedlings treated only with natural and 
supplemented light.  The transcriptomic profiles obtained from these samples were 
analyzed for quality, annotated, and then compared to other Hypericum transcriptomic 
data to ascertain whether other known polyketide biosynthetic transcripts are present in 
H. gentianoides.  After performing a differential gene expression analysis, we identified 
2,600 transcripts that are differentially expressed only after UV-B irradiation.  Many of 
these transcripts are homologous to steps in flavonoids biosynthesis, and several appear 
to be candidates for acylphloroglucinol biosynthesis. 
 Chapter 6, modified from a publication to be submitted to Plant Cell, focuses on our 
metabolomic and transcriptomic efforts in H. perforatum.  This chapter is split into 
several sections: 1) laser desorption ionization imaging of the leaves, petals, anthers, and 
sepal to identify discrete locations of acylphloroglucinols, dianthrones, and flavonoids in 
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fresh tissue; 2) collection and analysis of several H. perforatum tissues that were both 
sequenced with next generation sequencing and analyzed by using HPLC-UV; 3) 
correlating polyketides of interest to transcripts, filtering partially based on homology; 4) 
validation of a polyketide synthase involved with hyperforin biosynthesis using in 
vitrobiochemical assays.  Through these efforts, we identified two novel results. The first 
that several quercetin glycosides accumulate preferentially in the glandular nodules of H. 
perforatum;andthe second was identification of the polyketide synthase responsible for 
hyperforin biosynthesis, phlorisobutyrophenone synthase. 
 Appendix, an unpublished manuscript, characterizes a method for extraction, separation, 
and purification of acylphloroglucinols from H. gentianoides.  These acylphloroglucinols 
can be used for in vitro and in vivo bioassays.  
 
General Introduction 
 The genus Hypericum is diverse, encompassing nearly 500 species (Crockett and Robson, 
2011) of primarily yellow-flowered plants differing in size, life span, and presence of up to 2 
specialized glandular structures (Ernst, 2003; Crockett and Robson, 2011).  Hypericum, 
specificially H. perforatum (St. John‘s Wort), has been used as a medicinal aid since Roman 
times (Pasqua et al., 2003) It has also been noted that H. perforatum and other medicinal plants, 
have been used by primates even before this, given that modern chimpanzees will preferentially 
consume plants with anti-parasitic activities (Huffman et al., 1997).  Consumption of medicinal 
plants is capable of causing a medicinal effect; given the importance of several of these 
medicinal effects, scientists have worked to understand the metabolite(s) responsible for given 
activities.  
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From these studies, Hypericum species are known to accumulate several classes of bioactive 
specialized metabolites, including xanthones, acylphloroglucinols, flavonoids, and dianthrones 
(Ganzera et al., 2002; Hölscher et al., 2009; Ka Po Shiu and Gibbons, 2009).  These compounds 
are synthesized via the addition of variable numbers of decarboxylated malonyl-CoA subunits to 
an acyl-CoA subunit by a type III polyketide synthases (PKSs) (Figure 1).  In Hypericum, the 
acylphloroglucinols and dianthrones have been found to accumulate in two different specialized 
secretory structures.  Acylphloroglucinols accumulate in the one type of secretory structure, the 
translucent glands, which appear as small white dots made visible using transducing light on a 
stereo microscope (Figure 2A).  Dianthrones accumulate in the glandular nodules, which appear 
as black spots on the leaves, flower petals, and stamens (Figure 2A, 2B).  This dissertation will 
discuss nearly 30 different acylphloroglucinols, dianthrones, and flavonoids. 
 
Acylphloroglucinols 
Polyketides in Hypericum species have been examined for many bioactivities.  The 
acylphloroglucinols are a diverse class of metabolites have also been examined for anti-bacterial 
(Reichling et al. 2001, Avato et al. 2004, Joray et al. 2011), anti-carcinogen (Schempp et al. 
2002), and angiogenesis-inhibitoryproperties (Schempp et al. 2005).  These activities have been 
observed mainly in hyperforin, an acylphloroglucinol in H. perforatum found to have anti-
depressant properties (Brenner et al., 2000; Adam et al., 2002; Karppinen, 2010). However, 
bioactivity can also be observed from another sub-class of acylphloroglucinols, the 
diacylphloroglucinols.  Diacylphloroglucinols (acylphloroglucinols composed of two 
phlorisobutyrophenone molecules ligated by a methylene bridge) accumulate in several species 
of Hypericum and possess bioactivities similar to hyperforin (Ishiguro et al., 1987; Rocha et al., 
6 
 
1995; Rocha et al., 1996; Stein et al., 2012).  At least one diacylphloroglucinol, uliginosin B, has 
been identified as an anti-depressant in mice (Stein et al., 2012).  In H. gentianoides, the 
diacylphloroglucinols saroaspidin A, uliginosin A, and hyperbrasilol C have been identified as 
having the capacity to lower the infectivity of Human Immunodeficiency Virus (HIV) (Hillwig, 
2008).  Interestingly, based on experiments performed by our lab, an analysis of gene expression 
levels in embryonic kidney cells treated with these diacylphloroglucinols, showed a down-
regulation of CXCR4 (Feng et al., in prep), a human secondary binding receptor necessary for 
HIV to gain entry into T-cells. Since humans with a deletion in the gene encoding this receptor 
are resistant to HIV (Murakami and Yamamoto, 2010) this implies a possible mechanism behind 
the earlier observation of lower infectivity. 
 Much of the published research involving acylphloroglucinols in Hypericum has focused 
on their bioactivity, while the sites and process of their biosynthesis have not been intensely 
studied.  It has been previously established that hyperforin accumulates in the translucent glands 
in H. perforatum (Soelberg et al., 2007), and that valine is likely a precursor to hyperforin 
biosynthesis, as has been demonstrated in isotopic labeling studies (Karppinen et al., 2007).   
Valine is converted to 2-oxoisovalerate via valine-pyruvate transaminase (EC 2.6.1.66), prior to 
being converted to isobutyryl-CoA by the enzyme 2-oxoisovalerate dehydrogenase (EC. 
1.2.1.25).  The type III PKS phlorisobutyrophenone synthase (BUS) is believed to be responsible 
for phlorisobutyrophenone (the precursor polyketide) production (Klingauf et al., 2005).  
 Currently, this is the only of the type III PKS that does not have an enzymatically tested 
candidate in Hypericum, but it is expected to be homologous to isovalerate synthase, a bacterially 
derived PKS (Klingauf et al., 2005).  The rest of the hyperforin biosynthetic pathway is based on 
―paper chemistry‖, although, prenyl and geranyl groups appear to be present in the peripheries of 
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the translucent glands in H. perforatum (Soelberg et al., 2007), giving some indication that these 
compounds are synthesized in the translucent glands. 
 
Dianthrones 
In Hypericum, another unique set of metabolites is the hypericins, a class of dianthrones.  
These compounds accumulate in the glandular nodules (Karppinen et al., 2008, Chapter 6) and 
are thought to serve as defense compounds (Brockmöller et al., 1997).  In part, this is believed 
because hypericins are known to produce ratical oxygen species (ROSs) in the presence of light 
and given their accumulations are up-regulated when an H. perforatum plant is attacked by a 
generalist feeder but not when attacked by specialists (Sirvent et al., 2003).  As with the 
diacylphloroglucinols, some information is known about the bioactivity of dianthrones, but 
biosynthetic pathways for these compounds are largely unknown. 
 Based on ―paper chemistry‖, the hypericins are likely biosynthesized by acetyl-CoA 
(Košuth et al., 2011).  Acetyl-CoA is ligated to 7 malonyl-CoA molecules by an octaketide 
synthase (OKS), where it could cyclize, either spontaneously or enzymatically, to form emodin 
anthrone.  Although this specific activity has not been observed through in vivo and in vitro 
studies, an OKS has been identified in the glandular nodules of H. perforatum (Karppinen et al., 
2008).  In vitro studies using this protein produced emodin anthrone isomers but never emodin 
anthrone itself; however, it is still assumed that this OKS is emodin anthrone synthase because 
its transcript localized to the glandular nodules (Karppinen et al., 2008). 
 Emodin anthrone is converted to emodin dianthrone by one or more of the following 
three options: 1) the dimerization of emodin anthrone with emodin (Košuth et al., 2011); 2) the 
dimerization of two emodin anthrone molecules (Kirakosyan et al., 2004); 3) the dimerization of 
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two emodin molecules (Bais et al., 2003).  Emodin dianthrone is reduced to emodin 
dehydrodianthrone and reduced again to form protohypericin. Protohypericin can be converted to 
hypericin by light or enzymatically (Košuth et al., 2011). 
 Presently, only one other gene involved in hypericin biosynthesis has been identified, 
referred to as Hyp-1 (a phenolic oxidative coupling protein).  The protein translated from Hyp-1 
was shown through in vitro biochemical analysis to directly convert emodin to hypericin (Bais et 
al., 2003).  Given that roots do not accumulate glandular nodules (the hallmark of hypericin 
accumulation) and there are only small traces of hypericin in the roots (Košuth et al., 2007; 
Chapter 6), it is strange the Hyp-1 transcript accumulates highest in the root.  Furthermore, 
transcripts that seem to be Hyp-1 appear in several Hypericum species that do not accumulate 
glandular nodules nor any hypericin (Košuth et al., 2011; Chapter 5). 
 
Flavonoids             
While the hypericins and hyperforins are specialized metabolites found only in 
Hypericum species, flavonoids are much more widespread, produced in model organisms such as 
Arabidopsis and Glycine max (Soybean) (Naim et al., 1976; Yonekura-Sakakibara and Saito, 
2009).  Because of this, there is much more information about all aspects of their metabolism, 
including many of the genes involved in their biosynthesis.  As such, these compounds can 
usually be identified by correlating transcript and metabolite abundance.   
 Flavonoids are biosynthesized from the amino acid, phenylalanine, which is modified to 
form the activated molecule 4-coumaroyl-CoA (Watts et al., 2004).  As with dianthrones and 
acylphloroglucinols, a type III PKS ligates malonyl-CoA molecules to the activated CoA to form 
the precursor polyketide (Watts et al., 2004).  In flavonoids, 4-coumaroyl-CoA is ligated to 3 
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malonyl-CoA molecules through the action of chalcone synthase (CHS) and cyclized in a 
stereospecific manner by chalcone isomerase (CHI) to form naringenin (Winkel-Shirley, 2001).  
For flavonoids of interest in this study, naringenin is transformed into amentoflavone, the 
quercetins, or the anthocyanins. 
 Amentoflavone is a biapigenin and appears to be the product of asymmetrical 
dimerization of two modified apigenin molecules.  Interestingly I have never observed detectable 
amounts of apigenin in H. perforatum.  This might imply another mode of biosynthesis for 
amentoflavone, or that there is far less apigenin compared to amentoflavone, in vivo.   
 Quercetin is well characterized in Arabidopsis, where it is known that naringenin is acted 
on by a flavonoid 3-hydroxylase (F3H), flavonoid 3‘-hydroxylase (F3‘H), and flavonol synthase 
(FLS) to form quercetin.  Quercetin can be glycosylated on several positions, and we observed 
two different glycosylations (encompassing four different reactions) in H. perforatum: on the 3-
O position by a quercetin 3-O glycosyltransferase (Q3OGT), and a further glycosylation by 
quercetin 3-O glycosyl rhamnosyltransferase (Q3OGRT).  These correspond to the compounds 
hyperoside, isoquercitrin, quercitrin, and rutin in H. perforatum (Ganzera et al., 2002).  Unlike 
the dianthrones and the acylphloroglucinols, most of the quercetins in Hypericum are not thought 
to accumulate preferentially in one gland type or the other, although preferential accumuation of 
quercetins is observed in the glandular nodules (Chapter 6) 
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Figure 1- Biosynthesis of polyketides in Hypericum species occur via type III polyketide 
synthases.  This figure, adapted from Hillwig et al. (2008), illustrates the chemical diversity 
generated by this group of enzymes.   
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Figure 2- Hypericum perforatum exhibits two different secretory structures.  A) Translucent 
glands, or light glands, are abundant on the leaves, and appear as a white dot as illustrated. B) 
Glandular nodules, or dark glands, appear as dark spots and are prevalent on the leaves, flower 
petals, and stamen.  Their patternings are slightly different depending on the species; for 
example, H. perforatum accumulate these glands along the edges of the leaves and flower petals, 
but this is pattern not conserved throughout the genus. 
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Figure 3- Putative biosynthetic pathway of hyperforin in H. perforatum.  Valine has been 
established as the precursor to hyperforin biosynthesis by using L-[U-
13
C6]-Valine (Karppinen et 
al., 2007; Kappinen, 2010).  Valine is converted to isobutyryl-CoA, before catalyzation to 
phlorisobutyrophenone by isobutyrophenone synthase (BUS).  Phlorisobutyrophenone is then 
prenylated and geranylated to form hyperforin (Adam et al., 2002; Soelberg et al., 2007).  VPT: 
valine-pyruvate transaminase (EC 2.6.1.66); 2-ODH: 2-oxoisovalerate dehydrogenase (EC 
1.2.1.25); BUS: phlorisobutyrophenone synthase; PT: prenyltransferase; GT: geranyltransferase.  
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Figure 4- Putative hypericin biosynthetic pathways in H. perforatum.  Acetyl-CoA is the 
precursor of dianthrone biosynthesis; this compound is ligated to 7 malonyl-CoA to form the 
precursor polyketide emodin anthrone (Kosüth et al., 2011).  An octaketide synthase that could 
be responsible for this activity has been identified in the same location as hypericin, however, in 
vitro studies have shown only production of isomers, never emodin anthrone itself (Karppinen et 
al., 2008).  Currently three putative mechanisms of emodin dianthrones are hypothesized: 1) 
dimerization of emodin and emodin anthrone, 2) dimerization of two emodin anthrone 
molecules, and 3) dimerization of two emodin molecules.  Hyp-1, a protein able to produce 
hypericin from emodin in vitro (Bais et al., 2003), has been predicted to be involved in multiple 
steps (Košuth et al., 2011).  However; the true function of Hyp-1 is disputed, given its presence 
in Hypericum species that do not accumulate hypericin (Košuth et al, 2011; Chapter 5).  
Regardless of the biosynthetic machinery involved, a general consensus is that emodin 
dianthrone is sequentially oxidized to form emodin dehydrodianthrone, protohypericin, and 
finally hypericin.       
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Figure 5- Putative quercetin biosynthetic pathway in H. perforatum based on the pathway 
identified in Arabidopsis.  This pathway begins with the amino acid phenylalanine.  
Phenylalanine is converted to the activated CoA molecule 4-coumaroyl-CoA by EC 4.3.1.24 
(phenylalanine ammonia-lyase), EC 1.14.13.11 followed by EC 6.2.1.12.  4-coumaroyl-CoA is 
catalyzed to naringenin by the enzymes chalcone synthase and subsequently chalcone isomerase.  
Quercetin is biosynthesized via a series of hydrogenases and an oxidation (EC 1.14.11.9, EC 
1.14.13.88, EC 1.14.11.23).  Quercetin can be glycosylated through the action of quercetin 3-O-
glycosyltransferases to form hyperoside, isoquercitrin, and quercitrin.  Isoquercitrin can be 
further rhamnosylated through EC 2.4.1.159 to form rutin.  PAL, phenylalanine ammonia-lyase; 
TC4M, trans-cinnamate 4-monooxygenase; 4CL, 4-coumaroyl-CoA ligase; CHS, chalcone 
synthase; CHI, chalcone isomerase; F3H, flavonoid 3-hydroxylase; F3‘H, flavonoid 3‘-
hydroxylase; FLS, flavonol synthase; Q3OGT, quercetin 3-Oglycosyltransferase; Q3OGRT 
quercetin 3-Oglycosyl rhamnosyltransferase. 
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CHAPTER 2. USE OF METABOLOMICS AND TRANSCRIPTOMICS 
TO GAIN INSIGHTS INTO THE REGULATION AND 
BIOSYNTHESIS OF MEDICINAL COMPOUNDS: HYPERICUM AS A 
MODEL 
 
Modified from a chapter published in the textbook Biotechnologies in Medicinal Plants 
 
Matthew C. Crispin, Eve Syrkin Wurtele 
 
Abstract 
 Medicinal plants have been used in alternative medicine for thousands of years and 
produce many unique classes of compounds.  These compounds have effects on humans and 
cultured cells that include but are not limited to anti-viral, anti-bacterial, anti-depressive, and 
anti-oxidant properties.  The levels of accumulation and ratios of specialized metabolites are 
highly influenced by factors including genotype, natural variation due to biotic and abiotic cues, 
optimization of compounds, the intermediate chemicals within the pathways, sites of synthesis 
and the biosynthetic genes dictating their synthesis.  All these factors impact the quality of 
propagated material. This chapter will give an overview of 1) understanding the natural variation 
in bioactive compounds across different treatments and tissues; 2) an approach for finding 
putative biosynthetic genes utilizing transcriptomic and metabolomic technologies; and 3) the 
positive and negative effects on humans.  It will be illustrated with examples from the genus 
Hypericum. 
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Introduction  
 Herbal remedies have been used across cultures for thousands of years, and despite the 
availability of many pharmaceuticals, recently there has been a renaissance towards using herbal 
supplements.  Even though many of these products are not approved by the Food and Drug 
Administration, more than 15 million people in the United States use herbal supplements 
(Tachjian et al, 2010), grossing amounts above $34 billion per year (Eisenberg et al, 1998; 
Tachjian et al, 2010). According to Nalawade and Tsay (2004) this boom in popularity has 
created an overexploitation of medicinal plants, and threatened the survival of many medicinal 
species.  Consequently, there has been an increased need for propagation. Combined basic and 
applied research has aimed to propagate plants more efficiently and to increase bioactive 
compound yields in species such as Aloe vera (Liao et al., 2004), Atropa belladonna (Yang et al, 
2011), Catharanthus roseus (Murata et al, 2008), Digitalis purpurea (Einbond et al, 2010), 
Echinacea purpurea (Perry et al, 1997), and Hypericum (Karppinen et al., 2006).  Yet, current 
research strategies are not always effective in informing optimal propagation methods, 
discovering biosynthetic pathways for specialized plant compounds, or elucidating their effects.  
 In this chapter, incorporation of additional strategies is evaluated.  We discuss several 
research approaches enabled by recent technological advances in metabolomics and sequencing, 
in part using Hypericum as a case study.  These are 1) strategies for localizing the sites of 
synthesis and accumulation of bioactive compounds; 2) combined metabolomic and 
transcriptomic approach as a method of novel gene discovery; and 3) combined metabolomic and 
transcriptomic approach to determine the positive and negative effects of botanicals in humans.  
The knowledge gleaned from such studies can provide clues to development of propagation 
strategies (Figure 3).  
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Overview 
 This chapter will discuss strategies to gain a better understanding of medicinal plants. 
First we determine the location of bioactive compound synthesis and accumulation, and evaluate 
the genetic and environmental factors influencing the synthesis and accumulation of these 
bioactive compounds.  Second we leverage this knowledge to identify the genes that contribute 
to the metabolism and storage of the bioactive compounds, and to establish molecular 
―fingerprints‖ that can be used in breeding and research.  Third we worked to understand the 
intricacies of the effects of bioactive compounds on humans. These data can ultimately inform 
the propagation, breeding, and genetic engineering of plants such that they produce the 
compounds of interest at levels that are desired by the consumer/breeder/researcher/company.  
 
Detailing the sites/conditions of accumulation of bioactive compounds in the plant 
Importance   
 Understanding the factors that impact accumulation of bioactive compounds at the 
agronomic level, the physiological and molecular levels is greatly facilitated by a detailed 
understanding of where/under what conditions the compounds occur.  The term ―bioactive 
compounds‖ is defined as the specialized metabolites present in particular plant clades/species, 
for which there is either direct evidence of a biological affect on other biological systems, or a 
structural similarity to known bioactive compounds.  In most cases, the specific bioactive 
compounds or combination of bioactive compounds that induce particular effects in humans are 
not well understood. And many bioactive compounds in plants, even in currently medicinally-
used species, remain to be identified. 
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 Here, we focus on use of this understanding as a tool to identify the genes involved in 
bioactive compound metabolism: if synthesis and storage of bioactive compounds co-occurs, 
samples with high levels of bioactive compounds could be used to dissect the biosynthetic and 
regulatory genes. Thus, one major advantage of knowing the discrete regions and/or conditions 
of accumulation of bioactive compounds is that it empowers a comparative transcriptomics 
approach. In a transcriptomic approach, comparing plant samples that are synthesizing high 
levels of a given bioactive compound(s) to other samples not synthesizing these compounds, can 
be used to tease out the transcripts/genes involved in their synthesis.   
 A goal in selecting samples for sequencing is to minimize differences in transcriptomes 
between samples except for those transcripts involved with the metabolism of the compounds of 
interest.   For example, comparing Echinacea flower petals at a stage of development in which 
alkamides are not present with a slightly later stage in which alkamides synthesis is rapid 
provides a sensitive approach to identifying alkamides biosynthetic genes.  As a counter 
example, if comparing transcripts (expressed genes) of an Echinacea root that accumulates 
alkamides, with transcripts of an Echinacea leaf that does not accumulate these compounds, 
identification of the genes involved in metabolism of alkamides will be confounded by the whole 
range of other genes expressed in the leaf but not in the root that have nothing to do with 
metabolism of the alkamides.   Likewise, extracts made using broad classes of organs, such as 
―flowers‖ present a challenge because a flower contains a different metabolic ―fingerprint‖ in the 
petals, stamen, carpals, and sepals, and each of these organs has a distinct pattern of development 
and pattern of synthesis of bioactive compounds. 
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Technologies used for metabolomics analysis 
 Multiple methods are available and emerging for metabolomic analysis (Emmett et al., 
1998; Ganzera et al., 2002; Johnson et al., 2008; Cha et al., 2008; Blakney et al., 2011). 
Techniques for metabolomic analysis of bioactive compounds must be tailored to the compounds 
of interest (Nikolau and Wurtele, 2007); for example, fatty acids and essential oils can be 
analyzed using GC-MS (Cakir, 2004).  However, for the cyclic polyketides, LC-MS (or UV) are 
preferable because these compounds decompose at high temperatures and elute as multiple peaks 
in GC instead of only one peak.  Spatial detection is emerging as a powerful method for 
evaluating distribution of metabolites; one interesting approach (Cha et al, 2008) describes use of 
graphite assisted laser desorption ionization MS (GALDI-MS) to profile the spatial accumulation 
of flavonoids in cryo-sectioned Arabidopsis thaliana flowers and sepals.  This strategy has the 
distinct advantage of providing metabolite localization and levels simultaneously, and requires 
no microdissection; however, it also requires specialized equipment and expertise.     
 
Comprehensive metabolomics to identify known and putative bioactive compounds   
 In most medicinal species, there are a plethora of related chemicals, many of which may 
have bioactivities in animals and others of which have not been identified.  As an example of the 
complements of metabolites that occur in a medicinal plant species and its relatives, we focus on 
the genus Hypericum, which contains over 450 species and is within the Clusiaceae family.  The 
popular medicinal plant H. perforatum (St. John‘s Wort) accumulates compounds with putative 
anti-viral (Richman, 1991; Axarlis et al, 1998), anti-inflammatory (Hammer et al., 2007), anti-
depressive (Mennini and Gobbi, 2004; Butterweck and Schmidt, 2007; Kasper et al, 2008), and 
anti-bacterial (Franklin et al, 2009; Saddiqe et al, 2010) bioactivities.  In Hypericum there are 
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three major classes of specialized compounds.  The first is dianthrones, which include hypericins 
(hypericin, pseudohypericin, protopseudohypericin, and protohypericin) (Tatsis et al., 2007).  
These chemicals are present in H. perforatum, but not in all Hypericum species (e.g., H. 
gentianoides, Hillwig et al., 2008).  A second class of compounds is flavonoids, including 
quercetin and the quercetin glycosides (quercetin, rutin, hyperoside, isoquercitrin, quercitrin) 
(Ganzera et al., 2002).  A third class is acyl-phloroglucinols, which consist of hyperforin and 
adhyperforin in H. perforatum (Kirakosyan et al., 2004), and a wide variety of other compounds 
(Ishiguro et al., 1987), including nine structurally-similar acyl-phloroglucinols in H. gentianoides 
(Hillwig et al., 2008).  Despite the popularity of extracts from H. perforatum as medicinals, only 
two genes that may be involved in hypericin synthesis (Hyp-1 and HpPKS2) have been 
identified, but their roles are under debate (Bais et al., 2003; Karppinen et al., 2008; Košuth et 
al., 2011). 
  
Spatial differences in the same organ 
 A strategy that employs dissection of organs can be useful for obtaining samples that vary 
in specialized metabolites, particularly if there are distinct structures or morphologies that might 
correspond to the accumulation of a compound of interest.  For example, in most species of 
Hypericum, leaves have translucent glands (Figure 1A shows translucent glands in H. 
gentianoides), which appear to the eye as light spots.  It has been hypothesized that hyperforins 
accumulate in translucent glands in H. perforatum (Ernst, 2003).  If this is the case, dissection of 
leaves to separate the regions with the light glands from the regions without could provide a set 
of samples that vary in the concentration (and hopefully the synthesis) of bioactive compounds 
(for example, hyperforins or other acyl-phloroglucinols).  
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Developmental stage 
 Collection of distinct developmental stages can provide an approach for identifying 
samples that vary in specialized metabolites (Brown et al., 2003).  A discrete and easily 
recognizable example is H. gentianoides, which has two morphologically distinct phases, 
vegetative and reproductive (figure 1B and C).  In this species, the vegetative phase accumulates 
higher levels of acyl-phloroglucinols than the reproductive phase (Figure 2).  Depending on the 
population being studied, it is possible to obtain both reproductive and vegetative phases from 
the same plants, ensuring that these parts have been grown under the same conditions.   
 
Different populations 
 Due to genotypic differences, different populations/accessions have different levels of 
certain traits that can be used for examining specialized compounds or phenotypes.  For example, 
in H. perforatum, the accumulation of hyperforin varied between two genotypes, with one 
genotype having low but steady levels of hyperforin, the other hyperforinlevels initially having 
higher hyperforin levels which decreased during development (Bϋlter and Bϋlter, 2002).  
 
Induction by stress or other environmental perturbation 
 Identifying a treatment that induces bioactive compound synthesis can also facilitate 
obtaining samples that have many expressed genes in common, but vary in specialized 
metabolites (Brechner et al., 2011).  For example, in H. perforatum, UV-B, tryptophan, methyl 
jasmonate, tridiazuron (a plant defoliant) and 2,3-dihydroxypropyl jasmonate each induces 
accumulation of bioactive compounds  (Liu et al., 2007a; Liu et al., 2007b, Germ et al., 2010).  
This provides the added advantage that if the accumulation of the bioactive compounds is 
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induced, the biosynthetic transcripts will be likely be accumulated also, since induction typically 
requires expression of the genes required to make the compounds.  Timing is important: if 
samples are collected following a stressor, the lag time between the induction and increase in a 
transcript and the induction of the corresponding metabolite needs to be considered.   
 
Use of transcriptomics and metabolomics to discover putative biosynthetic genes 
Importance 
 Patterns of transcript and metabolite accumulation across multiple datasets can be used to 
provide fingerprints of the status of medicinal plants. In addition, as discussed below, 
comparisons of transcripts expressed in samples synthesizing the bioactive compounds versus 
transcripts in samples not synthesizing the bioactive compounds provide a major criteria for 
identifying the putative metabolic and regulatory genes.   
 
Technologies for transcriptomic analysis 
 The power of nucleic acid sequencing has vastly impacted all of biology (Schuster, 
2008). Previously, Sanger sequencing was used for sequencing nucleic acids; however, next 
generation sequencing (NGS) has immerged as a far better option.  Unlike Sanger, NGS 
technologies do not use traditional PCR techniques, which can cause a loss of some sequences; 
more importantly, NGS platforms have provided researchers with the ability to sequence an 
entire genome or transcriptome for much cheaper than possible with Sanger (Metzker, 2010), as 
well as the ability to detect alternative splicing and gene fusions (Ozsolak and Milos, 2011).  
Methods for sequencing and its computational analysis are rapidly evolving (Jiang and Wong, 
2009; Trapnell et al., 2009).  For transcriptomic sequencing, Illumina Genomic Analyzers are 
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currently common; these have advantages over Roche 454 because 454 can yield hundreds of 
thousands of reads, whereas Illumina normally yields tens of millions.  Illumina has lower costs 
for reagents and are far better at variant discovery (Mardis, 2008; Metzker, 2010).  Even longer 
reads/more depth is becoming possible with, e.g.,  Pacific Bioscience real time sequencing 
platform (Eid et al., 2009). 
 
Assumptions and experimental procedures 
 To identify biosynthetic transcripts for bioactive compounds by comparing plant samples 
with high accumulation of these compounds with those of no/low accumulation, two criteria 
must be met.  First, the compounds must be synthesizedin the same place that they are 
accumulated.  For example in H. perforatum, hypericin accumulates in the black glandular 
nodules on the leaves (Ciccarelli et al., 2001).  If hypericin is not synthesized in the leaves, but 
rather transported from the stems, despite hypericin being present in leaves there would be no 
biosynthetic transcripts, because the biosynthetic machinery is located elsewhere.  The second 
criterion is that the compound(s) of interest must be actively being synthesized at the time the 
plant material is collected.  If not, despite high concentrations of the compounds, there would be 
no corresponding transcripts.   
 Here, localization becomes very critical.  With an idea of which tissues to harvest, this 
approach can be used and material can be extracted for RNA and metabolites.   
 Figure 3 shows a flow chart of a possible protocol. This approach uses different aliquots 
from the same tissue samples for both transcript and the metabolite analysis.  For next-generation 
sequencing of a previously unsequenced species, a reference sample should be sequenced in 
order to assemble what is sometimes referred to as a ―de novo transcriptome‖ or ―artificial 
32 
 
genome‖ (Meyer et al., 2009).  In order to most thoroughly represent the possible transcriptome 
space, this reference sample should consist of a pooled collection of material from a combination 
of tissues, developmental stages, and stresses. After the de novo transcriptome is assembled, the 
individual samples can be sequenced, and contigs are assembled and quantified according to 
fragments per kilobase per million reads (FKPM) (Trapnell et al, 2010).  Concurrently 
metabolites can be extracted and analyzed from these samples (18.3.4-18.3.7).   
 
Advantages  
 Detecting differentially expressed genes by sequencing, rather than a microarray-based 
technology, provides higher accuracy, quantitative analysis, and much more depth (Trapnell et 
al, 2010).  Because there is no longer a requirement to use an organism with a sequenced 
genome, or annotated genome any organism of interest, such as coral (Meyer et al., 2009), can be 
sequenced and the transcriptome of individual samples can be determined.  Large-scale 
sequencing efforts focused on medicinal plants have accumulated significant sequence data for 
28 medicinal species (http://medplanttranscriptomes.uic.edu for the Medicinal Plant/Human 
Health Consortium, and http://medicinalplantgenomics.msu.edu/ for the Medicinal Plant 
Consortium). 
 This approach is very advantageous when samples can be obtained in which the 
transcriptomic profile should be very similar except for the transcripts of interest, for example in 
regions of an organ with differential accumulation of bioactive compounds (e.g., 18.3.4). The 
advantage of mass spectrometry is that if precursors are unknown, but are observed to correlate 
to a compound of interest, further identification of that precursor can be done using MS/MS. 
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Disadvantages 
 As is with most techniques, there are some disadvantages.  For example, as discussed, the 
bioactive compounds of interest must be actively synthesized in a subset of the samples.  Also, 
most medicinal species are not well characterized genetically, and different accessions/genotypes 
of a species will have different transcript sequences, making comparisons challenging.  In 
addition, plant contamination (such as E. coli, thrips, or an unknown pathogen) can confound 
sequence data.  A researcher needs to consider that metabolomics and transcriptomics are rapidly 
changing technologies, and both the instrumentation and the analytic tools are evolving and 
becoming more powerful. 
 
Effects of medicinal plants in humans 
 The interplay for survival and reproduction among each plant clade and the pathogens, 
competitors, symbionts, and pollinators of that clade has been evolving for hundreds of 
thousands of years.  As a consequence, plants have complements of compounds with complex 
bioactivities toward many organisms, and some of these compounds also have bioactivities in 
humans.  Because of potential variation among genetic lines and growth and extraction 
conditions, and the vast array of unusual bioactive compounds in most medicinal plants, 
bioactivity must be evaluated in conjunction with the metabolomics studies of the specific 
extracts used in each study; this is often only partially done or not done at all.  In this section, 
bioactive effects of a single genus, Hypericum, will be discussed as an example.  Table 1 lists 
some of the medicinal properties observed for Hypericum.  Transcriptomics studies evaluating 
the effects of low levels of Hypericum extracts on human cells show that the transcriptome of 
different cell types are complexly and differently affected (Holtrup et al., 2011).   
34 
 
Positive effects 
Effect of Hypericum on human immunodeficiency virus (HIV) infectivity 
 Considerable evidence indicates that the putative bioactive compounds of Hypericum 
have many beneficial effects in humans (Table 1).  H. perforatum extracts added to HIV-infected 
cells decreases the infectivity of this virus (Richman, 1991).  Possibilities suggested for the 
targets of the extract include virus adsorption, virus-cell fusion, reverse transcription, integration, 
and translation (De Clercq, 2000).  However, H. perforatum extracts interact with human 
CYP3A4 (Moore et al., 2000), and alters transcription in mammalian cells (Hammer et al., 2010; 
Holtrup et al., 2011; Jungke et al., 2011) so it is possible the extract interaction with human cells 
also impacts the virus. 
 
Hypericum as an anti-depressant 
 In addition to anti-retroviral properties, one of the commonly studied effects of 
Hypericum is as an anti-depressant.  According to Brenner (2000), the Hamilton Rating Score for 
Depression (HAM-D) and Clinical Global Impression Scale were significantly decreased by 
Hypericum treatments and by the selective serotonin reuptake inhibitor (SSRI) sertraline.  Of the 
patients in the study who had a clinical response (as characterized by a 50% decrease in HAM-
D), the difference between Hypericum and the SSRI was not statistically significant, 
demonstrating for this small group that the two treatments were effective in treating mild to 
moderate depression.  This study does not identify the specific compound(s) causing this effect.  
Other studies, such as Mennini and Gobbi (2004), indicated that hyperforin is the active 
compound in the anti-depressive response. 
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Negative effects 
Cytotoxicity of Hypericum 
 Several Hypericum compounds show significant cytotoxicity at high concentrations.  Of 
these, the Hypericum perforatum dianthrones, pseudohypericin and hypericin, are most toxic, 
causing unpigmented regions of skin in mammals to become photosensitive (Fields et al., 1990; 
Traynor et al., 2005), and death of cells in culture (Schmitt et al., 2006). 
 
H. perforatum decreases the effect of anti-retroviral drugs 
 Previous studies have shown that H. perforatum can act as a double-edged sword in the 
treatment of retrovirus, most specifically in HIV, because although the extracts have inhibitory 
effects on the virus, they also cause a decrease in the effectiveness of anti-retroviral drugs.  One 
explanation behind this is the lipophilic nature of the Hypericum polyketides.  The polyketides 
elicit an increase in cytochrome P450s that remove the polyketides and the anti-retroviral drugs 
(Adam et al, 2002): it is unclear whether there are additional interacting factors. 
 
Other interactions of drugs with H. perforatum 
 Anti-retroviral drugs are not the only targets for inhibition by H. perforatum (De Clercq, 
2000).  Other compounds whose effectiveness is reduced or altered by Hypericum include 
digoxin, clopidogrel, warfarin, simvastatin, paroxetine, class IA and III ant arrhythmic agents, 
cyclosporine, and theophylline. In clopidogrel; however, the activity increases, giving some level 
of evidence to suggest that there are multiple factors interacting with these drugs and it is not 
always the cytochrome P450‘s that are moving compounds out of the serum.  
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H. perforatum can cause interactions in people with cardiovascular diseases 
 People with cardiovascular diseases are at risk for negative effects.  According to 
Tachjian et al. (2010), H. perforatum extracts can cause increased heart rate and blood pressure 
when combined with monoamine oxidase inhibitors (MAOI), and decrease the concentration of 
digoxin.  It is interesting and ironic that heart disease is quite prevalent in the United States, yet 
more and more people are using extracts that may exacerbate cardiovascular disease. 
 
Medicinal supplement use 
 Even though there may be numerous positive effects of medicinal plants, there can be 
negative properties as well.  As with any other pharmaceutical, people should do their best to 
evaluate specific risk factors with respect to their own health before they use medicinal plant 
extracts on a regular basis.  Personalized medicine will provide additional information. Because 
medicinal species contain a complement of bioactive compounds, it is important to provide well-
characterized and consistent extracts to the public.   
 
Conclusions 
 Medicinal plants have been critical in medicine since civilization and probably earlier 
(Fox et al., 2001).  Despite many studies on medicinal species, much remains to be understood 
about how the bioactive compounds are synthesized, what drives their accumulation, and 
mechanistically how the extracts and their components affect humans.  The revolution in 
transcriptomics and metabolomics technologies provides new strategies to gain a further 
understanding as well as to further characterize plant material.  With these strategies, more 
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mysteries associated with the accumulation and bioactivities of bioactive compounds in these 
species can be unraveled. 
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Table 1-Effects of Hypericum extracts on mammalian cells and mammals. 
Effect Investigated In References 
Anti-Viral Friend murine leukemia virus in 
human1; human diploid 
embryonic lung fibroblasts 
(MRC-5) (Biomerieux-France) 
against human cytomegalovirus2; 
HIV in mice3 
Richman, 19911; Axarlis et al., 
19982; Meruelo et al., 19883 
Anti-Depressive Humans with mild to moderate 
depression1; and in mice2 
Brenner, 20001; Kasper et al., 
20081; Mennini and Gobbi, 
20042; Butterweck and Schmidt, 
20072; Crupi et al., 20112 
Anti-Inflammatory 264.7 Mouse Macrophage Cells1; 
and in mice2 
Hammer et al., 20071; Hammer et 
al., 20101; Galati et al., 20082 
Anti-Bacterial Many species of gram positive 
and gram negative bacteria 
incubated on plates and 
inoculated with extracts 
Rabanal et al., 2002; Peeva-
Naumovska et al., 2010; Saddiqe 
et al., 2010 
Anti-Fungal Fungal species Collectotrichum 
acutatum, Collectotrichum 
fragariae, Collectotrichum 
gloeosporioides1 
Crockett et al., 20101 
Anti-Cancer Human patients with reoccurring 
malignant gliomas1; DA3 breast 
carcinoma-derived lung 
metastases2; SQ2 murine 
squamous cell carcinoma-derived 
metastases2; cell cultures of 
human leukemic lymphoma cell3; 
human prostate cells in vivo and 
implanted in mice4; autologous 
MT-450 breast carcinoma in 
immunocompetent Wistar rats5.  
Couldwell et al., 20111*; Blank 
et al., 20042; Schempp et al., 
2002b3; Martarelli et al., 20044; 
Schempp et al., 2002a5 
Anti-Malarial A multidrug-resistant W2mef 
laboratory strain, and a field 
isolate (SHF4) of Plasmodium 
falciparum1. 
Zofou et al., 20111* 
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Table 1. Continued 
Treatment of Mild To Moderate 
Atopic Dermititis 
Humans using skin cream with 
Hypericum1 
Schempp et al., 20031 
Cytotoxicity In Cells HaCaT human keratinocytes1; 
A431 tumour cells2; LLC-MK2 
monkey kidney epithelial cells3 
Schmitt et al., 20061; 
Vandenbogaerde et al., 19982; 
Zofou et al., 20113* 
Photosensitivity Mammals1; HaCaT human 
keratinocytes supplemented with 
UV-A2 
Fields et al., 19901; Traynor et 
al., 20052 
Lowers Anti-Retroviral Drug 
Concentration 
Human patients taking anti-
retroviral drugs for HIV1 
Adam et al., 20021 
Increases Blood Pressure And 
Heart Rate 
Humans on monoamine oxidase 
inhibitors1 2 
Tachijan et al., 20101; Schroeder 
et al., 20042* 
Lowers Serum Concentration Of 
Many Drugs 
Human patients using several 
categories of heart disease 
medications1 
Tachijan et al., 20101 
*-no statistically significant effect observed 
 
 
49 
 
 
Figure 1-H. gentianoides, accession Ames 27729 (http://www.ars-grin.gov/cgi-
bin/npgs/acc/display.pl?1668188), germinated and grown in greenhouse conditions. A) The 
adaxial side of a leaf from the vegetative phase of a 3-month-old plant. Its many translucent 
glands appear as light spots on the leaf.  B) The vegetative phase of an 8 and a half-month-old 
plant. C) The reproductive phase of an 11-month-old plant. 
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Figure 2-Accumulation pattern of acylphloroglucinol in the vegetative and reproductive tissue in 
H. gentianoides plants. 
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Figure 3-Flow chart illustrating a strategy to co-evaluate the metabolome and transcriptome of a 
previously unsequenced medicinal plant species. The strategy is designed to facilitate the 
identification of the enzyme-coding and regulatory transcripts involved in the synthesis, 
accumulation and catabolism of bioactive compounds.  It also provides a means to identify a 
fingerprint of transcripts that characterize particular stages of the plant. 
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Abstract 
 Species of the genus Hypericum contain a rich array of unusual polyketides, however, 
only a small proportion of the over 450 Hypericum species, other than the popular medicinal 
supplement St. John‘s Wort (H. perforatum), have even been chemically characterized.  H. 
gentianoides, a small annual used medicinally by Cherokee Americans, contains bioactive 
acylphloroglucinols.   
Here, we identify acylphloroglucinol constituents of H. gentianoides and determine a potential 
pathway to their synthesis.  Liquid chromatography/electrospray ionization-mass spectrometry 
(LC/ESI-MS) and HPLC-UV indicate that the level of accumulation and profile of 
acylphloroglucinols in H. gentianoides vary little seasonally when grown in a greenhouse, but do 
vary with development and are highly dependent on the accession, highlighting the importance 
of the selection of plant material for study.   We identify the chemical structures of the nine 
prevalent polyketides, based on LC/ESI-MS and hybrid quadrupole orthogonal time-of-flight 
mass (Q-TOF) spectrometry; these metabolites includeone monomeric phlorisobutyrophenone 
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(PIB) derivative and eight dimeric acylphloroglucinols. Q-TOF spectrometry was used to 
identify eight additional PIB derivatives that were not detected by LC/ESI-MS.   
These data lead us to propose that diacylphloroglucinols are synthesized via modification of PIB 
to yield diverse phloroglucinol and filicinic acids moieties, followed by dimerization of a 
phloroglucinol and a filicinic acid monomer to yield the observed complement of 
diacylphloroglucinols.  The metabolomics data from H. gentianoides are accessible in PMR 
(http://www.metnetdb.org/pmr), a public metabolomics database with analysis software for 
plants and microbial organisms. 
 
Abbreviations Used 
 
 PIB, phlorisobutyrophenone; 1‘pren3‘me4‘oxoPIB, 1‘-prenyl-3‘-methyl-4‘-oxo-
phlorisobutyrophenone; 1‘pren3‘4me4‘oxoPIB, 1‘-prenyl-3‘,4-dimethyl-4‘-oxo-
phlorisobutyrophenone; [1‘pren3‘4me4‘oxoPIB]-[3‘prenPIB], 3,5-dihydroxy-2-methyl-4-(3-
methylbut-2-enyl)-4-(2-methylbutanoyl)-6-(2,4,6-trihydroxy-3-isobutyryl-5-(3-methylbut-2-
enyl)benzyl)cyclohexa-2,5-dienone; 1‘3‘pren45‘me4‘oxoPIB, 1‘,3‘-diprenyl-4,5‘-dimethyl-4‘-
oxo-phlorisobutyrophenone; 3‘mePIB, 3‘-methyl-phlorisobutyrophenone; [3‘mePIB]-
[1‘pren3‘me4‘oxoPIB], 3,5-dihydroxy-4-isobutyryl-2-methyl-4-(3-methylbut-2-enyl)-6-(2,4,6-
trihydroxy-3-isobutyryl-5-methylbenzyl)cyclohexa-2,5-dienone;3‘4mePIB, 3‘,4-dimethyl-
phlorisobutyrophenone; 3‘3‘me6‘oxoPIB, 3‘,3‘-dimethyl-6‘-oxo-phlorisobutyrophenone; 
3‘3‘4me6‘oxoPIB, 3‘,3‘,4-trimethyl-6‘-oxo-phlorisobutyrophenone; [3‘3‘4me6‘oxoPIB]-
[3‘prenPIB], 3,5-dihydroxy-4,4-dimethyl-2-(2-methylbutanoyl)-6-(2,4,6-trihydroxy-3-
isobutyryl-5-(3-methylbut-2-enyl)benzyl)cyclohexa-2,5-dienone;3‘prenPIB, 3‘-prenyl-
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phlorisobutyrophenone; LC/ESI-MS, liquid chromatography/electrospray ionization-mass 
spectrometry; MW, molecular weight; RT, retention time; Q-TOF, quadrupole orthogonal time-
of-flight; µmol g
-1
 FW, µmol per gram of fresh weight tissue 
 
Introduction 
 Specialized phytochemicals provide complex defense strategies to combat insects, fungi, 
animals, or abiotic stressors, as well as attractants for pollination or dispersal.  Such 
phytochemicals encompass tremendous structural diversity, from terpene alkaloids as in Digitalis 
purpurea (Chappell 2008), to polyketide alkylamides as in Echinacea (Wu et al., 2009), to waxes 
and scents (Fatland et al., 2002; Klingauf et al., 2005).  Often, specialized metabolites are 
contained in discreet compartments. For example, peltate glands in the young leaves of sweet 
basil (Ocimum basilicum) accumulate monoterpenes (Iijima et al., 2004); 2-carene, α-terpinene, 
and limonene are concentrated in the glandular trichomes of tomato (Solanum lycopersicum) 
(Schilmiller et al. 2009); and the toxic dianthrone hypericin accumulates in nodular glands of H. 
perforatum (Piovan et al., 2004; Košuth et al., 2011).   
 Hypericum encompasses over 450 species, few of which have been chemically profiled 
(Crispin and Wurtele 2013), and is the largest genus within Clusiaceae, fossils of which date to 
the Late Cretaceous (90 million years ago) (Gustafsson et al., 2002).  H. perforatum (St. John‘s 
Wort) is commonly used by humans medicinally (Ernst, 2003; Birt et al., 2009).  Extracts of H. 
perforatum, when applied to bacterial, viral or animal systems, induce complex, context-
dependent changes to cellular and physiological functions.  Medicinally ―desirable‖ bioactivities 
include: anti-viral (Axarlis et al., 1998; Maury et al., 2009), anti-inflammatory (Hammer et al. 
2007), anti-depressive (Mennini and Gobbi 2004; Butterweck and Schmidt, 2007; Kasper et al., 
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2008), and anti-bacterial (Franklin et al., 2009; Saddiqe et al., 2010).  Furthermore, these 
compounds have been used to treat obsessive compulsive disorder (Camfield et al., 2011).  
 Potentially negative effects of H. perforatum include: cytotoxicity in HaCaT human 
keratinocytes (Schmitt et al., 2006); photosensitivity in mammals (Traynor et al., 2005; Onoue et 
al., 2011); decreased serum concentrations of anti-retroviral and anti-cancer pharmaceuticals in 
humans (De Maat et al., 2001; Caraci et al., 2011); and increased blood pressure and heart rate in 
humans taking MAOIs (Tachjian et al., 2010).   
 A single chemical compound in H. perforatum, the acylphloroglucinol hyperforin, is 
believed to be the source of the anti-depressive activity (Mennini and Gobbi, 2004; Brenner et 
al., 2000; Tu et al., 2010; Carpenter, 2011).  Hyperforin is also toxic to gram-positive bacteria 
(Reichling et al., 2001; Avato et al., 2004; Joray et al., 2011), has been shown to be a potential 
anticarcinogen (Schempp et al., 2002) and is an angiogenesis inhibitor (Schempp et al., 2005).  
Four less studied, acylphloroglucinols, saroaspidin A, saroaspidin B, uliginosin A, and uliginosin 
B have also been shown to have a variety of biological activities (Ishiguro et al., 1987; Rocha et 
al., 1995; Stein et al., 2012) 
 H. gentianoides (Orange grass, Pineweed), is a small annual that grows throughout the 
central and eastern United States and Canada (USDA Natural Resources Conservation Service 
http://plants.usda.gov/java/profile?symbol=HYGE).  Cherokee Native Americans used this plant 
to cure ailments as mild as nosebleeds and sores, and as severe as fever and venereal diseases 
(Hamel and Chiltoskey, 1975). Interestingly, neither hypericin nor hyperforin have been detected 
in this species (Crockett et al., 2005; Hillwig et al., 2008).  Overall, H. gentianoides has been 
characterized by a few studies of its biological activities (Hillwig et al., 2008; Huang et al., 2011) 
and in relation to its geographical distribution (Bliss et al., 2002). Despite lacking hypericin or 
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hyperforin, extracts from H. gentianoides, and non-polar fractions of these extracts that are 
highly enriched in putative acylphloroglucinols, have anti-inflammatory bioactivity in mouse 
macrophage cells (Hillwig et al., 2008).  H. gentianoides accumulates nine unusual specialized 
phytochemicals that have similar UVspectra, and are postulated to be acylphloroglucinols 
(Hillwig et al., 2008).  Three of these compounds have been identified as saroaspidin A, 
uliginosin A, and hyperbrasilol C by NMR (Hillwig, 2008).  
 Identifying the range of existing acylphloroglucinols and the routes to their synthesis will 
enhance our understanding of the development of diversity in biology, and inform the 
evolutionary origin of this branch of the polyketide pathway. In part because of their high-energy 
content and diverse chemical functionalities, polyketides in general provide a major potential as 
biorenewable chemicals to replace petroleum as a feedstock for polymer production (Nikolau et 
al., 2008; Oliver et al., 2009).  Acylphloroglucinol research has particular potential for practical 
application in medicinal venues. For example, given the complex effects of hyperforin and other 
acylphloroglucinols on cellular and viral function, the availability of a spectrum of 
acylphloroglucinols would better enable researchers to define structure-function relationships in 
humans and other animals.  
 Here, we determine the structures of the six previously unidentified major accumulating 
constituents in H. gentianoides as a monomeric and five dimeric acylphloroglucinols. We 
identify nine additional monomeric acylphloroglucinols that are implicated as precursors.  
Finally, we compare the accumulation patterns of these acylphloroglucinols between vegetative 
and reproductive phases of growth, and across two standardized accessions.   
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Results 
 
Liquid chromatography/electrospray ionization-mass spectroscopy (LC/ESI-MS)-based 
structural identification of nine acylphloroglucinols of H. gentianoides 
 H. gentianoides (accessions Ames 27657 and Ames 28015) has been shown to contain 
multiple metabolites with retention times, mass spectra, and distinctive three-peaked UV spectra 
indicative of acylphloroglucinols (Hillwig et al., 2008).  Three of these compounds (MWs 446 D, 
500 D, 554 D; ret times 23.418, 24.820, 24.993 min) have been previously identified in our lab 
as saroaspidin A, uliginosin A, and hyperbrasilol C (Hillwig, 2008).  These spectra were also 
compared to the 2-D NMR of the same compounds isolated from other species of Hypericum: 
saraospidin A, in H. japonicum (Ishiguro et al., 1987); uliginosin A, in H. uliginosum (Taylor 
and Brooker, 1969); and hyperbrasilol C, in H. brasilense (Rocha et al., 1995).  
 To further identify the chemical nature of the acylphloroglucinol-like compounds in H. 
gentianoides, plants of the accession PI 664838 were germinated from seeds, and grown in a 
greenhouse under natural plus supplemental light.  Shoots in the vegetative phase of 
development were harvested from 11 months old plants (Figure 1).  To minimize potential 
alteration or degradation of the polyketide constituents, we reduced the exposure of plant 
material and extracts to oxygen and Hypericum enzymes during pulverization, extraction and 
separation (Hillwig et al., 2008).  The methanolic extract was analyzed by HPLC-UV and 
LC/ESI-MS (Figures S1, S2).  
 HPLC-UV of the H. gentianoides methanolic extract shows nine non-polar compounds 
with the characteristic three-peaked UV spectra with maxima at 220, 300, and 350 nm, indicative 
of acylphloroglucinols (Figure S1).  Three of these nine compounds are saraospidin A, uliginosin 
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A, and hyperbrasilol C, based on molecular mass, retention time, UV spectra, molecular 
fragmentation products, and NMR (Hillwig, 2008).  The extract was analyzed by LC/ESI-MS 
tofurther determine the structures of the nine acylphloroglucinols observed at m/z‘s of 359, 497, 
445, 459, 513, 499, 553, 567. Table 1 shows fragment ions and retention times from each 
MS/MS spectrum, of which are shown in Figure S1.  Throughout this paper, there are several 
compounds that are newly identified, and do not have commonly used names; rather than make 
up a series of new names, these compounds will be referred to by abbreviations according to 
their chemical properties (Tables 1, 2). 
 MS/MS spectra, in negative ion mode, of H. gentianoides extract constituents saraospidin 
A, uliginosin A, and hyperbrasilol C indicate that the methylene bridge that connects the two 
decorated PIB molecules is the main fragmentation target (Table 1).  The six additional 
acylphloroglucinols in H. gentianoides detected by LC/ESI-MS, which had not been previously 
characterized, were identified based on the following criteria: the MS/MS spectra for a 
diacylphloroglucinol should reveal the m/z of the two decorated PIB molecules composing said 
diacylphloroglucinol.  For example, the MS/MS spectra in negative ion mode of hyperbrasilol C 
is composed of ions at 263, 277, and 289 m/z, corresponding to 3‘-prenyl-PIB (3‘prenPIB), 1‘-
prenyl-3‘-methyl-4‘-oxo-PIB (1‘pren3‘me4‘oxoPIB), and 1‘pren3‘me4‘oxoPIB with a methyl 
group fragment of the methylene bridge that connected the two monomers together, respectively. 
The fragmentation pattern of the three NMR identified compounds were used to establish an 
additional four compounds identity as: uliginosin B, 3,5-dihydroxy-4-isobutyryl-2-methyl-4-(3-
methylbut-2-enyl)-6-(2,4,6-trihydroxy-3-isobutyryl-5-methylbenzyl)cyclohexa-2,5-dienone, 
(abbreviated as [3‘mePIB]-[1‘pren3‘me4‘oxoPIB]); 3,5-dihydroxy-4-4-dimethyl-2-(2-
methylbutanoyl)-6-(2,4,6-trihydroxy-3-isobutyryl-5-(3-methylbut-2-enyl)benzyl)cyclohexa-2,5-
59 
 
dienone (abbreviated as [3‘3‘4me6‘oxoPIB]-[3‘prenPIB]); and 3,5-dihydroxy-2-methyl-4-(3-
methybut-2-enyl)-4-(2-methylbutanoyl)-6-(2,4,6-trihydroxy-3-isobutyryl-5-(3-methylbut-2-
enyl)benzyl)cyclohexa-2,5-dienone (abbreviated as [1‘pren3‘4me4‘oxoPIB]-[3‘prenPIB] ) 
(Table 1).  The compound at RT=23.761 min is a diacylphloroglucinol which could be either 
saroaspidin B or japonicin A; both compounds have the same molecular weight and MS/MS 
spectral pattern, and thus cannot be formally distinguished by MS/MS.  NMR analysis was not 
performed on this compound, or the other five previously unidentified acylphloroglucinols in H. 
gentianoides, because of the difficulty in obtaining purified compound necessary for 
crystallization.  Saroaspidin B is a dimer of a phloroglucinol moiety (3‘,4-dimethyl-PIB 
(3‘4mePIB), m/z=223) and a filicinic acid moiety (3‘,3‘-dimethyl-6‘-oxo-PIB (3‘3‘me6‘oxoPIB), 
m/z=223), while japonicin A is a dimer of two filicinic acid moieties (3‘3‘me6‘oxoPIB).  Given 
that the other seven diacylphloroglucinols in H. gentianoides are each heterodimers composed of 
one phloroglucinol moiety (3‘-methyl-PIB (3‘mePIB), 3‘4mePIB, 8-isobutyryl-2,2-dimethyl-
chromene-5,7-diol (8ib22meC57diol), 3‘prenPIB) and one filicinic acid moiety 
(3‘3‘me6‘oxoPIB, 3‘,3‘,4-trimethyl-6‘-oxo-PIB (3‘3‘4me6‘oxoPIB), 1‘pren3‘me4‘oxoPIB, 1‘-
prenyl-4,5‘-dimethyl-4-oxo-PIB (1‘pren3‘4me4‘oxoPIB), we view saroaspidin B as the more 
likely identity (Figure 2A).  The first-eluting compound of the nine major acylphloroglucinols in 
H. gentianoides has the typical characteristic acylphloroglucinol UV absorbance spectrum, 
eluted at 21.566 minutes, and has a molecular weight of 360 D, [M-H]
-
 ion at m/z 359.  This 
compound, unlike the other eight predominant acylphloroglucinols, should be a 
monoacylphloroglucinol, because the minimum weight possible for a diacylphloroglucinol is 404 
D.  A modification to 1‘pren3‘4me4‘oxoPIB, specifically a 3‘-prenylation as observed in 
3‘prenPIB, could account for a molecular weight of 360.  We predicted this compound to be 
60 
 
1‘,3‘-diprenyl-4,5‘-dimethyl-4‘-oxo-PIB (1‘3‘pren45‘me4‘oxoPIB).  Consistent with this 
interpretation, the MS/MS spectrum of this compound shows an intense fragmented ion at222 
m/z; an m/z of 222 corresponds to the core cyclic ring of this compound with 4 and 5‘ methyl 
groups but without 1‘ and 3‘ prenyl groups.  We also expected a peak at m/z=69 corresponding to 
the fragmented prenyl group.  However, possibly because of the low abundance of this ion 
(Table 1, Figure S2), we were unable to detect this peak through Q-TOF or LC. 
 One possible synthetic route for diacylphloroglucinols is that PIB is first decorated, 
followed by dimerization of the resultant monomer pool to form the diacylphloroglucinols.  In 
this case, eight acylphloroglucinol monomers (synthesized from PIB) would be sufficient to 
account for all of the H. gentianoidesdiacylphloroglucinols, as a variety of combinations can be 
made (exemplified in Figure 2A). Furthermore, if the ―monomer pool‖ biosynthetic route were 
correct, we might expect that there would be low levels of the eight acylphloroglucinol monomer 
precursors in H. gentianoides (Figure 2B).  
 An alternate process that could account for biosynthesis of the observed 
diacylphloroglucinols is that a single diacylphloroglucinol might be formed and decorated to 
form the other diacylphloroglucinols. If this ―diacylphloroglucinol decoration‖ route were 
correct, we would anticipate the presence of the precursors: partially decorated 
diacylphloroglucinols, and the fully undecorated dimer (di-PIB) (Figure 2C). 
 
Acylphloroglucinol accumulation differs between life phases and accessions of H. gentianoides 
 To facilitate detection of acylphloroglucinol precursors, which might be present at lower 
abundance or be more difficult to detect by the methods used, we wanted H. gentianoides 
material with high acylphloroglucinol concentrations and that was relatively easy to obtain.  To 
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evaluate which plant material might have higher levels of acylphloroglucinols, the concentrations 
of major acylphloroglucinols were compared under different conditions of plant growth.  For 
these analyses, we used accessions of H. gentianoides (Ames 27657 and PI 664838) whose seeds 
are being maintained within the US National Plant Germplasm System. 
 First, we determined whether acylphloroglucinol accumulation in H. gentianoides varied 
with the season of the year, using the greenhouse growth conditions we had previously 
established for optimal plant growth.  Under these conditions, supplemental light was used to 
create similar 12-hour daily photoperiods throughout the year.  To determine whether the season 
affected the level of accumulation of acylphloroglucinols, batches of H. gentianoides were 
planted at four-month intervals, allowed to grow six months, and vegetative shoots were 
harvested (harvests in February and June).  The growth and morphology of these greenhouse-
grown H. gentianoides plants was not visibly distinguishable, irrespective of the growth season.  
A comparison of acylphloroglucinol accumulation in February versus June is shown in Figure 
S3.  The slope of the regression between the two time points was 1.01 and an R-squared value of 
0.994.  Thus, under these growth conditions, both the development of the H. gentianoides and 
the relative concentrations of each of its predominant acylphloroglucinols are similar across 
these dates. 
 Relative concentrations of acylphloroglucinols in H. gentianoides accession PI 664838 
was compared at three stages of development (seedling, mature vegetative, and flowering 
reproductive) (Figures 1, 3A; Table S1).   Reproductive phase shoots (stem, leaves and flower 
buds) and vegetative phase shoots (stem and leaves) were harvested from plants that had both of 
these stages simultaneously.  Thus, levels of acylphloroglucinol accumulation were determined 
for vegetative and reproductive phase shoots from the same plants.  The vegetative phase shoots 
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accumulate higher amounts of all diacylphloroglucinols (p<1.9*10
-6
 to p<0.03) in µmol per gram 
fresh weight tissue (µmol g
-1
 FW) (Figure 3B); the least abundant major accumulating 
constituent, 1‘3‘pren45‘me4‘oxoPIB, is more than 10-fold higher in the vegetative phase 
(p<0.055).  
 Seedling shoots from the two standardized accessions Ames 27657 and PI 664838 were 
evaluated for acylphloroglucinols (Figure 3B; Table S1).  PI 664838 accumulated between 2 to 
7.5 fold higher amounts of each of the nine major acylphloroglucinols (p<0.0005 to p<0.039) 
than did Ames 27657.  The greater acylphloroglucinol accumulation in seedling shoots and in the 
mature vegetative shoots of PI 664838, together with the shorter time to harvest of seedlings, led 
us to use seedling shoots from accession PI 664838 for further identification of H. gentianoides 
acylphloroglucinols. 
 
Hybrid quadrupole orthogonal time-of-flight mass spectrometry (Q-TOF) detects PIB and eight 
other monoacylphloroglucinols  
 Determination of the complement of mono- and diacylphloroglucinols present in H. 
gentianoides could provide evidence for the biosynthetic route to the major accumulating 
acylphloroglucinols. Because LC/ESI-MS did not reveal potential diacylphloroglucinol 
intermediates, we chose a more sensitive method, hybrid quadrupole orthogonal time-of-flight 
mass (Q-TOF) spectrometry.  This method not only detects molecules that might be undetectable 
using LC/ESI-MS, but also yields precise data on mass (up to 10
-4
 of a dalton).   
 To experimentally determine whether the eight acylphloroglucinol monomers that we 
postulated to be precursors of the diacylphloroglucinols in H. gentianoides are actually present in 
that species, high diacylphloroglucinol-accumulating seedlings of PI 664838 were extracted in 
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methanol, and these extracts were diluted with 5 mM ammonium acetate in 
CHCl3:MeOH:IPAand analyzed by Q-TOF.  All nine of the acylphloroglucinols detected by 
LC/ESI-MS (Table 1) were also detected by Q-TOF spectrometry (Table 2).  
Q-TOF spectrometry also showed compounds that could not be detected by LC/ESI-MS. 
 Notably, molecular weights and empirical formulas corresponding to all eight of the 
monoacylphloroglucinols that could explain synthesis of the H. gentianoides major accumulating 
acylphloroglucinols were identified, as was the precursor PIB and two putative partially 
decorated dimers (Figure 2).  To provide additional evidence as to the identity of the putative 
monomers and partially decorated dimers, we employed Q-TOF-MS/MS on these masses (Figure 
S4).  Because of the low abundance of MS/MS fragmentation ions at m/z values corresponding to 
the predicted monomers 3‘4mePIB and 8ib22meC57diol, these two compounds were not 
included in this analysis.  Using MS/MS itself does not positively identify these compounds, 
however, we have been able to leverage NMR data from saroaspidin A and hyperbrasilol C, 
which are composed of monomers 3‘mePIB, 3‘3‘me6‘oxoPIB, 3‘prenPIB, and 
1‘pren3‘me4‘oxoPIB collectively (Ishiguro et al. 1987, Rocha et al. 1996; Hillwig 2008), for the 
identification.  Our MS/MS analyses indicate the methylene bridge is the primary fragmentation 
target, yielding 3‘mePIB and 3‘3‘me6‘oxoPIB from saroaspidin A as well as 3‘prenPIB and 
1‘pren3‘me4‘oxoPIB from hyperbrasilol C.  These ions were each fragmented again, and Q-
TOF-MS/MS/MS was employed to identify the fragmentation patterns of 3‘mePIB, 
3‘3‘me6‘oxoPIB, 3‘prenPIB, and 1‘pren3‘me4‘oxoPIB.  These, in turn, were directly compared 
to the Q-TOF-MS/MS profiles corresponding to the predicted 3‘mePIB, 3‘3‘me6‘oxoPIB, 
3‘prenPIB, and 1‘pren3‘me4‘oxoPIB.  Identical fragmentation patterns confirm that the Q-TOF-
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MS derived masses are indeed 3‘mePIB, 3‘3‘me6‘oxoPIB, 3‘prenPIB, and 1‘pren3‘me4‘oxoPIB 
(Figure 4, Table 3).   
 MS/MS analysis of these monomers indicates an isobutane is fragmented from the 
isobutyryl group in 3‘mePIB, 3‘3‘me6‘oxoPIB, 3‘prenPIB, and 1‘pren3‘me4‘oxoPIB.  This is 
the only fragmentation, with the exception of the molecular ion, present in MS/MS spectra of 
3‘mePIB, and 3‘3‘me6‘oxoPIB.  MS/MS spectra for 3‘prenPIB have four ions present at 
m/z=151, 194, 219, and 263 (the molecular ion).  The ion at 151 m/z corresponds to 
fragmentation of the isobutane and prenyl group, while 194 m/z corresponds to fragmentation of 
only the prenyl group, and 219 m/z is a fragmentation of only the isobutane.  MS/MS spectra of 
1‘pren3‘me4‘oxoPIB follow the same pattern of fragmentation as 3‘prenPIB, in which the 
isobutyl and prenyl groups are the primary target, yielding ions at 166, 208, and 233 m/z (Figure 
S4). We cannot identify 3‘4mePIB, 3‘3‘4me6‘oxoPIB, 8ib22meC57diol, or 
1‘pren3‘4me4‘oxoPIB with as great a certainty as 3‘mePIB, 3‘3‘me6‘oxoPIB, 3‘prenPIB, and 
1‘pren3‘me4‘oxoPIB, but the ion at m/z=291 is likely 1‘pren3‘4me4‘oxoPIB, given the primary 
fragmentation ion of this compound is at m/z=222, exactly the same mass as seen in MS/MS 
spectra of 1‘3‘pren45‘me4‘oxoPIB.  This is expected given m/z=222 would correspond to a 
fragmentation of one prenyl group from 1‘pren3‘4me4‘oxoPIB and two fragmented prenyl 
groups from 1‘3‘pren45‘me4‘oxoPIB.  Suggestive MS/MS spectra for 1‘pren3‘4me4‘oxoPIB 
along with the confirmed presence of 3‘mePIB, 3‘3‘me6‘oxoPIB, 3‘prenPIB, and 
1‘pren3‘me4‘oxoPIB indicate the m/z do indeed correspond to the monomers.  The monomers 
that we observed were probably not detected in previous studies of Hypericum spp that contain 
diacylphloroglucinols (Taylor et al. 1969, Ishiguro et al. 1987, Rocha et al. 1996, Huang et al. 
2011) because of the detection method or their lower abundance.  Also identified by Q-TOF-
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MS/MS were the partially decorated dimers [3‘3‘me6‘oxoPIB]-[PIB] and 
[1‘pren3‘me4‘oxoPIB]-[PIB] (Table 3, Figure 2C).  These partially decorated dimers are 
fragmented at the methylene bridge in the same way as observed for the fully decorated dimers; 
yielding fragmentation ions at 195 and 223 m/z for [3‘3‘me6‘oxoPIB]-[PIB] and 195 and 277 
m/z for [1‘pren3‘me4‘oxoPIB]-[PIB].  
 
Discussion    
 The mono- and diacylphloroglucinols thus far identified from Hypericum spp.display a 
wealth of structural variety (Avato et al., 2004; Gibbons et al., 2005; Manning et al., 2011).  
These compounds have also been demonstrated to induce a diversity of bioactivities when 
applied to other organisms (Schempp et al., 2002; Avato et al., 2004; Mennini et al., 2004; 
Beerhues, 2006; Hillwig et al., 2008; Henry et al., 2009; Saddiqe et al., 2010; Wang et al., 2011; 
Stein et al., 2012; Zaher et al., 2012).  Hyperforin, a monoacylphloroglucinol of St. John‘s Wort, 
has been the center of the study for bioactive acylphloroglucinols.  However, this popular 
medicinal species does not contain any diacylphloroglucinols.   This has not stopped the surge 
towards understanding the biological activities of diacylphloroglucinols.  For example, 
Uliginosin B has been shown to have anti-depressive effects when given to mice before a forced 
swim stress test (Stein et al., 2012).  While saroaspidin A, B, uliginosin A, B, and hyperbrasilol 
C, have been shown to have anti-bacterial activity properties in Staphylococcus aureus, and 
Bacillus cereus assays (Ishiguro et al., 1987; Rocha et al., 1995; Rocha et al., 1996; 
Winkelmann, 2001; Franҫa and Kuster, 2009).  Diacylphloroglucinols also show variability with 
respect to a given activity.  For example, saroaspidin A is active in anti-inflammatory assays 
with mouse macrophage cells, while uliginosin A has little activity (Hillwig et al., 2008).  The 
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multiple bioactive effects, combined with the specificity of the action of individual 
acylphloroglucinols, emphasize the scope of potential medical applications for these compounds.  
 The major acylphloroglucinols of H. gentianoides are a single monoacylphloroglucinol 
and eight diacylphloroglucinols.  Three of the diacylphloroglucinols, [3‘mePIB]-
[1‘pren3‘me4‘oxoPIB], [3‘3‘4me6‘oxoPIB]-[3‘prenPIB], [1‘pren3‘4me4‘oxoPIB]-[3‘prenPIB], 
had not been previously described in any species. Identifying the acylphloroglucinol constituents 
of in H. gentianoides is a prerequisite to deciphering the pathways by which they are 
biosynthesized.  Ultimately, such data will be critical for identifying the primary sequences and 
three-dimensional structures of enzymes and regulatory proteins that control this pathway, and 
will provide an important step towards understanding that pathway in the context of its evolution 
(Schmidt et al., 2003; O‘Maille et al., 2008; Ngaki et al., 2012). 
 From an applied aspect, the determination of the chemical nature of Hypericum 
polyketide constituents is important for those who use extracts of this genus as medical 
supplements.  Furthermore, the availability of a wide variety of acylphloroglucinols will provides 
researchers with tools to investigate the mechanisms by which members of this class of 
compounds affect other organisms, and to dissect the enzymes and regulatory factors that lead to 
these compounds in plants. This information sets the stage for genetic engineering of custom 
acylphloroglucinols (Crispin and Wurtele, 2013; http://www.metnetdb.org/pmr/) and other 
polyketides, which is significant because of the potential medicinal applications. 
Virtually nothing had been reported previously about the pathway leading to the biosynthesis of 
diacylphloroglucinols.  Here, we combine previous knowledge and our new understanding of the 
acylphloroglucinols in H. gentianoides to propose a pathway leading to the biosynthesis of 
diacylphloroglucinols (Figure 5) and describe a potential mechanism for dimerization (Figure 6).  
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 Biosynthesis of the monoacylphloroglucinol hyperforin in H. perforatum is becoming 
better understood (Beerhues, 2003; Soelberg et al., 2007; Karppinen, 2010) and provides a 
possible template for the initial steps of diacylphloroglucinol biosynthesis (Figure 5).  PIB could 
be derived from either pyruvate or valine in H. perforatum (Adam et al., 2002).  Isotopically 
labeled L-[U-
13
C6]-valine was preferentially incorporated into the acyl chain of hyperforin in 
liquid cultures of 12 day old H. perforatum, indicating that valine is likely the major precursor 
under this condition (Karppinen, 2010).  In H. perforatum, PIB is an intermediate of hyperforin 
(Paniego et al., 1999; Adam et al., 2002; Soelberg et al., 2007; Karppinen, 2010) via its 
prenylation to form 3‘prenPIB  (Adam et al., 2002; Karppinen et al., 2007).  Presumably the 
early pathway to acylphloroglucinols is common among Hypericum spp; consistent with this 
supposition, we identified PIB and 3‘prenPIB in H. gentianoides. Either of two processes could 
yield the array of diacylphloroglucinols present in H. gentianoides.  1) PIB monomers might be 
decorated, and the pool of decorated monomers then dimerized (decoration of monomer pool); 
and/or 2) PIB monomers might be dimerized and then the dimers might be further modified 
(decoration of dimers) 
 Our observations, taken together, indicate that the synthesis of diacylphloroglucinols 
likely occurs via a pool of decorated monomers (Figure 5).  PIB and eight other 
monoacylphloroglucinols, each a derivative of PIB, were detected in H. gentianoides.  The H. 
gentianoides monomers, in different combinations, would exactly explain the presence of each of 
the diacylphloroglucinols.  Thus, the particular complement of acylphloroglucinol monomers 
supports the ―monomer pool‖ concept, in which the monomers are first decorated and then 
dimerized.  We could not detect any completely undecorated dimers, nor six of the eight partially 
decorated dimers that would be expected if diacylphloroglucinol biosynthesis occurred by a 
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process in which an ―undecorated‖ acylphloroglucinol dimer is biosynthesized, followed by a 
stepwise derivatization.  We did, however, detect low concentrations of two of the eight partially 
decorated dimers, that would be anticipated if the ―decoration of dimers‖ process took place, 
[3‘3‘me6‘oxoPIB]-[PIB] and [1‘pren3‘me4‘oxoPIB]-[PIB].  The presence of substantial 
concentrations of 1‘3‘pren4‘5‘me4‘oxoPIB lends further support for the ―monomer pool‖ 
concept.  This acylphloroglucinol is detectable through every method we have tested, and is not 
able to be dimerized as the available carbons are derivatized.  It would be rather convoluted to 
consider that, as would be predicted by the decoration of dimer model, the plant would first 
dimerize two PIB molecules, decorate them, break them apart, and then prenylate the fragmented 
half as would be necessary to synthesize this monoacylphloroglucinol.  The idea that one 
monomer becomes fully decorated and thus accumulates as such, as would be predicted by the 
decoration of monomer pool model, is much more direct. 
 A notable difference between hyperforin and diacylphloroglucinol biosynthesis is the 
creation of a methylene bridge in diacylphloroglucinols.  There is no reported mechanism 
describing this reaction, however, the mechanism for EC 1.21.3.3, which forms a methylene 
bridge during the formation of (S)-scoulerine from (S)-reticuline (Kutchan and Dittrich, 1995), 
has been described.  EC 1.21.3.3 has features in common with the dimerization of 
acylphloroglucinols, as both involve formation of a methylene bridge between two phenolic 
rings.  Applying the EC 1.21.3.3 mechanism to diacylphloroglucinol formation, the enzymatic 
synthesis of a methylene bridge between two PIB molecules could proceed as shown in Figure 6. 
 In summary, we characterize the mono- and diacylphloroglucinols of H. gentianoides, 
and describe their accumulation in different biological accessions and developmental stages. The 
data is deposited in the public PMR metabolomics database (http://metnetdb.org/PMR/; Hur et 
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al., 2013), enabling accessibility and extension by the research community. The data lead us to 
propose a network for acylphloroglucinol biosynthesis in which PIB is decorated to yield the 
observed monomers, followed by condensed in various combinations, giving rise to the observed 
major constituents.  These data enhance our understanding of the diversity of this medicinal 
species, and set the stage for characterization of the genes and enzymes involved in 
acylphloroglucinol metabolism.   
 
Materials and Methods 
 
Plant material   
            Hypericum gentianoides germplasm (as seeds), accessioned in the US National 
Germplasm System as PI 664838 (and for studies in Figure 3A, Ames 27657), was obtained 
from the USDA North Central Regional Plant Introduction Station, Ames, Iowa.  Accession PI 
664838 of H. gentianoides provides the advantage that both vegetative and reproductive 
developmental phases are present on a given plant simultaneously under the growth conditions 
used in this study. For determinations of relative concentrations of acylphloroglucinols across 
shoot (leaf and stem, with flower buds for reproductive stage) material, plants were grown in 
randomized block design.  Seeds were planted in a growing medium (Sunshine LC1 SUN-COIR, 
Sun Gro Horticulture, Canada) in a greenhouse with natural light supplemented by an 8/16 hr 
photoperiod at 120 μmol m-2 s-1, in temperatures between 19-25 degrees Celsius. Plants were 
watered daily, and fertilized bi-weekly.  During each harvest, samples were collected beginning 
at 11 am. Vegetative shoots and reproductive shoots that had differentiated but had not begun to 
flower were collected from individual plants in triplicate (approximately 5-8 shoots per 
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biological replicate).  In experiments to evaluate seasonal variation, H. gentianoides seeds were 
planted in the greenhouse under the conditions described at four-month intervals, and grown 6 
months, and harvested. (Plantings in September and January; harvests in February and June) 
Plant samples were placed in a 1.5 mL Eppendorf tubes, and immediately stored in liquid 
nitrogen to minimize degradation of polyketides. Samples were kept in liquid nitrogen until they 
were extracted.  
 
Preparation of extracts 
 Before extraction of each sample, liquid nitrogen was allowed to evaporate; then, the 
plant material was weighed without thawing and placed in a liquid nitrogen cooled mortar.  10 
µL of apigenin in methanol at a concentration of 1 mg/mL was added to each sample as an 
internal standard.  More liquid nitrogen was added to prevent thawing, and the mixture was 
finely ground with a pestle.  2 mL of methanol was added, the mixture was further ground, and 
then vortexed for 30 s, and centrifuged at 13,000 rpm for 2 min.  The supernatant was decanted, 
filtered through a 0.45 micron nylon syringe filter, and the filtrate was placed under nitrogen gas 
to minimize oxidation of compounds that might be present at low concentrations and detected by 
mass spectrometry but not by a UV detector.  Extracts were stored in a -80°C freezer until 
analysis.  
 
High pressureliquid chromatography (HPLC) 
 HPLC conditions resembled those of Hillwig et al. (2008). A Beckman Coulter Gold 
HPLC System (Fullerton, CA) with a Detector 168 photo diode array detector was used for 
determination of metabolite levels.  A Synergi Max-RP 4 micron 150 x 4.6 mm column 
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(Phenomenex, Torrance, CA 90501) was used for separation.  A 10 mM ammonium acetate 
(solvent A) and 9:1 v/v acetonitrile/methanol (solvent B) mobile phase was used.  The gradient 
consisted of 87% A/13% B in 10 min to 83% A/17% B, then to 100% B in 25 min and held for 5 
min.  The flow rate was 1.0 mL/min, the solvent gradient and flow rate was initially described by 
(Ganzera et al. 2002).  All solvents and the apigenin internal standard used were HPLC grade 
(Sigma, St. Louis, MO).  
 
Liquid chromatography/electrospray ionization-mass spectrometry (LC/ESI-MS) 
 Samples were placed under nitrogen gas to minimize oxidation of low-accumulating 
compounds that might be detected by mass spectrometry but not by a UV detector. An Agilent 
Technologies Ion Trap 1100 was used for LC/ESI-MS analysis. Analytical separation was 
accomplished using a Synergi Max-RP 4 micron 150 × 4.6 mm column (Phenomenex, Torrance, 
CA 90501) with a 10 mM ammonium acetate (solvent A) and 9:1 v/v acetonitrile/methanol 
(solvent B) mobile phase, with a gradient from 85% A/15% B to 80% A/20% B over a 10 min 
time, to 100% B over 25 min, and held at 100% B for 5 minutes.  The flow rate was 0.75 
mL/min.  All solvents were HPLC grade (Sigma, St. Louis, MO).  This LC/ESI-MS analysis 
detected the nine final acylphloroglucinolsbut only two of eight precursors. 
 
Metabolite quantification based on an internal standard 
 The relative concentrations of the acylphloroglucinols were quantified using HPLC- 
photo diode array UV, against 0.05 g (185.020 μmol) of apigenin (MW 270.24) as internal 
standard.  Apigenin was added at the time of extraction to each biological replicate.  Extracts 
derived from three independent biological replicates for each sample were analyzed, data 
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normalized, converted to a relative scale of nmol based on the apigenin standard, and further 
normalized by dividing μmol of compound by the fresh weight of the plant material (μmol g-1 
FW). 
 
Q-TOF mass spectrometry and spectral interpretation 
 High resolution mass spectrometric analysis was performed on a hybrid quadrupole 
orthogonal time-of-flight mass spectrometer (Waters SYNAPT G2 HDMS, Manchester, U.K.) 
equipped with an automatic chip-based nanoelectrospray source NanoMate HD (Advion 
BioSciences, Ithaca, NY). Ionization voltage was set to 1.09 kV, gas pressure to 1.45 psi in the 
negative-ion mode, and the source was controlled by Chipsoft 8.3.1 software (Advion 
BioSciences). All samples were diluted with 5 mM ammonium acetate in CHCl3:MeOH:IPA 
(1:2:4, v/v/v) and infused. The system was equipped with an integral Advion LockSpray unit 
with its own reference sprayer that was controlled automatically by the acquisition software to 
collect a reference scan every 10 s, for 1 s.  Reference internal calibrant (leucine enkephalin) was 
introduced into the lock mass sprayer at a constant flow rate of 3 μL/min using an internal pump 
connected to the LockSpray. A single lock mass calibration at m/z 554.2615 in the negative-ion 
mode was used for the complete analysis.  Spectral interpretation was performed with 
MassLynx
TM
 v.4.1 Mass Spectrometry Software (Waters Co., Milford, MA, USA). After peak 
picking, elemental formulas were calculated and assigned on the basis of m/z values within a 6 
ppm error range. Standard conditions for plant metabolomics data (Cc HhOo , c ≤ 500, h ≤ 1000, 
o ≤20; -1.5 ≤ Double Bond Equivalent ≥ 50.0) were used in these calculations.  
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Table 1- Molecular and MS/MS ions of acylphloroglucinols from H. gentianoides using 
LC/ESI-MS.   Blue, metabolites identified for the first time in this study.  Rust, identified in H. 
gentianoides (this study) and other Hypericum species 
Relative Retention 
Time (min) 
Abbreviation/common name m/z Fragment Ions 
21.566  1‘3‘pren45‘me4‘oxoPIB 359 222 
23.32  Uliginosin B 497 223, 235, 261 
23.418  Saroaspidin A 445 209, 223, 235 
23.791  Saroaspidin B 459 223, 235 
24.090  [3‘mePIB]-[1‘pren3‘me4‘oxoPIB] 499 209, 221, 277, 289 
24.510 [3‘3‘4me6‘oxoPIB]-[3‘prenPIB] 513 237, 249, 263, 275 
24.820 Uliginosin A 499 223, 235, 263, 275 
24.993 Hyperbrasilol C 553 263, 277, 289 
25.265 [1‘3‘pren45‘me4‘oxoPIB]-
[3‘prenPIB]  
567 263, 291, 303 
a
 LC/ESI-MS analysis. Molecular ions measured in negative-ion mode. Vegetative phase shoots 
from 11-month-old plants of H. gentianoides accession PI 664838.  RT, retention time.  
b
Saroaspidin B and japonicin A have the same MW and MS/MS spectra and cannot be formally 
distinguished by our analysis.  Japonicin A is a homodimer of two filicinic acid moieties, while 
saroaspidin B is a heterodimer.  Because the other seven diacylphloroglucinols are heterodimers 
of a phloroglucinol and filicinic acid moiety we believe saroaspidin B to be the more likely 
compound. 
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Table 2- Molecular ions, predicted empirical formulas, and designations of acylphloroglucinols 
and their putative precursors present in H. gentianoides, as identified by high-resolution Q-TOF 
mass analysis.  Blue, metabolites identified for the first time in this study.  Rust, identified in H. 
gentianoides (this study) and other Hypericum species. 
 
Relative 
Abundance 
(μmol g-1 FW)* 
Predicted 
m/z 
Measured 
m/z 
Predicted 
Empirical 
Formula 
Mass 
Difference 
(ppm) 
Systematic Name Compound Abbreviation/ 
Common Name 
.0706 195.07 195.0657 C10 H11 O4  0.0 2’,4’,6’-trihydroxy-
isobutyrophenone 
PIB/Phlorisobutryophenone 
1,2, 
this study
 
.3844 209.08 209.0816 C11 H13 O4  1.0 3’-methyl-
phlorisobutyrophenone 
3’mePIB thisstudy 
.3516 223.10 223.0972 C12 H15 O4  0.9 3’,3’-dimethyl-6’-oxo-
phlorisobutyrophenone 
or 3’4-dimethyl-
phlorisobutyrophenone 
3’3’me6’oxoPIB or 
3’4mePIBthisstudy 
.0756 237.11 237.1128 C13 H17 O4  0.4 3’,3’,4-trimethyl-6’-oxo-
phlorisobutyrophenone 
3’3’4me6’oxoPIBthisstudy 
.0693 261.11 261.1219 C15 H17 O4  --- 8-isobutyryl-2,2-
dimethyl-chromene-5,7-
diol 
8ib22meC57diol
thisstudy
 
.5344 263.13 263.1285 C15 H19 O4  0.8 3’-prenyl-
phlorisobutyrophenone 
3prenPIB
 4, this study
 
.4525 277.14 277.1442 C16 H21 O4  0.7 1’-prenyl-3’-methyl-4’-
oxo-
phlorisobutryophenone 
1’pren3’me4’oxoPIBthisstudy 
.0429 291.16 291.0848 C17 H23 O4  --- 1’-prenyl-3’,4-dimethyl-
4’-oxo-
phlorisobutyrophenone 
1’pren3’4me4’oxoPIBthisstudy 
.0403 359.22 359.0747 C22 H31 O4  --- 1’,3’-diprenyl-4,5’-
dimethyl-4’-oxo-
phlorisobutyrophenone 
1’3’pren45’me4’oxoPIBthisstudy 
.7890 445.18 445.1862 C24 H29 O8  0.0 3,5-dihydroxy-2-
isobutyryl-4,4-dimethyl-
6-(2,4,6-trihydroxy-3-
isobutyryl-5-
methylbenzyl)cyclohexa
-2,5-dienone 
Saroaspidin A
 2, 5, this study
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Table 2. Continued 
.2344 
 
459.20 459.2019 C25 H31 O8  0.0 3,5-dihydroxy-2-
isobutyryl-4,4-dimethyl-
6-(2,4,6-trihydroxy-3-
methyl-5-(2-
methylbutanoyl)benzyl)
cyclohexa-2,5-dienone 
Saroaspidin B
 2, this study
 
.0706 
 
497.22 497.2226 C28 H33 O8 -1.6 2-((5,7-dihydroxy-8-
isobutyryl-2,2-dimethyl-
2H-chromen-6-
yl)methyl)-3,5-
dihydroxy-6-isobutyryl-
4,4-dimethylcyclohexa-
2,5-dienone    
Uliginosin B 
1, 6, this study
 
.0416 
 
499.23 499.0497 C28 H35 O8  --- 3,5-dihydroxy-4-
isobutyryl-2-methyl-4-
(3-methylbut-2-enyl)-6-
(2,4,6-trihydroxy-3-
isobutyryl-5-
methylbenzyl)cyclohexa
-2,5-dienone 
[3’mePIB]-
[1’pren3’4me4’oxoPIB] this study 
3.437 499.23 499.2330 C28 H35 O8 -0.4  3,5-dihydroxy-2-
isobutyryl-4,4-dimethyl-
6-(2,4,6-trihydroxy-3-
isobutyryl-5-(3-
methylbut-2-
enyl)benzyl)cyclohexa-
2,5-dienone 
Uliginosin A 
1, 5, this study
 
.5092 
 
513.25 513.2330 C29 H37 O8 -1.0 3,5-dihydroxy-4,4-
dimethyl-2-(2-
methylbutanoyl)-6-
(2,4,6-trihydroxy-3-
isobutyryl-5-(3-
methylbut-2-
enyl)benzyl)cyclohexa-
2,5-dienone 
[3’3’4me6’oxoPIB]-
[3’prenPIB] this study 
2.103 553.28 553.2800 C32 H41 O8 -0.2 3,5-dihydroxy-4-
isobutyryl-2-methyl-4-
(3-methylbut-2-enyl)-6-
(2,4,6-trihydroxy-3-
isobutyryl-5-(3-
methylbut-2-
enyl)benzyl)cyclohexa-
2,5-dienone 
Hyperbrasilol C 
3, this study
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Table 2. Continued 
.0756 567.29 567.2965 C33 H43 O8  1.2 3,5-dihydroxy-2-
methyl-4-(3-methylbut-
2-enyl)-4-(2-
methylbutanoyl)-6-
(2,4,6-trihydroxy-3-
isobutyryl-5-(3-
methylbut-2-
enyl)benzyl)cyclohexa-
2,5-dienone 
[1’3’pren45’me4’oxoPIB]-
[3’prenPIB]  this study 
*
 Relative abundance based on an apigenin internal standard. 
 1
Taylor and Brooker, 1969; 
2
Ishiguro et al., 1987; 
3
Rocha et al., 1996; 
4
Adam et al., 2002; 
5
Huang et al., 2011; 
6
Stein et al., 
2012.  Abbreviation: phloroisobutyrophenone=PIB; methyl=me; pren=prenyl; oxo=oxo; 
ib=isobutyryl; C=chromene   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
Table 3- Molecular ions and MS/MS of putative monomers and partially decorated 
diacylphloroglucinols from H. gentianoides detected using Q-TOF.  With the exception of 
3‘3‘4me6‘oxoPIB and 1‘pren3‘me4‘oxoPIB, an isobutane is fragmented from the isobutyl group 
on all monomers.  MS/MS of 3‘prenPIB and 1‘pren3‘me4‘oxoPIB show a fragmentation on the 
prenyl group as well.  3‘4mePIB and 8ib22meC57diol are not shown due to low ion abundance.  
The partially decorated dimers (3‘3‘me6‘oxoPIB and PIB and 1‘pren3‘me4‘oxoPIB and PIB) are 
fragmented at the methylene bridge connecting them, similar to what is observed in the full 
decorated dimers.  Blue, metabolites identified for the first time in this study.  Rust, identified in 
H. gentianoides (this study) and other Hypericum species 
Compound Abbreviation m/z Fragment Ions (m/z) 
PIB 195 111, 151 
3‘mePIB 209 165, 209 
3‘3‘me6‘oxoPIB 223 179, 223 
3‘3‘4me6‘oxoPIB 237 193, 237 
3‘prenPIB 263 151, 194, 219, 263 
1‘pren3‘me4‘oxoPIB 277 166, 208, 233 
1‘pren3‘4me4‘oxoPIB 291 222 
[3‘3‘me6‘oxoPIB]-[PIB] 431 195, 223 
[1‘pren3‘me4‘oxoPIB]-[PIB] 485 195, 277 
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Figure 1- Developmental phases of H. gentianoides life cycle.  In some accessions of H. 
gentianoides, including PI 664838, both vegetative and reproductive phases often occur 
concurrently on a single plant. 
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Figure 2- Diacylphloroglucinols in Hypericum gentianoides 
A) Each diacylphloroglucinol identified in H. gentianoides (see Table 1) is composed of one 
phloroglucinol and one filicinic acid; many of these diacylphloroglucinols share a common 
phloroglucinol or filicinic acid.  For example, Saroaspidin A, Saroaspidin B, Uliginosin A, and 
Uliginosin B, all share the filicinic acid 3‘,3‘-dimethyl-6‘-oxo-phlorisobutyrophenone 
(3‘3‘me6‘oxoPIB). 
B) Four PIB derivatives from H. gentianoides identified by Q-TOF.  Methylation and/or 
prenylation of PIB would give rise to each of these compounds. Additional methylation and/or 
cyclization of the resultant compounds would give rise to four more monomers, creating a pool 
of eight monomers sufficient to explain the synthesis of all nine highly accumulated 
acylphloroglucinols, without any post-dimerization modifications.  
C) Nine diacylphloroglucinols would be possible if diacylphloroglucinol biosynthesis occurred 
via a ―diacylphloroglucinol decoration‖ route.  In black are compounds that were identified 
through our Q-TOF analyses, in red are compounds that were not detected in our Q-TOF analysis 
of H. gentianoides extracts.  The fully undecorated dimer (diPIB), and six of the eight partially 
decorated dimers that would be required if synthesis followed the ―diacylphloroglucinol 
decoration‖ route were not detected.  We assume the two partially decorated dimers present in H. 
gentianoides are 1) degradation products of diacylphloroglucinol end products or 2) products 
resulting from dimerization of a decorated monomer to a PIB molecule. 
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Figure 3- Accumulation of acylphloroglucinols in Hypericum gentianoides varies with 
developmental stage and accession.  HPLC analysis was used for relative quantification of the 
nine major acylphloroglucinol metabolites.  Three biological replicates were used for each 
sample. Data is analyzed and visualized inthe interactive Plant Metabolomics Resource 
(www.metnetdb.org/pmr).  Complete data is shown in Table S1.  Volcano plots illustrates a 
comparison of two of the most diverse materials. In this plot, the Y-axis represents the p-value 
(lower p-values indicate a more significant difference); the X-axis represents the fold change (the 
farther from 1, the greater the fold-change).  p-values are determined using a student T-test after 
log (base 2) transformation.  1-1‘3‘pren45‘me4‘oxoPIB; 2-Uliginosin B; 3-Saroaspidin A; 4-
Saroaspidin B; 5-[3‘mePIB]-[1‘pren3‘me4‘oxoPIB]; 6-[3‘3‘4me6‘oxoPIB]-[3‘prenPIB]; 7-
Uliginosin A; 8-Hyperbrasilol C; 9-[1‘3‘pren45‘me4‘oxoPIB]-[3‘prenPIB]  
(a) Accumulation of 9 major acylphloroglucinols is between 2-7.5 fold greater in young 
seedlings of standardized accession PI 664838 compared to Ames 27657 young seedlings. (n=3, 
p values range from 0.0009 to 0.05) 
(b) Accumulation of 9 major acylphloroglucinols (is between 1.7-10.9 fold greater in vegetative 
phase shoots than in reproductive phase shoots (preflowering) in the standardized accession PI 
664838). (n=3, p values range from 1.9*10
-6
 to 0.03) 
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Figure 4- Q-TOF-MS/MS/MS of H. gentianoides extract to validate the identity of the predicted 
monomers of Table 2.  The fragmentation pattern corresponding to 3‘mePIB, 3‘3‘me6‘oxoPIB, 
3‘prenPIB, and 1‘pren3‘me4‘oxoPIB was compared to that of the previously identified 
uliginosin A, saroaspidin A, and hyperbrasilol C.  Identical fragmentation patterns indicate that 
these masses in fact correspond to these four monomers and not any other isomer.  MS/MS 
spectra at the molecular weights of the putative monomers 3‘3‘4me6‘oxoPIB and 
1‘pren3‘4me4‘oxoPIB were analyzed (Table 3).  None of the previously identified 
acylphloroglucinols contain either of these two monomers.  Therefore these fragmentation 
patterns are consistent with the presence of 3‘3‘4me6‘oxoPIB and 1‘pren3‘4me4‘oxoPIB in H. 
gentianoides.   
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Figure 5- Acylphloroglucinols in Hypericum gentianoides as detected by Q-TOF-MS, Q-TOF-
MS/MS and LC/ESI-MS analysis and a postulated biosynthetic network.  All 
acylphloroglucinols involved in the biosynthesis of the nine acylphloroglucinol products are 
shown in this schematic. Valine and possibly pyruvate are likely primary metabolite precursors 
of acylphloroglucinols in H. perforatum (Karppinen 2010). Q-TOF and LC/ESI analysis 
indicates that H. gentianoides contains PIB and PIB derivatives that are decorated by prenylation 
or methylation, or are cyclized (in the case of 8ib22meC57diol).  Every acylphloroglucinol dimer 
in H. gentianoides can be accounted for as a dimerization product of one of the detected 
phloroglucinol monomers and one of the detected filicinic acid monomers.  Thus, the 
complement of monomers in H. gentianoides is consistent with the concept that monomers are 
first decorated and then dimerized to yield the diacylphloroglucinols .  Blue, metabolites 
identified for the first time in this study; rust, identified in H. gentianoides (this study) and other 
Hypericum species (see Table 2). Hyperforin (grey) accumulates in H. perforatum (Soelberg et 
al. 2007).PIB* and 3‘prenPIB* are postulated to be a hyperforin precursor in H. perforatum 
(Adam et al. 2002).  [1]=3‘mePIB, [2]=3‘4mePIB, [3]=3‘3‘me6‘oxoPIB, [4]=3‘3‘4me6‘oxoPIB, 
[5]=8ib22meC57diol, [6]=3‘prenPIB, [7]=1‘pren3‘me4‘oxoPIB, [8]=1‘pren3‘4me4‘oxoPIB, 
[9]=1‘3‘pren45‘me4‘oxoPIB, [10]=[3‘mePIB]-[1‘pren3‘me4‘oxoPIB], 
[11]=[3‘3‘4me6‘oxoPIB]-[3‘prenPIB], [12]=[1‘pren3‘4me4‘oxoPIB]-[3‘prenPIB] 
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Figure 6- Proposed mechanism of methylene bridge formation in diacylphloroglucinol 
biosynthesis.  The formation of a diacylphloroglucinol from two monoacylphloroglucinols 
proceeds via a multi-step process similar to that of reticuline oxidase (Kutchan and Dittrich, 
1995).  First one of the monomers would have to be methylated, that methyl group would 
become charged.  A nucleophilic attack of this charged methyl group by the other monomer 
would form the observed methylene bridge.  A third basic residue would assist in stabilizing the 
second monomer completing the observed diacylphloroglucinols.  R1 and R2 are chemical groups 
corresponding to PIB decorations.  B1, B2, and B3 are proposed basic residues of the enzyme 
involved in diacylphloroglucinol formation. 
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Table S1- Comparison of the nine major acylphloroglucinols in H. gentianoides between 
vegetative and reproductive phase of PI 664838, and seedlings of PI 664838 and Ames 27657, as 
identified and quantified by HPLC-UV.  Blue, metabolites identified for the first time in this 
study.  Rust, identified in H. gentianoides (this study) and other Hypericum species.  There were 
3 replicates per sample. 
 
Abbreviation/common 
name 
Sample 1 Sample 2 Relative 
Abundance 
of Sample 
1 (µmol g-1 
FW) 
Relative 
Abundance 
of Sample 
2 (µmol g-1 
FW) 
Fold 
Change 
(log 2) 
P-Value 
(log 2) 
13‘‘pren45‘me4‘oxoPIB Vegetative 
Phase 
Reproductive 
Phase 
0.30 0.03 1.87 0.0791 
Uliginosin B Vegetative 
Phase 
Reproductive 
Phase 
0.31 0.10 1.56 0.00426 
Saroaspidin A Vegetative 
Phase 
Reproductive 
Phase 
2.89 1.28 1.17 0.00129 
Saroaspidin B Vegetative 
Phase 
Reproductive 
Phase 
0.80 0.43 .89 0.00248 
[3‘mePIB]-
[1‘pren3‘me4‘oxoPIB] 
Vegetative 
Phase 
Reproductive 
Phase 
2.29 1.36 .76 0.00364 
[3‘3‘4me6‘oxoPIB]-
[3‘prenPIB] 
Vegetative 
Phase 
Reproductive 
Phase 
11.19 4.39 1.35 0.000002 
Uliginosin A Vegetative 
Phase 
Reproductive 
Phase 
0.75 0.28 1.42 0.00188 
Hyperbrasilol C Vegetative 
Phase 
Reproductive 
Phase 
8.39 3.89 1.11 0.000071 
[1‘pren3‘4me4‘oxoPIB]-
[3‘prenPIB]  
Vegetative 
Phase 
Reproductive 
Phase 
0.15 0.04 1.5 0.0185 
13‘‘pren45‘me4‘oxoPIB PI 664838 Ames 27657 0.22 0.04 3.32 0.03885 
Uliginosin B PI 664838 Ames 27657 0.66 0.16 2.06 0.001375 
Saroaspidin A PI 664838 Ames 27657 2.31 0.78 1.58 0.00364 
Saroaspidin B PI 664838 Ames 27657 0.42 0.15 1.56 0.00755 
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Table S1. Continued 
[3‘mePIB]-
[1‘pren3‘me4‘oxoPIB] 
PI 664838 Ames 27657 2.83 1.03 1.45 0.00955 
[3‘3‘4me6‘oxoPIB]-
[3‘prenPIB] 
PI 664838 Ames 27657 7.50 1.08 2.83 0.00071 
Uliginosin A PI 664838 Ames 27657 0.37 0.05 2.98 0.00197 
Hyperbrasilol C PI 664838 Ames 27657 9.71 1.58 2.63 0.001275 
[1‘pren3‘4me4‘oxoPIB]-
[3‘prenPIB]  
PI 664838 Ames 27657 0.18 0.08 1.31 0.03685 
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Figure S1-HPLC-UV analysis of methanolic extracts of H. gentianoides.  A) chromatograph 
illustrating the accumulation and retention time of the nine major acylphloroglucinols, B)-J) are 
the UV spectra of each of the nine acylphloroglucinols.  B) 1‘3‘pren45‘me4‘oxoPIB, C) 
uliginosin B, D) saroaspidin A, E) saroaspidin B, F) [3‘mePIB]-[1‘pren3‘me4‘oxoPIB], G) 
[3‘3‘4me6‘oxoPIB]-[3‘prenPIB], H) uliginosin A, I) hyperbrasilol C, J) 
[1‘3‘pren45‘me4‘oxoPIB]-[3‘prenPIB].  Units are in milliamps (mA). 
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Figure S2-LC/ESI-MS/MS analysis was performed on the nine major acylphloroglucinols of H. 
gentianoides.  A) 1‘3‘pren45‘me4‘oxoPIB, B) uliginosin B, C) saroaspidin A, D) saroaspidin B, 
E) [3‘mePIB]-[1‘pren3‘me4‘oxoPIB], F) [3‘3‘4me6‘oxoPIB]-[3‘prenPIB], G) uliginosin A, H) 
hyperbrasilol C, I) [1‘3‘pren45‘me4‘oxoPIB]-[3‘prenPIB]. 
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Figure S3- Levels of accumulation of the nine major acylphloroglucinols of H. gentianoides 
were similar across different seasons for plants grown in the greenhouse. Supplemental light was 
used to keep a constant day length and approximate consistent light quality and quantity 
independent of season. Batches of H. gentianoides plants were planted in the greenhouse at two 
different seasons, and grown for 11 months.  Batch 1 was planted in March and vegetative shoots 
were harvested and extracted the following February. Batch 2 was planted in July and vegetative 
shoots were harvested the following June.  Extracts were analyzed by HPLC-UV, and values 
were normalized to an apigenin internal standard.  Linear regressions of levels of the nine major 
acylphloroglucinols show that the two harvests are indistinguishable in acylphloroglucinol 
profile, indicating that under these growth conditions, there is negligible seasonal variation in 
acylphloroglucinol accumulation.   
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Figure S4-Q-TOF-MS/MS spectra of phlorisobutyrophenone, acylphloroglucinol precursors, 
and the two partially decorated diacylphloroglucinols in H. gentianoides.  A) 
Phlorisobutyrophenone, m/z=195, B) 3‘mePIB, m/z=209, C) 3‘3‘me6‘oxoPIB, m/z=223, D) 
3‘3‘4‘me6‘oxoPIB, m/z=237, E) 3‘prenPIB, m/z=263, F) 1‘pren3‘me4‘oxoPIB, m/z=277, G) 
1‘pren3‘4me4‘oxoPIB, m/z=291, H) [3‘3‘me6‘oxoPIB]-[PIB], m/z=431, I) 
[1‘pren3‘me4‘oxoPIB]-[PIB], m/z=485. 
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Abstract- 
 Hypericum perforatum (St. John‘s Wort) synthesizes a variety of bioactive compounds, 
including hypericin the monoacylphloroglucinol hyperforin.  H. gentianoides, a less-studied 
species with anti-inflammatory and anti-retroviral bioactivities when applied to mammalian 
cells, accumulates mono- and diacylphloroglucinols with chemical structures that are quite 
distinct from constituents of H. perforatum.  This study focuses on further understanding the 
localization and biosynthesis of the acylphloroglucinols that accumulate in this novel medicinal 
plant species. 
 Two complementary approaches were used to evaluate the cellular distribution of 
acylpholoroglucinols.  H. gentianoides leaves were microdissected into translucent glands and 
mesophyll regions and analyzed by direct infusion electrospray ionization (ESI) Fourier 
transform ion cyclotron resonance mass spectrometry (FTICR-MS) and high performance liquid 
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chromatography-electrospray ionization-mass spectrometry (HPLC-ESI-MS).  In addition, fresh 
fixed young leaves were evaluated by laser desorption ionization-mass spectroscopy imaging 
(LDI-MSI).   
 The data indicate that acylphloroglucinol biosynthetic intermediates and 
diacylphloroglucinol end products, from phlorisobutyrophenone onward, accumulate in the 
translucent glands.  Acylphloroglucinols were not detected in other regions of the leaf.  Light 
microscopy (LM) and transmission electron microscopy (TEM) were used to discover the 
patterns of translucent gland development.  These acylphloroglucinols were not detected in other 
regions of the leaf.  The translucent glands proceed through six stages of schizogenous 
development.  Throughout the earlier stages, mitochondria, plastids, and ribosome are present in 
the peripheral cells. This co-location of all acylphloroglucinols and their intermediates, along 
with the presence of mitochondria, plastids and ribosomes within the developing glands, 
provides a strong indication that biosynthesis of acylphloroglucinols occurs in the translucent 
glands.  
 
Introduction 
 Dianthrones, flavonoids, xanthones, and acylphloroglucinols of  the Hypericum genus 
have been implicated in protection against biotic and abiotic stressors. Such stressors include 
generalized herbivores (Sirvent et al., 2003), microbial pathogens (Çirak et al., 2005; Conceição 
et al., 2006), and UV damage (Brechner et al., 2011).  Hypericum species have a rich history in 
human medicine.  Hypericum perforatum (St. John's wort) has been used as an herbal remedy in 
Greek and Roman times (Pasqua et al., 2003) and is used today, in particular for its 
antidepressant activity (Kasper et al., 2010).  The compound implicated in the antidepressant 
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effect is the acylphloroglucinol, hyperforin (Brenner et al., 2000; Linde et al., 2008; Klemow et 
al., 2011).   
 Among the different members of the Hypericum genus a wealth of different metabolic 
modifications can occur to the common precursor phlorisobutyrophenone, yielding an array of 
acylphloroglucinols (Figure 1).  The phlorisobutyophenone precursor appears to be derived from 
the amino acid valine (Adam et al., 2002).  This amino acid is converted to isobutyryl-CoA by 
valine-pyruvate transaminase and 2-oxoisovalerate dehydrogenase (Harper et al., 1984; 
Ævarsson et al., 1999).  The resultant isobutyryl-CoA would reacts sequentially with 3 malonyl-
CoA molecules to form phlorisobutyrophenone via the activity of a phlorisobutyrophenone 
synthase (BUS) (Klingauf et al., 2005); neither the phlorisobutyrophenone synthase enzyme, or 
the gene(s) encoding it have yet been isolated from any Hypericum species. 
 The exact pathways by which phlorisobutyrophenone is converted to its various 
acylphloroglucinol products are not yet elucidated.  In H. perforatum, phlorisobutyrophenone 
appears to be sequentially prenylated, geranylated, methylated, and reduced to yield hyperforin 
(Adam et al., 2002; Soelberg et al., 2007).  Monoacylphloroglucinols such as hyperforin are not 
the only acylphloroglucinol produced in Hypericum; several species of Hypericum accumulate 
diacylphloroglucinols, composed of two phlorisobutyrophenone-derived molecules ligated by a 
methylene bridge (Taylor and Brooker, 1969; Ishiguro et al., 1987; Rocha et al., 1995; Rocha et 
al., 1996; Stein et al., 2012; Crispin et al., 2013). 
 Individual diacylphloroglucinols, and/or extracts from plants containing them, have been 
reported to have anti-depressant activities similar to hyperforin (Nakane et al., 1991; Bharate et 
al., 2008; Leuner et al., 2010; Stein et al., 2012), and as well as anti-inflammatory effects 
(Hillwig et al., 2008; Haarberg et al., 2010).  Eight diacylphloroglucinols and one 
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monoacylphloroglucinol have been identified in H. gentianoides (Crispin et al., 2013), an 
herbaceous annual found throughout much of the central and eastern US and southern Canada.  
 Growth and development in H. gentianoides differs significantly from most other 
Hypericum species (Crispin et al., 2013).  Most notably, H. gentianoides shoots undergo a drastic 
elongation and morphological change during their transition from vegetative to reproductive 
phase.  After the transition into the reproductive phase the branches of the plant resemble pine 
needles, this led to the creation of the plant‘s common name, pineweed.  A less obvious but 
pharmacologically relevant characteristic is the lack of black glandular nodules in H. 
gentianoides. The bioactive dianthrone hypericin accumulates in black glandular nodules of H. 
perforatum (Karppinen et al., 2008); the absence of such nodules in H. gentianoides may be 
associated with the absence of dianthrones such as hypericin (Hillwig et al., 2008).  Translucent 
glands are a distinct specialized secretory structure present on all known in Hypericum species 
(Ciccarelli et al., 2001).  Translucent glands are the site of hyperforin accumulation in H. 
perforatum (Soelberg et al., 2007) and thus may be a likely hallmark of the presence of 
acylphloroglucinols (Babka, 2009). 
 Here, we use direct infusion electrospray ionization (ESI)-Fourier transform-ion 
cyclotron resonance mass spectrometry (FTICR-MS) and laser desorption ionization mass 
spectrometry imaging (LDI-MSI) to determine that the nine major acylphloroglucinols of H. 
gentianoides (Crispin et al., 2013) accumulate in translucent glands.  Additionally, we use 
FTICR-MS, LDI-MSI, and HPLC-ESI-MS to identify the localization pattern of 
phlorisobutyrophenone and the predicted acylphloroglucinol precursors (Crispin et al., 2013); 
each intermediate was located within translucent glands, but not detectable in non-glandular 
material.  Developing translucent glands, as observed by light microscopy (LM), and 
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transmission electron microscopy (TEM) are rich in mitochondria, plastids, and ribosomes, 
reflective of biochemical activities.  This, combined with acylphloroglucinol localization, 
indicate that the translucent glands are likely the site of biosynthesis and accumulation of 
acylphloroglucinols.   
 
Results 
 
FTICR-MS reveals acylphloroglucinol end products and intermediates are present in the region 
of the translucent glands 
 We first used ESI-FTICR-MS as the analytical technique for two reasons.  First, ESI is a 
soft ionization technique and produces almost no fragmentation (Glish and Vachet, 2003), thus 
making it easier to distinguish each acylphloroglucinols.  Specifically, most acylphloroglucinols 
(Figure 1) have acidic protons that can be easily deprotonated and analyzed in negative ion 
mode.  Secondly, FTICR-MS provides higher mass resolution compared to any other mass 
spectometers and can provide accurate mass information that can be used to directly derive 
chemical compositions of each compound (Emmett et al., 1998).    
 To determine the location of acylphorologlucinols in H. gentianoides, fresh leaves were 
dissected using a micro-scalpel to obtain regions of primarily translucent glands and comparable 
regions without glands.  Dissected material was placed directly into methanol, and subsequently 
homogenized and extracted with methanol.  Extracts were mixed with 0.1% ammonium acetate 
(1:1 (v/v)) and analyzed with ESI in negative ion mode. 
 FTICR-MS analysis detected 3'3'-dimethyl-6'-oxo-phlorisobutyrophenone 
(3‘3‘me6‘oxoPIB, 3‘prenPIB), and 1'-prenyl-3'-methyl-4'-oxo-phlorisobutyrophenone 
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(1‘pren3‘me4‘oxoPIB) and eight of the nine major acylphloroglucinols (Table I).  Each of these 
compounds accumulate in the regions that are enriched with the translucent glands; 
concentrations in the leaf material with glands are between 10
3
-10
4
 fold greater than in leaf 
material without the glands (Table I; Figure 2B, C). 
 Because of the possible fragmentation during the ionization process, although minimal in 
ESI condition, we cannot avoid the possibility that the monoacylphloroglucinols in Table I might 
be fragmentation products of the diacylphloroglucinols.  To confirm the acylphloroglucinol 
precursors are naturally occurring compounds in planta, we used the HPLC-ESI-MS method 
previously described in Crispin et al. (2013).  Unlike direct infusion, LC-MS analysis can 
distinguish naturally occurring acylphloroglucinol precursor from diacylphloroglucinol 
fragmentation products.  Figure S1A shows that detectable amounts of 2 peaks shown in the box 
at ~23.5 minutes.  Based on peak abundance, m/z values (Figure S1B, C) and the retention times 
of these compounds being within the range of acylphloroglucinols, earlier than the 9 major 
acylphloroglucinols which is consistent with acylphloroglucinol with lower m/z values; these 
compounds were tentatively assigned as 1‘pren3‘me4‘oxoPIB and 1'-prenyl-3'4-dimethyl-4'-oxo-
phlorisobutyrophenone (1‘pren3‘4me4‘oxoPIB).  These two techniques indicate the major 
acylphloroglucinols and four acylphloroglucinol intermediates accumulate in planta and they are 
highly enriched in the tissue that contain the translucent glands. 
 
LDI-MSI documents acylphloroglucinol accumulation specifically in the translucent glands 
 To determine whether the diacylphloroglucinol precursors co-localize spatially with the 
translucent glands, leaves were analyzed with LDI-MSI.  This method enables visualization of 
the entire H. gentianoides leaf surface and molecules within the tissue, and resolves the spatial 
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accumulation sites of acylphloroglucinols in the leaves at a higher resolution than is possible by 
micro-dissection: mass imaging by LDI-MSI provides a spatial resolution of 25 µm.  
Furthermore, LDI-MSI allows for the use of tissue without any physical disruption of the cellular 
organization of the material.  The LDI-MSI spectra obtained across the leaf were examined in 
negative ion mode for peaks at 445.188, 499.235, and 553.282 m/z; these peaks correspond to 
saroaspidin A, uliginosin A, and hyperbrasilol C, respectively.  These images serve as validation 
controls because the location of these molecules in translucent glands had been previously 
established (Babka, 2009).  Figure 3 illustrates that the spatial distribution of translucent glands 
corresponds exactly with the spatial distribution of saroaspidin A, uliginosin A, and hyperbrasilol 
C.  Furthermore, five of the six other major acylphloroglucinols are localized in these glands, 
indicating their localization in these glands; the diacylphlorioglucinol, 3,5-dihydroxy-4-
isobutyryl-2-methyl-4-(3-methylbut-2-enyl)-6-(2,4,6-trihydroxy-3-isobutyryl-5-
methylbenzyl)cyclohexa-2,5-dienone ([3‘mePIB]-[1‘pren3‘me4‘oxoPIB]) was not detected. The 
high levels of uliginosin A combined with the similarity in m/z between [3‘mePIB]-
[1‘pren3‘me4‘oxoPIB] and uliginosin A (499.1 and 499.235, respectively), likely mask the 
[3‘mePIB]-[1‘pren3‘me4‘oxoPIB] from direct detection by laser desorption analysis, but it has 
been easily detected by using an HPLC separation method (Crispin et al., 2013).   
 Additionally, the LDI-MSI spectra was examined in negative ion mode for 
phlorisobutyrophenone (m/z=195.066) and the eight phlorisobutyrophenone derivatives 
hypothesized to create a "monomer pool" used to biosynthesis the major acylphloroglucinol 
(Crispin et al., 2013).  Figure 4 illustrates that the spatial distribution of the translucent glands 
and the major acylphloroglucinols correspond with the spatial distribution of these precursors.  
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 To further confirm that metabolites are efficiently ionized from the non-glandular regions 
of the leaf and detected by LDI, and thus contributing to the apparent asymmetric accumulation 
in the glands, we examined the accumulation pattern of quercetin.  We chose quercetin because it 
is a cyclic polyketide similar to acylphloroglucinols, and we theorized the two analytes ionize 
with similar efficiency.  Figure 5 demonstrates that quercetin occurs throughout the non-
glandular regions of H. gentianoides leaves, and is not detected in the translucent glands 
 
Morphology and ultrastructure of translucent glands  
 Little has been published about the ultrastructure of the translucent glands of Hypericum 
(Ciccarelli et al., 2001), and virtually nothing is known about the glands of H. gentianoides.  To 
define the ontogeny of the glandular structures that accumulate diacylphloroglucinols in H. 
gentianoides, plant organs were subjected to light microscopy (LM), scanning electron 
microscopy (SEM), and transmission electron microscopy (TEM).  The ontogenesis of sepal 
glands and leaf glands is indistinguishable (TEM data not shown); since sepal glands are 
plentiful and can be easily staged, this material was the primary focus of our analysis.   
 Based on the large number and size of glands on the sepal, and the developmental 
gradient of glandular stages on each sepal, we chose to investigate glandular structure and 
development in this organ.  Detailed microscopic observations from approximately 15 glands on 
each of 20 sepals from flower buds of different ages revealed the pattern in the developmental 
gradient.  We were able to assign glands to six developmental stages based on the following 
criteria.  Stage 1 glands contain cytoplasmically dense secretory cells, small, uniform peripheral 
cells, and little to no luminal cavity (Figure 6A).  Stage 2 glands have cytoplasmically dense 
secretory cells, peripheral cells that are heavily osmium-stained indicative of high lipid content, 
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degraded cell walls and the initial appearance of a lumen (Figure 6B).  The secretory cells of 
Stage 3 glands are much reduced and remain cytoplasmically dense, peripheral cells are highly 
osmium-stained, and an enlarged luminal cavity is present, sometimes observed containing an 
osmium-stained droplet (Figure 6C).  By Stage 4, secretory cells are becoming filled with 
vesicle-like structures, peripheral cells stain less intensely with osmium, and a lumen is present 
(Figure 6D).  Stage 5 glands contain secretory cells with enlarging vesicle-like structures and are 
less cytoplasmically dense, peripheral cells are less densely osmium-stained, and lumen is 
present (Figure 6E).  Stage 6 glands have a greatly reduced secretory cell volume as the cells 
become appressed to the peripheral cells, peripheral cells  are highly vacuolated, and the gland 
volume is primarily taken up by the lumen  (Figure 6F). 
 
Young glands (stages 1 and 2) 
Young translucent glands are packed with cytoplasmically dense cells (Figures. 6, 7, S2-S4).  
Within the cytoplasm of the secretory cells of these glands is a dense network of ER and 
associated ribosomes (Figure S2C, D); this abundance of ribosomes may indicate a high level of 
translational activity, perhaps to synthesize the enzymes necessary for secretory product 
synthesis.  The elongated plastids are unusual and filled with multidirectional tubuli (Figure 
S2C-E); such structures have also been described previously in plastids of secretory duct cells of 
several plant species (Fahn, 1979).  The only mitochondria present are ―ghost-like‖, presumably 
degenerating structures (Figure S2B–D), possibly indicating that these young secretory cells no 
longer require the energy or metabolic products from internal mitochondria.  A few secretory 
cells of stage 1 glands contain small vesicles that stain evenly or unevenly with osmium (Figure 
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S2C); large vesicles filled with osmium-staining particulates are common in secretory cells of 
stage 2 glands (Figure S2D-F).   
The cell walls separating the peripheral cells from the secretory cells are thicker than those 
separating secretory cells in stage 1 and 2 glands (Figure S2B).  Vesicle-like structures line the 
secretory cell walls in a zipper-like fashion (Figure S2B).  By stage 2, cell walls begin to 
degenerate, as evident by bulbous growths along the secretory cell walls and breakdown of the 
middle lamellae (Figure S2C).   
The peripheral cells surrounding these glands contain chloroplasts with starch granules and grana 
as well as normal-appearing mitochondria (Figure S2B, F).  Vacuoles of peripheral cells are 
large and stain heavily with osmium.  The cytoplasm of peripheral cells is significantly less 
dense than that of the secretory cells.  All these are characteristics of a metabolically active cell.   
 
Developing glands (stages 3 and 4) 
At these stages of development glands are characterized by an increasingly thin line of secretory 
cells pushed against the peripheral cells (Figures. 6, S3).  Figure S3B shows a droplet of lightly 
osmium-stained material located in the lumen of a stage 3 gland. Mitochondria are no longer 
visible in secretory cells once they enter stage 3.  The secretory cells of glands contain more 
vesicle-like structures than at theearlier stages of development, some of which stain darkly with 
osmium (Figure S3B-I).   
A major factor that distinguishes stage 3 from stage 4 glands is the greater cytoplasmic density of 
stage 3 secretory cells.  In particular, the vesicle-like structures in stage 3 secretory cells stain 
more densely with osmium, but by stage 4 the osmium-stained material within the vesicle-like 
bodies is more granular.  Also, the cytoplasm of stage 3 secretory cells is replete with ER, 
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ribosomes, and specialized plastids that contain multidirectional tubuli (Figure S3E-F).  These 
unusual plastids do not appear to be the source of the osmium-stained vesicle-like structures, as 
no intermediate structures are observed.   
The cell walls of secretory cells in stage 3 and 4 glands are thinner than the walls of the outer 
peripheral cells (Figure S3C, D,G, K).  Secretory cell walls are deformed, with invaginations on 
the luminal side of the cell (Figure S3B, K).  Fibrillar projections from these invaginations 
maybe fragmentsof degraded cell wall and/or secretory material.  Vesicles of <0.5 μm diameter 
containing an osmiophillic substance also line portions of the secretory cell‘s luminar wall 
(Figure S3B, K).  The lumen of the gland contains material lightly stained with osmium, which is 
likely comprised of the secretory products.  
By stage 4, the chloroplasts of the peripheral cells still contain starch, but are starting to 
degenerate (Figure S3K), and peripheral cells have reduced cytoplasmic density ascompared to 
glands at the earlier stage of development (Figure S3G, K).  By this developmental stage the 
amount of osmium-stained material present within peripheral cell vacuoles is also reduced 
(Figure S3D).     
 
Mature glands (stages 5 and 6) 
In mature glands the secretory cells are almost completely free of cytoplasm as the secretory 
functionof these cells terminates (Figure S4).  Specialized plastids can still be observed in the 
cytoplasm of stage 5 secretory cells, but in greatly reduced numbers (Figure S4B, F).  No 
plastids were observed in stage 6 glands.  By stage 6, dark osmium-stained droplets are 
contained within enlarged vacuoles (Figure S4G-L).  The lumen of the mature gland contains 
lightly-stained, presumably secretory, material (Figure S4A, B, D, F, K).  Along the cell walls of 
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secretory cells material appears to be sloughed off the walls into the central lumen (Figure S4I, 
J).  It is unclear whether this fibrillar material consist of cell wall debris or secretory products 
deposited via direct diffusion. 
The vacuoles of the peripheral cells are also enlarged (stage 5 and 6); chloroplasts are present in 
the cytoplasm of stage 5 glands (Figure S4B, F), but by stage 6 the peripheral cells appear filled 
primarily with particulate material (Figure S4H).   
 
Discussion 
 
The major acylphloroglucinols, phlorisobutyrophenone, and the acylphloroglucinol precursors 
accumulate in the translucent glands 
Due to their potent and diverse bioactivities in mammals (Brenner et al., 2000; Sarris et al., 
2012), considerable effort has been devoted to understanding the metabolism of 
acylphloroglucinols (Abe et al., 2004; Enning et al., 2011; Tassone et al., 2011; Leuner et al., 
2012; Crispin et al., 2013).  Studies focused on understanding the accumulation of the 
acylphloroglucinol, hyperforin, have found that this metabolite accumulates in the translucent 
glands (Soelberg et al., 2007).  FTICR-MS analysis of sections of leaves with and without 
translucent glands show nearly a 10
4
 fold increase in the abundance of diacylphloroglucinols in 
the section with glands compared to without (Figure 2).  This difference is certainly suggestive, 
however, we aimed to increase the resolution of our sectioning from 0.2 mm, using FTICR-MS 
analysis, to a 25 µm section possible when using LDI-MSI.  Mass imaging, through LDI-MSI, is 
an excellent tool for identifying compounds of interest at a resolution of a single cell (Jun et al., 
2010; Lee et al., 2012).  Another advantage of this tool specifically for identifying the 
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accumulation site of the major acylphloroglucinols is we are now able to examine all the glands 
and all the non-glandular tissue on the leaf simultaneously.  From the mass imaging of H. 
gentianoides leaves, we found that 8 of the 9 major acylphloroglucinols accumulate exclusively 
in the translucent glands (Figure 3).  The major acylphloroglucinol that was not detected using 
FTICR-MS and LDI-MSI, [3'mePIB]-[1'pren3'me4'oxoPIB], is an isomer of uliginosin A that 
accumulates nearly two orders of magnitude lower than uliginosin A (Crispin et al., 2013).  With 
this, we expect that [3'mePIB]-[1'pren3'me4'oxoPIB] is actually accumulating the same way as 
the other 8 major acylphloroglucinols, however, the tools utilizing direct infusion in study are 
unable to separate the isomers.  What is striking about the mass imaging of the major 
acylphloroglucinols is not just that they seem to accumulate only in the glands, but the intensity 
of each respective acylphloroglucinol seems to be the same over all the glands on the leaf.  This 
suggests that the major acylphloroglucinols are generated or stored relatively early in gland 
development or we expect there to be more a gradient in accumulation levels between the 
developmental stages of the glands. 
After examining the localization of the major acylphloroglucinols, we examined the LDI-MS 
spectra corresponding to phlorisobutyrophenone and the acylphloroglucinol intermediates 
predicted to be involved in the biosynthesis of the major acylphloroglucinols by Crispin et al. 
(2013).  As was observed with the major acylphloroglucinols, LDI-MS showed that the site of 
accumulation for phlorisobutyrophenone and the acylphloroglucinol intermediates are the 
translucent glands (Figure 4).  However, we observed that the diacylphloroglucinols can be 
fragmented into their constituent monomer precursors by the high-energy laser used in LDI mass 
imaging (unpublished data), rendering us unable to distinguish the mass peaks corresponding to 
fragmentation products from those that reflect the in situ occurring acylphloroglucinol 
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intermediates.  Despite this artifact of ionization, using an HPLC separation method, we were 
able to identify two of the in situ occurring acylphloroglucinol intermediate (Figure S1).  An 
HPLC-ESI-MS separation method was utilized to search for the acylphloroglucinol precursors.  
This technique does employ ionization like FT-ICR/MS and LDI-MSI, and it will generate 
detectable amounts of fragmented ions.  However, by the time any of the diacylphloroglucinols 
or their fragmentation products, have eluted from the column, we have already detected two in 
situ occurring acylphloroglucinol precursors, 1‘pren3‘me4‘oxoPIB and 1‘pren3‘4me4‘oxoPIB 
(Figure S1).  This result indicates that although the abundance of the acylphloroglucinol 
intermediates is artifically inflated by the fragmented diacylphloroglucinols, these metabolites 
are present and accumulate preferentially in the translucent glands. 
 
Translucent glands in H. gentianoides develop schizogenously and accumulate biosynthetic 
organelles 
Given the critical importance of translucent glands, we examined how the translucent glands 
develop over time and as well as the ultrastructure of each stage using electron microscopy.  
From our observation, we determined that the translucent glands can be classified into six 
distinct developmental stages (according to observable histological criteria), culminating in 
mature glands with a fully formed lumen.  These different developmental stages are not 
distributed in any clear pattern across the leaf (e.g., mature glands near the leaf tip).  Current 
microscopy and LDI-MSI technologies are destructive, enabling us to determine either a gland's 
developmental stage, or the distribution of acylphloroglucinols across the leaf.  From the results 
in Figures 3 and 4, it appears that acylphloroglucinols are at a similar level across all glands in 
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the leaf, but it still remains possible that development of a technique examining gland stage and 
acylphloroglucinol content simultaneously would yield a correlative pattern. 
In addition to examining the relationship between gland stage and acylphloroglucinol content, 
we used electron microscopy to determine whether the organelles necessary for 
acylphloroglucinol biosynthesis are even present within any stage(s) of the gland.  Based on our 
previous experiment showing that all the metabolites necessary for generation of the 9 major 
acylphloroglucinols accumulate preferentially within the glands, we expected to observe the 
presence of mitochondria, plastids, and ribosomes.  Ribosomes and plastids are generated 
throughout the development of the glands, but the mitochondria are only present in the early 
stages of gland development (Figure 7).  Assuming acylphloroglucinols are generated within the 
glands, the mitochondria would be necessary for the conversion of isobutyryl-CoA to 
phlorisobutyrophenone, because 2-oxoisovalerate dehydrogenase, the enzyme responsible for 
conversion of 2-oxoisovalerate to isobutyryl-CoA occurs only in the mitochondria (Wynn et al., 
1992).  Interestingly, the disappearance of the mitochondria early in developmental combined 
with the consistent acylphloroglucinol content throughout development indicates these 
mitochondria are responsible for the CoA pool used to generate acylphloroglucinols.      
We also suspect that the dimethylallyl diphosphate molecules used as the prenyl groups 
transferred to phlorisobutyrophenone molecules accumulate in these peripheral cells, given the 
source of the osmium staining material in the glands are unsaturated fatty acids that likely 
include dimethylallyl diphosphate (Wigglesworth, 1964).  The presence of plastids within the 
glands represents a means for the production of the prenyl groups through a non-mevalonate 
pathway (Soelberg et al., 2007).  We realize that the mevalonate pathway can biosynthesize 
prenyl groups in the cytosol; however, it has been previously shown that prenyl groups in 
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hyperforin biosynthesis are generated in H. perforatum, in fact, via the non-mevalonate pathway 
in H. perforatum (Adam et al., 2002). 
 
A proposed model For acylphloroglucinol biosynthesis in the translucent glands 
With the information gathered from LDI-MSI, histochemical analysis, and electron microscopy, 
we suspect that the entire acylphloroglucinol biosynthetic pathway is encompassed in the 
translucent glands (Figure 8).  Using information previously gathered by Crispin et al. (2013), 
we hypothesize that the isobutyryl-CoA and malonyl-CoA used to form the precursor 
acylphloroglucinol, phlorisobutyrophenone, is generated very early in the development of the 
glands.  Based on our electron microscopy, we expect that the methyl and prenyltransferases 
necessary to transfer chemical groups to phlorisobutyrophenone are in close proximity within the 
peripheral cells of the translucent glands.  After, these acylphloroglucinol precursors become the 
"monomer pool" used to generate the 9 major acylphloroglucinols.  1'pren3'4me4'oxoPIB is 
prenylated a second time to form the first major acylphloroglucinol 1'3'pren45'me4'oxoPIB, 
while the other 8 diacylphloroglucinols are generated via the mechanism described in Crispin et 
al. (2013). 
These results can likely be extrapolated to acylphloroglucinols in other Hypericum species, 
suggesting, for example, that hyperforin biosynthesis may occur in the translucent glands of H. 
perforatum.  Phlorisobutyrophenone and 3‘prenPIB are two acylphloroglucinol that are present 
in both H. gentianoides and H. perforatum and are required for a diverse array of end products 
seen in both species.  As we discussed earlier, hyperforin accumulates in the translucent glands.  
If phlorisobutyrophenone and 3‘prenPIB follow the same pattern in H. perforatum, then the 
118 
 
biosynthetic machinery for this pathway, including the non-mevalonate components, should be 
isolated in the translucent glands as well.  
 
Materials and Methods 
 
Translucent gland dissection and extraction 
Fresh leaves were pinned at both ends to a watchglass filled with Sylgard (Dow Corning 
Corporation, Midland MI).  Translucent glands were separated from regions without glands 
using a microscalpel (Fine Science Tools, Inc, Foster City, CA) under a Leica EZ4 (Buffalo 
Grove, IL) dissecting microscope using the transducing light source built into microscope.  
Similar amounts of non-secretory and secretory tissues were harvested, taking care between 
harvests to ensure that none of the translucent gland lumen had contaminated the microscapel 
blade.  
Sections of dissected leaves of approximately 20 μg were placed into 20 μL of methanol, and the 
tissue was ground into a fine particulate.  Ground extracts were vortexed for 30 s before being 
centrifuged at 13,000 rpm for 2 min.  Supernatants from centrifuged samples were removed with 
a 20 μL pipette, placed into a 0.45 micron filter, and filtered into a vial for analysis. 
 
FTICR-MS analysis 
Hypericum gentianoides methanolic extracts were analyzed using a FTICR-MS from Bruker 
Solarix (Billerica, MA).  Prior to analysis, 0.1% ammonium acetate in water was added to the 
methanolic extract at a ratio of 1:1 (v:v).  This modified extract was directly infused into the 
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machine and analyzed in the negative ion mode, which subsequently yielded the spectra seen in 
Figure 2. 
 
Acylphloroglucinol Identification 
Acylphloroglucinol terminology follows that of Crispin et al. (2013).  Diacylphloroglucinols 
were identified by using HPLC-UV and LC/ESI-MS based on the characteristic UV-spectra, 
molecular weights, and retention times of these compounds (Hillwig et al., 2008; Crispin et al., 
2013).  The identities of acylphloroglucinols from LDI analyses were based on masses as 
obtained previously by using Q-TOF-MS (Crispin et al., 2013).   
 
Plant sample preparation for LDI mass spectrometric imaging 
Hypericum gentianoides was grown at 25°C under a 16h photoperiod with an illumination at 110 
µE m
-2
s
-1
 and at ambient relative humidity. Plant tissues were collected and immobilized on 
stainless steel sample plates with conductive double-sided tape (3M, St. Paul, MN). MS imaging 
was conducted with a MALDI linear ion trap-Orbitrap hybrid mass spectrometer (MALDI LTQ 
Orbitrap-Discovery; Thermo Fisher Scientific, San Jose, CA, USA) with an external Nd:YAG 
laser (UVFQ; Elforlight Ltd., Daventry, UK). Laser power and the number of laser shots were 
optimized for individual experiments. Each spectrum was obtained from 10 laser shots, and 2 
spectra were averaged for each pixel. Data were collected in negative ion mode with a 25 µm 
raster step size. Images were generated by using Thermo ImageQuest software (Thermo 
Scientific, Waltham MA). 
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Microscopic and Macroscopic Analysis   
Five complete inflorescences of H. gentianoides plants (Figure 2A) were collected and divided 
into separate vials (two different-aged nodes and internodes per vial) containing 2% 
paraformaldehyde, 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2.  Samples were kept on 
ice and subjected to 1 h of vacuum (15 psi), then placed at 4
o
C for up to one week.  The samples 
were rinsed three times with 0.1 M cacodylate buffer, pH 7.2, before secondary fixation with 1% 
osmium tetroxide in 0.1 M cacodylate buffer, pH 7.2 for 1 h.  Following two rinses with 0.1 M 
cacodylate buffer, pH 7.2, tissue was en bloc stained with 2% aqueous uranyl acetate (aq) for 1 
h.  Samples were rinsed with deionized water and dehydrated, by using the following progression 
of ethanol solutions for 30 min each: 25%, 50%, 75%, 95%, 100%, and 100%, followed by three 
changes of pure acetone.  The samples were infiltrated with Spurr‘s resin using the following 
ratios of acetone to Spurr‘s: 3:1, 1:1, and 1:3.  The samples were embedded after two changes of 
pure Spurr‘s and polymerized at 60oC for 48 h. 
Samples for SEM (10 flower buds, 10 seed pods, and 10 leaves) were fixed as above up to 100% 
ethanol.  After the final dehydration in 100% ethanol, samples were placed in ultra-pure ethanol.  
Samples were critical point dried, mounted, sputter coated with palladium gold, and viewed 
using a JEOL 5800LV SEM.  Images were captured digitally using the SIS ADDA II system.       
Leaves were cleared (i.e., pigments and soluble cellular contents were removed) by placing in 
three baths of 90% ethanol for 25 min each at 90
o
C.  The leaves were rehydrated in 70% ethanol 
at room temperature.  The rehydrated samples were placed in a modified Hoyer‘s clearing 
solution (30 g gum arabic, 20 ml glycerol, 150 g chloral hydrate, 60 ml distilled water) (Ilarslan 
et al., 1997; Liu and Meinke, 1998) for 2-4 d.  For LM (thick, 1 µm) and for TEM (thin, 60 nm) 
sections were cut from at least 20 flower buds and leaves using a Diatome diamond knife on a 
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Leica UC6 ultramicrotome and stained with 5% uranyl acetate in water for 30 min and in lead 
citrate for 25-30 min (Sato, 1968).  For TEM observations, approximately 35 glands were 
observed.   
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Table 1- Ion abundance of acylphloroglucinols in Hypericum gentianoides leaf material with and 
without translucent glands as quantified with FTICR-MS analysis.  This analysis is consistent 
that of Babka(2009) and laser desorption ionization (LDI) (Figures 3,4, this paper).  
Acylphloroglucinol precursors are shown in black, major acylphloroglucinols are shown in 
orange. 
 Abundance  (Ion intensity) 
Abbreviation/Common 
Name 
With glands Without glands 
3‘3‘6‘oxoPIB 3.0x107 Undetected 
3‘prenPIB 3.0x106 Undetected 
1‘pren3‘me4‘oxoPIB 7.0x108 Undetected 
1‘3‘pren45‘me4‘oxoPIB 1.0x107 Undetected 
Saroaspidin A 5.0x10
9
 3.0x10
7
 
Saroaspidin B 2.0x10
9
 Undetected 
Uliginosin A 5.0x10
10
 9.0x10
7
 
Uliginosin B 2.0x10
6
 Undetected 
[3‘3‘4me6‘oxoPIB]-
[3‘prenPIB] 
9.0x10
9
 Undetected 
Hyperbrasilol C 1x10
11
 5x10
7
 
[1‘3‘pren45‘me4‘oxoPIB]-
[3‘prenPIB] 
3.0x10
9
 Undetected 
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Figure 1- A wealth of structurally diverse acylphloroglucinols synthesized in species of 
Hypericum include a variety of prenylated and geranylated derivatives.  Examples used here: 
Empetrifranzinan B, empetrifelixin A, and empetriferdinan B, H. empetrifolium (Schmidt et al., 
2012a; Schmidt et al., 2012b); olympicin A, H. olympicum (Shiu et al., 2012); chipericumin A, 
H. chinense (Abe et al., 2011); japonicum A and saroaspidin A, H. japonicum (Ishiguro et al., 
1987); hyperforin, H. perforatum (Adam et al., 2002); 1‘3‘pren45‘me4‘oxoPIB, H. gentianoides 
(Crispin et al., 2013).   
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Figure 2- Localization of acylphloroglucinol intermediates in H. gentianoides leaves by FTICR-
MS. A) Stereo microscope image of a H. gentianoides leaf.  Glands are visualized as the light 
spots scattered across the leaf.  B) FTICR-MS analysis of dissected leaf pieces containing 
translucent glands (this section is illustrated by the top circle on 2A).  This material has high 
levels of acylphloroglucinols.C) FTICR-MS analysis of dissected leaf pieces not containing 
translucent glands (this section is illustrated by the bottom circle on 2A).  This section contains 
no detectable amounts of any acylphloroglucinol intermediates, and 10
3
-10
4
 fold lower 
abundance of saroaspidin A, uliginosin A, and hyperbrasilol C.   
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Figure 3-Location of diacylphloroglucinols in translucent glands of H. gentianoides leaves as 
revealed by laser desorption ionization (LDI).  Mass imaging was performed on the same section 
as the optical image each mass image shows the presence of a particular diacylphloroglucinol.  
Heatmaps and optical images of the same leaf at the same frame were overlaid illustrating 
preferential accumulation of diacylphloroglucinols in the translucent glands.  A) Optical image 
of leaf showing the leaf and translucent glands (black spots) taken prior to the ionization process; 
B) 1‘3‘pren45‘me4‘oxoPIB, 359.222 m/z; C) uliginosin B, 497.217 m/z; D) saroaspidin A, 
445.188 m/z; E) saroaspidin B, 459.203 m/z; F) [3‘prenPIB]-[3‘3‘4me6‘oxoPIB], 513.251 m/z; 
G) uliginosin A, 499.235 m/z; H) hyperbrasilol C, 553.282 m/z; I) [1‘pren3‘4me4‘oxoPIB]-
[3‘prenPIB], 567.295 m/z.  Ions were isolated in negative ion mode.  Intermediates were selected 
for analysis based on Crispin et al.(2013).  Scale bar=0.1 mm 
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Figure 4- Localization of (mono) acylphloroglucinol intermediates in translucent glands of H. 
gentianoides leaves.  Mass imaging was performed on the same section as the optical image; 
each mass image shows the presence of a particular acylphloroglucinol intermediate.  A mass 
image corresponding to each acylphloroglucinol of interest was overlaid on the optical image, 
illustrating that these compounds accumulate preferentially in the translucent glands.   A) Optical 
image of the leaf showing the leaf and translucent glands (black spots) taken prior to the 
ionization process; B) phlorisobutyrophenone, 195.066 m/z; C) 3‘-methyl-
phlorisobutyrophenone, 209.081 m/z; D) 3‘,3‘-dimethyl-6‘-oxo-phlorisobutyrophenone, 223.097 
m/z; E) 3‘,3‘,4-trimethyl-6‘-oxo-phlorisobutyrophenone, 237.112 m/z; F) 8-isobutyryl-2,2-
dimethyl-chromene-5,7-diol, 261.112 m/z; G) 3‘-prenyl-phlorisobutyrophenone, 263.129 m/z; H) 
1‘-prenyl-3‘-methyl-4‘-oxo-phlorisobutyrophenone, 277.144 m/z; I) 1‘-prenyl-3‘,4-dimethyl-4‘-
oxo-phlorisobutyrophenone, 291.159 m/z.  Ions were isolated in negative ion mode.  
Intermediates were selected for analysis based on Crispin et al. (2013).  Scale bar=0.1 mm       
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Figure 5- Quercetin is dispersed exclusively in the non-secretory tissue of H. gentianoides 
leaves.  Overlaying the acylphloroglucinol end products and intermediates on the optical image 
of the translucent glands (Figures 3, 4) illustrates that these compounds accumulate in the 
translucent glands.  To ensure that the non-glandular regions of the leaf contain ionizable 
metabolites, and to determine whether cyclic polyketides accumulate preferentially in the 
translucent glands we examined the accumulation pattern of the flavonoids quercetin. The 
regions corresponding to the translucent glands are the only place where there is no quercetin 
detected. A) Optical image of H. gentianoides leaf.  B) mass image of quercetin.  Sample 
analyzed in negative ion mode. Scale bar=0.1 mm  
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Figure 6-Development of translucentglands in sepals of Hypericum gentianoides. Sepals were 
harvested from flowers of different ages; individual sepals contains all six developmental stages 
of glands.Sections of fixed, embedded material were stained with 1% toludine blue O and 
visualized by bright field LM.  Drawings of glandsshow peripheral cells in red and secretory 
cells in blue.  Stage 1.  Glands small withcytoplasmically-dense secretory cells (white arrow); a 
few peripheral cells which are cytoplasmically-dense and contain osmium-stained material.  
Stage 2.  Secretory cell cytoplasm is dense, but a lumen is starting to form. Peripheral cells 
almost surround secretory cell region.  Stage 3.  Significant expansion of gland.  Secretory cells 
line large lumen with droplet of lightly osmium-stained material apparent within.  Osmium-
stained material still present in peripheral cells.  Stage 4.Central lumen has little osmium-stained 
material; decrease of osmium-stained material in peripheral cells.  Stage 5.  Secretory cells 
contain more vesicle-like structures; peripheral cells stain less intensely with osmium and show 
reduced cytoplasmic contents.  Stage 6.  Secretory cells are slender and appressed to peripheral 
cells; peripheral cells appear empty.  Scale bar=20 µm, l= lumen, pc= peripheral cells, sc= 
secretory cells 
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Figure 7- Development of translucent glands and identification of organelles putatively involved 
with acylphloroglucinol biosynthesis.  Sepals were harvested from flowers of different ages; 
individual sepals contains all six developmental stages of glands. In early gland development (A, 
B), mitochondria, plastids and ribosomes are abundant in the peripherial and secretory cells (B).  
As gland develop (C) osmium bodies and vesical like structures become apparent in secretory 
cells.  By Stage 2 (D) vesical-like structures have enlargened; mitochondria, plastids, and 
ribosomes are still present in peripherial and secretory cells.  By stage 3 (E, F), osmium bodies 
and vesical like structures are present, but mitochondria are no longer detectable in by Stage 4.  
Stage 4 and through the rest of development,no organelles are not visible.  The translucent gland 
at this point continues to develop a more massive lumen, as well as vacuoles and vesicle-like 
structures.  Figure abbreviations.  c= chloroplast, cw= cell wall, f= fibrillar material, m= 
mitochondria, ob= osmium-body, l=lumen, p= plastid, pc= peripheral cells, sc= secretory cells, 
v= vacuole, vs= vesicle-like structures. 
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Figure 8- Model of the localization of the acylphloroglucinol biosynthetic pathway in H. 
gentianoides.  Valine is converted to 2-oxoisovalerate via valine-pyruvate transaminase (VPT, 
EC 2.6.1.66).  It is uncertain whether valine synthesis takes place inside or outside the 
translucent glands.  2-oxoisovalerate can be catalyzed into isobutyryl-CoA through the 
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mitochondrial enzyme, 2-oxoisovalerate dehydrogenase (2ODH, EC 1.2.1.25).  Isobutyryl-CoA 
is converted into phlorisobutyrophenone by action of isobutyrophenone synthase (BUS, 
characterized from H. perforatum, Klingauf et al., 2005).  Given that phlorisobutyrophenone 
accumulates in the translucent glands exclusively, this step must take place within the glands.  
Dimethylallyl diphosphate (the compound responsible for prenyl group formation) used in 
hyperforin synthesis, is biosynthesized through the non-mevalonate pathway in H. perforatum 
(Adam et al., 2002).  The presence of plastids in the glands indicates this is possible in H. 
gentianoides.  Phlorisobutyrophenone can be methylated (M) or prenylated (P) to form four of 
the decorated acylphloroglucinol intermediates, which can be further methylated, prenylated, or 
cyclized (C) to form the other four intermediate acylphloroglucinols, while 
1‘pren3‘4me4‘oxoPIB can be prenylated to form the smallest major acylphloroglucinol, 
1‘3‘pren45‘me4‘oxoPIB.  Four of these acylphloroglucinol intermediates, 3‘mePIB, 3‘4mePIB, 
3‘prenPIB, and 8ib22meC57diol can be methylated on the 5‘ position as a primer for the 
dimerization reaction, predicted to be similar to that of reticuline oxidase. The highly 
accumulating acylphloroglucinols are depicted in blue; compounds that may accumulate in or out 
of the translucent glands are depicted in red.  AHAS- acetohydroxy acid synthase, AHAR- 
acetohydroxy acid reductase, DHAD- dihydroxy-acid dehydratase, VPT-valine-pyruvate 
transaminase, 2ODH- 2-oxoisovalerate dehydrogenase, BUS- Phlorisobutryophenone synthase, 
DXS- 1-deoxyxylulose-5-phosphate synthase, DXR- 1-deoxyxylulose-5-phosphate 
reductoisomerase, CMS- 4-diphosphocytidyl-2C-methyl-erythritol synthase, CMK- 4-
diphosphocytidyl-2C-methylerythritol kinase, MCS- 2C-methyl-erythritol 2,4-cyclodiphosphate 
synthase, HDS- 1-hydroxy-2-methyl-2-butenyl 4-diphosphate synthase, IDS- isopentenyl 
diphosphate synthase, IDI- isopentenyl diphosphate isomerase.  
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Figure S1- Acylphloroglucinol monomers are present in HPLC separation method.  Given the 
difficulty in separating truly accumulating acylphloroglucinol precursors created by the 
fragmentation of diacylphloroglucinols in the FTICR-MS and LDI analyzes, we analyzed H. 
gentianoides leaf tissue with translucent glands using a separation method on an HPLC-ESI-MS.  
A) LC-ESI mass spectrum for H. gentianoides leaf material.  B) Mass spectra for peak with 
m/z=277, based on weight, abundance, and retention time. It is assumed this is the 
acylphloroglucinol precursor 1‘pren3‘me4‘oxoPIB.  C) Mass spectra for peak with m/z=291, 
based on weight, abundance, and retention time. It is assumed this is the acylphloroglucinol 
precursor 1‘pren3‘4me4‘oxoPIB.  Detectable amounts of 2 acylphloroglucinols shown in the box 
at ~23.5 minutes (1‘pren3‘me4‘oxoPIB and 1‘pren3‘4me4‘oxoPIB) were identified based on 
molecular weight and relative retention time.  These are truly accumulating acylphloroglucinol 
precursors since they elute 4 minutes before the first major acylphloroglucinol elutes (the second 
arrow).  This indicates that although ionization techniques create some diacylphloroglucinol 
fragments, there are acylphloroglucinol precursors being biosynthesized by H. gentianoides.   
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Figure S2-Young Hypericum gentianoidesglands.  A) Stage 1 gland with cytoplasmically-dense 
secretory cells and large peripheral cells.  Large vacuoles containing dark osmium-stained 
material are prominent in peripheral cells.  B) Vesicle-like structures form in the cytoplasm of 
secretory cells along cell walls.  C) The cell walls of secretory cells appear degraded.  D) 
Vesicle-like structures within secretory cells contain material stained with osmium.  The dense 
cytoplasm of secretory cells contains plastids with tubuli, ghost-like mitochondria, and a network 
of ER and ribosomes.  E) Tubuli containing plastids and vesicles of secretory cells.  Osmium-
bodies and vesicle-like structures are present in the cytoplasm of secretory cells.  F) Peripheral 
cells contain chloroplasts with grana and starch.  The vacuole of the peripheral cell is packed 
with material densely stained with osmium.  The cell walls separating the peripheral cells and 
secretory cells are very thick, while walls separating the secretory cells from the lumen are 
thinner.  Osmium-staining material is present in vesicle-like structures.  Bars: (A) 10 µm, (B – F) 
2 µm.  Figure abbreviations.  c= chloroplast, cw= cell wall, m= mitochondria, n= nucleus, no= 
nucleolus, ob= osmium-body,  p= plastid, pc= peripheral cells, sc= secretory cells, vs= vesicle-
like structures.  
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Figure S3-Developing Hypericum gentianoides glands.  A) Cytoplasm of secretory cells 
contains more vesicle-like structures compared to secretory cells found in younger glands.  
Vesicle-like structures lightly stained with osmium accumulate against a thinned cell wall.  B) 
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Large osmium-bodies are present in some secretory cells.  Fibrillar material can be seen 
extending from the cell wall on the luminal side of the secretory cell.  C) Secretory cell filled 
with vesicle-like structures.  Small vesicle-like or merged structures appear along the thinned 
secretory cell wall.  D) Specialized plastids with tubules are still apparent in cytoplasmically-
dense secretory cells.  The peripheral cells contain darkly-stained material and chloroplasts.  E) 
Secretory cell containing many plastids and osmium-bodies.  F) Secretory cell cytoplasm is filled 
with plastids containing tubuli and is peppered with ribosomes.  G) Developing glands have an 
enlarged lumen filled with secretory material.  The secretory cells are pushed up against the 
peripheral cells.  The cytoplasm of both the secretory cells and peripheral cells is becoming less 
dense.  H) Cytoplasm is less dense and several vesicle-like structures containing osmium stained 
particulate material are present.  I) Larger-vesicle-like structures within a secretory cell 
containing osmium-stained material.  J) Secretory cells with reduced cytoplasm and peripheral 
cells with enlarged vacuoles containing osmium-stained material.  K) Secretory cell cytoplasm is 
degenerated and osmium-stained vesicle-like structures are found along a thinned cell wall.  The 
cytoplasm of the peripheral cell is degraded and the chloroplasts are degenerated.  Note that the 
cell wall separating the peripheral cell from the secretory cell is much thicker and more 
organized than the wall separating the secretory cell from the lumen.  L) Enlarged vesicle-like 
structures containing osmium within secretory cells.  Scale bars=G) 20 µm, (A-E, H, I) 2 µm, J) 
10 µm, (F, K) 2 µm.  Figure abbreviations.  c= chloroplast, cw= cell wall, f= fibrillar material, 
m= mitochondria, ob= osmium-body, p= plastid, pc= peripheral cells, sc= secretory cells, v= 
vacuole, vs= vesicle-like structures.  
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Figure S4- Maturing Hypericum gentianoides glands.  A) Portion of a secretory cell with an 
elongated vacuole filled with osmium-stained material.  Chloroplasts can be found in peripheral 
cells.  B) Cytoplasm of secretory cell found in a mature gland.  Plastids containing tubuli are still 
present, but cytoplasm is less dense than cytoplasm observed in secretory cells from younger 
glands.  C) Cell wall separating peripheral and secretory cell walls are much thicker than walls in 
between secretory cells.  D) Vesicle-like structures with osmium-stained material within a 
secretory cell.  E) Large vesicle-like structure located in a cytoplasm-containing secretory cell, 
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while a neighboring peripheral cell contains little to no cytoplasm.  F)  Secretory cell with 
cytoplasm and plastids containing tubuli.  Material can be seen in the lumen.  G) Mature glands 
contain a large central lumen and secretory cells are appressed to peripheral cells.  Secretory 
cells are practically devoid of cytoplasm and contain a large vacuole that contains droplets of 
osmium-stained material.  H) Droplets of osmium-stained product are present in the large 
vacuoles of secretory cells.  I) Osmium-stained droplets in secretory cell vacuole.  Note fibrillar 
material on the lumen side of secretory cell wall and secretory product in lumen.  J) Secretory 
cell vacuole contains osmium-stained droplets.  Fibrillar material is present along the secretory 
cell wall on the lumen side.  K) Secretory cells and peripheral cells contain large vacuoles in 
mature glands.  In mature glands, more densely stained material is localized to secretory cells.  
Scale bars: (A – F) 2 µm, G) 20 µm, H) 10 µm, (I – J) 2 µm, K) 10 µm, L) 2 µm, Figure 
Abbreviations. c= chloroplast, cw= cell wall, f= fibrillar material, m= mitochondria, p= plastid, 
pc= peripheral cells, sc= secretory cells, v= vacuole, vs= vesicle-like structures.  
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Abstract 
 Members of the genus Hypericum produce a diverse array of polyketides, including 
dianthrones, acylphloroglucinols, and flavonoids, which function in plant defense or pollinator 
attraction.  H. gentianoides, a small herbaceous annual, biosynthesizes a complement of nine 
acylphloroglucinols with anti-depressant and anti-bacterial activities.  To develop a 
transcriptomic profile that theoretically would allow us to identify acylphloroglucinol 
biosynthetic transcripts,we identified a set of tissues that differ primarily in acylphloroglucinol 
accumulation.  The first was collected after exposure to UV-B, which increased the levels of 
acylphloroglucinol accumulation more than 2 fold in H. gentianoides seedlings (accession Ames 
27657) over their untreated counterparts.  A second accession was also sampled (PI 664838), 
which accumulates acylphloroglucinols at levels 2-7.5 fold higher than does the accession Ames 
27657.  From this set of plants, we generated both metabolomic and transcriptomic profiles.  
From the transcriptomic profiles, we identified several transcripts that were homologous to 
enzymatic steps involved in specialized polyketide metabolism.  To identify unigenes that were 
significantly up-regulated under UV-B, we performed a differential gene expression analysis.  
We identified several up-regulated unigenes involved with flavonoid metabolism, as well as 
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polyketide synthases, methyltransferases, prenyltransferases, and reticuline oxidases that may 
play roles in the production of acylphloroglucinols.  
 
Introduction 
 Polyketides, such as dianthrones, flavonoids, xanthones, and acylphloroglucinols, 
accumulated in the genus Hypericum and are important specialized metabolites.  They protect the 
plant against biotic and abiotic stressors such as herbivory (Balandrin et al., 1985), pathogens 
(Çirak et al., 2005; Conceição et al., 2006), and harmful UV damage (Agati et al., 2012). 
Hypericum species, most notably Hypericum perforatum L. (St. John‘s wort), have a rich history 
in medicine, dating back to use as a medicinal plant in Greek and Roman times (Pasqua et al., 
2003).  Today, H. perforatum is widely marketed as an herbal supplement because of its 
antidepressant activity (Stein et al., 2012).  Extracts from this species also show anti-microbial 
(Saddiqe et al., 2010), anti-viral (Axarlis et al., 1998), anti-cancer (Couldwell et al., 2011), and 
anti-malarial (Zofou et al., 2011) activities.  Based on the results of these previous studies, it was 
determined that specialized polyketides are responsible for these bioactivities. 
 Biosynthesis of polyketides proceeds via condensation of an activated CoA and variable 
numbers of malonyl-CoA molecules (Ferrer et al., 1999; Jiang et al., 2006; Li et al., 2011).  The 
biosynthesis of the initial polyketide chain is analogous to fatty acid biosynthesis (Austin and 
Noel, 2003).  Polyketide intermediates undergo cyclization, methylation, prenylation, 
geranylation, or dimerization to form a diverse array of natural products.  The polyketide, 
quercetin, a flavonoid that accumulates to high levels in Hypericum, is widely distributed across 
many plant genera.  The genes responsible for the enzymes of quercetin biosynthesis have been 
described in model organisms like Arabidopsis and soybeans (Ralston et al., 2005; Yonekura-
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Sakakibara and Saito, 2009).  Additionally, the enzyme responsible for production of the 
precursor to these flavonoids, chalcone synthase, has been isolated from alfalfa, moss, and 
soybeans (Ferrer et al., 1999; Jiang et al., 2006; Cho et al., 2013). 
 This enzyme has been used as a template to identify polyketide synthases (PKS) in 
Hypericum perforatum.  Chalcone synthase, benzophenone synthase, and an octaketide synthase 
believed to be involved in hypericin biosynthesis have been identified by isolation and in vitro 
biochemical assays in H. perforatum and Garcinia mangostana L. (Karppinen et al, 2008; 
Nualkaew et al., 2012)  However, despite considerable effort put into understanding the 
biosynthesis of these polyketides, other than these three PKSs and a gene hypothesized to be 
involved in the dimerization step of dianthrone biosynthesis (Hyp-1; Bais et al., 2003), many 
genes involved in Hypericum-specific polyketide biosynthesis remain to be identified.   
 The PKSs from Hypericum had been identified by analyzing cDNA libraries (Klingauf et 
al., 2005; Karppinen et al., 2008).  Strategies employing next generation sequencing combined 
with metabolomic efforts to identify discrete sites/conditions of polyketide synthesis through are 
providing a new venue for gene discovery in Hypericum polyketide biosynthesis (Crispin and 
Wurtele, 2013).  The genes involved with the biosynthesis of acylphloroglucinols are of 
particular interest.  To date, many of the metabolite intermediates are known or predicted (Adam 
et al., 2002; Crispin et al., 2013), yet phlorisobutyrophenone synthase and other 
machinery/regulators required to synthesize the important antidepressant constituent hyperforin, 
or any other acylphloroglucinol remains obscured.  Given the difficulty involved with isolating 
and identifying acylphloroglucinol related transcripts in other species of Hypericum, we focused 
our efforts on a related species with a large array of acylphloroglucinols, H. gentianoides.      
147 
 
 H. gentianoides is a small herbaceous annual present throughout the central and eastern 
United States and Canada, with a history of medicinal use by the Native Americans for a variety 
of ailments (Crispin et al., 2013).  It accumulates nine acylphloroglucinols detectable with 
HPLC-UV, LC/ESI-MS, and Q-TOF-MS.  Five of these compounds, saroaspidin A and B, 
uliginosin A and B, and hyperbrasilol C have been shown to possess antibacterial properties 
(Crispin et al., 2013).  Uliginosin B has also recently been identified as an antidepressive in mice 
in a forced swim test (Stein et al., 2012).   
 Here, we describe a method that utilizes liquid chromatography for metabolite 
accumulation and Illumina GAII for de novo transcriptome assembly with UV-B stressed H. 
gentianoides.  Metabolite analysis of six different samples revealed a set of tissues with distinct 
accumulation levels of acylphloroglucinol end products, most notably a ~2-5 fold increase in 
acylphloroglucinol end product production after 24 h of UV-B exposure.  This set of tissues was 
harvested, extracted, and sequenced with Illumina sequencing, which yielded 6.9 GB of 
nucleotides.  Unigenes with homology to all the known genes involved with quercetin and 
anthocyanin biosynthesis as well as many involved with early acylphloroglucinol biosynthesis 
were identified.  Unigenes related to Hyp-1 as well as several unigenes that could be involved 
with later acylphloroglucinol biosynthesis were identified as a means of demonstrating the power 
of a metabolomic/transcriptomic correlational approach.  This is the first effort to assemble a 
transcriptomic profile for H. gentianoides, and our results here can be used to further our 
understanding in the biosynthesis of these bioactive compounds from this novel medicinal plant 
species.                
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Results 
 
Identification of stressors capable of altering acylphloroglucinol levels 
 The accumulation of specialized metabolic products in plants is known to be altered by a 
wealth of stressors.  A few examples of these stressors are plant pathogens such as 
Colletotrichum gloeosporioides Penz. (Sirvent and Gibson, 2002), cytokinins and the plant 
defoliant tridiazuron (Liu et al., 2007), jasmonic acid (Binns et al., 2001), methyl jasmonate, 
salicylic acid (Sirvent and Gibson, 2002), mechanical wounding (Crockett and Boevé, 2011), and 
UV-B irradiation (Germ et al., 2010). 
 To further identify how these stressors affect acylphloroglucinol accumulation, seeds of 
an accession of H. gentianoides (Ames 27657) were germinated in the greenhouse under natural 
plus supplemental light.  Thirty days after planting (DAP), stressors were applied to seedlings 
potted in soil, chemical and mechanical stressors were applied every six hours over a 24 h time 
period, while seedlings exposed to UV-B stress were put under UV-B lamps for 48 h. 
 Figure 1 highlights that of the stressors applied to Ames 27657 and PI 664838 seedlings, 
only UV-B applied to Ames 27657 altered acylphloroglucinol accumulation levels noticeably or 
to a statistically significant level.  Interestingly, not only did UV-B treatment cause an increase 
in the acylphloroglucinol content of the seedlings, it also causes a variegation of green and 
purple color over the aerial portion of the plants.  This increase in purple pigments likely 
corresponds with an increase in flavonoid content in response to UV irradiation.  This change is 
also observable in the extraction pellet of the negative-UV control when compared to treatment 
(Figure 2).   
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 Because we had large number of PI 664838 seedlings, we also exposed some of these 
seedlings to UV-B stress.  Unlike the Ames 27657 seedlings, seedlings from PI 664838 showed 
no change in acylphloroglucinol content over the 48 h time course.  No purple coloring was 
observed indicating no up-accumulation of the flavonoids, suggesting a correlation between an 
increase in both acylphloroglucinol and flavonoid content under UV-B stress.          
 
UV-B irradiation elucidates increased accumulation of acylphloroglucinols compared to a 
control 
 Preliminary HPLC analysis indicated that UV-B increased all nine major 
acylphloroglucinols in Ames 27657 over a time course of 48 h.  To further establish at what time 
point and to what extent UV-B increases acylphloroglucinol content, we created a controlled 
environment in the greenhouse to test the effect of UV-B compared to non-UV-B growth lights.  
As with the previous analysis using Ames 27657 plants, 30 DAP seedlings were used.  Four days 
prior to UV-B exposure, both control and treatment pots were placed into the lighting apparatus.  
 In order to prevent bleeding of UV-B light into our control samples, the entire UV-B 
lighting apparatus was wrapped in tin foil.  To prevent changes in acylphloroglucinol content 
that might be caused by air flow or humidity changes in the treatment due to the foil, four days 
prior to the initiation of UV-B exposure, both the control and treatment lighting apparatuses were 
wrapped in saran wrap. 
 In the control, uliginosin B is the only compound with a statistically significant difference 
between any of the time points (UV-B at 0 h compared to 12 h (Figure 3A)).  However, given the 
absence of statistically significant differences in uliginosin B concentrations when comparing 
any other time points, we assume the increase in the treatment was attributed only to UV-B 
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stress.  UV-B treated samples show a significant increase of 1‘3‘pren45‘me4‘oxoPIB; 
hyperbrasilol C; and [1‘pren3‘4me4‘oxoPIB]-[3‘prenPIB] as quickly as 6 h after the start of UV-
B treatment (Figure 3B).  After 12 h of UV-B exposure, uliginosin B and 
[1‘pren3‘4me4‘oxoPIB]-[3‘prenPIB] are the only acylphloroglucinols significantly increased 
(p<0.05) compared to 0 h time point.  By 24 h, all nine acylphloroglucinols are significantly 
increased (p<0.035) compared to the 0 h time point, with an average fold change of ~3.5x 
(Figure 3B).  As observed in preliminary UV-B experiment, there was an increase of flavonoids 
over the UV-B time course, indicating that under UV-B stress accumulation of 
acylphloroglucinols and flavonoids may be correlated.                       
 
De novo sequencing and assembly of a pooled sample 
 To obtain an gene expression profile for H. gentianoides that encompasses as much of the 
transcriptome as possible, RNA was collected from two accessions (Ames 27657 and PI 664838) 
with differing acylphloroglucinol concentrations, and from one accession (Ames 27657) 
undergoing a time course under UV-B irradiation.  As discussed above, aliquots of the same 
samples were analyzed using HPLC-UV, the rest had RNA extracted and were sequenced with 
an Illumina GAII by the Beijing Genomics Institute.  After removal of the adaptor sequences and 
short nucleotide sequences, 6,899,321,000 (6.9 GB) nucleotides composing 68,993,210 clean 
paired end reads were obtained.  The Q20 and GC content of the reference sample was 89.25 and 
50.87 percent respectively.  Assembly of unigenes from short reads was accomplished in a step-
wise manner using SOAP de novo software (REF).  A total of 125,571 unigenes (≥200 bp) with 
an average length of 325 and an N50 of 352 were assembled (Table 1).  Figure 4A illustrates the 
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length distribution of obtained unigenes.  Figure 4B shows 98.74% of the unigenes contain no 
gaps. 
 
Annotation and classification of reference sample 
 As an initial step prior to annotation or classification, unigenes were oriented using 
BlastX alignment (e-value<1.00x10
-5
) against the following protein databases: Cluster of 
Orthologous Groups (COG), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes 
(KEGG), GenBank non-redundant (NR), and Swiss-Prot.  Though these databases, 66,140 
(52.67%) unigenes were annotated (Table 2)    
 Analyses based on COG (http://www.ncbi.nlm.nih.gov/COG/) compare unigenes in terms 
of broad functionality.  This gives a more generic classification than other protein databases.  
COG analyses clustered 14,748 unigenes (11.74%) into 25 functional categories (Figure S1), 
with nearly all of these unigenes falling into multiple categories.  Similar to previous research of 
H. perforatum by He et al. (2012), we observed that a high proportion of these annotations only 
address the general function prediction only and transcription annotations. 
 GO (http://www.geneontology.org/) employs a standardized vocabulary in order to assign 
annotations to sequences that can be broadly understood.  Using GO, we were able to assign GO 
terms to 32,299 unigenes (25.72%).  As observed in our COG analysis, the most prevalent 
annotations in H. gentianoides are the same as those seen in He et al. (2012).  Figure S2 shows a 
GO analysis that goes further into the hierarchy of each of the three domains.   
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Transcripts related to polyketide metabolism 
 H. gentianoides produces two classes of specialized polyketides that are either detectable 
visually or detected through our HPLC method; these classes being the flavonoids, and 
acylphloroglucinols respectively.  Unlike H. perforatum, H. gentianoides does not accumulate 
any of the hypericins or display the black glandular nodules where hypericins accumulate 
(Crispin et al., 2013).  Our annotated library still revealed 13 unigenes with homology to Hyp-1 
(Hypericum perforatum phenolic oxidative coupling protein), a gene with the capacity to 
catalyze the conversion of emodin to hypericin in vitro (Bais et al., 2003).  Of these unigenes, 9 
are capable of producing proteins homologous to Hyp-1 and more than ~20 amino acids long.  
One of these 9 unigenes (annotated in the expression library as Unigene22184) is capable of 
producing a protein that has 80% coverage, 80% identity, and 96% positives to Hyp-1 in H. 
perforatum (Figure S3).  This unigene is highly affected by UV-B stress, inducing a change from 
approximately 100 to 2,000 FPKM in the presence of UV-B.  
 The Hyp-1 annotation still corresponds to a process that is quite poorly understood, so it 
was a goal of this part of the study to find transcripts related to specialized metabolic processes 
that are more completely understood.  The genes involved in the biosynthesis of the flavonoid 
quercetin, the subsequent quercetin glucosides, and anthocyanins have been identified in 
Arabidopsis (Yonekura-Sakakibara and Saito, 2009).  In Arabidopsis, flavonoids such as 
quercetin, the quercetin glycosides, and the anthocyanin are biosynthesized from phenylalanine 
via 4-coumaroyl-CoA and malonyl-CoA (Ferrer et al., 1999).  After importing pathways from 
Plantcyc and adding our annotated library, we find that there are unigenes corresponding to all 
the steps involved with biosynthesizing flavonoids from phenylalanine (Figure S4). 
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These specialized metabolites are important in species of Hypericum species, especially with 
regard to tolerating UV-B irradiation.  However, the most abundant specialized metabolites in H. 
gentianoides are its nine acylphloroglucinols.  According to Karppinen (2010), valine is utilized 
by H. perforatum in the biosynthesis the acylphloroglucinol hyperforin.  The early steps of 
biosynthesis of hyperforin are theorized to be homologous to that of acylphloroglucinol 
biosynthesis in H. gentianoides (Crispin et al., 2013).  With that knowledge, the first unigenes of 
interest would be those involved with the production of isobutyryl-CoA. We identified 19 
unigenes homologous to valine aminotransferase in Arabidopsis, which is responsible for the 
conversion of valine to 2-oxoisovalerate.  We identified 21 unigenes that annotated as 2-
oxoisovalerate dehydrogenase, a multiple step enzyme similar to pyruvate dehydrogenase, which 
is responsible for converting 2-oxoisovalerate to isobutyryl-CoA (EC: 1.2.1.25). 
 The last enzymatic step we examined in this pathway based on homology was the 
conversion of isobutyryl-CoA to phlorisobutyrophenone.  This conversion has been previously 
shown to be catalyzed by phlorisobutyrophenone synthase (Klingauf et al., 2006).  This type III 
polyketide synthase has yet to be positively identified, but likely shares homology with the other 
known PKSs.  With that in mind, all transcripts with homology to any PKS were examined.  We 
identified 78 unigenes (46 homologous to CHS, 31 homologous to benzophenone synthase, and 
1 homologous to a type III PKS). 
 
Identification of putative genes encoding diacylphloroglucinol synthase. 
 The final step in the biosynthesis of diacylphloroglucinols in H. gentianoides is a 
dimerization reaction, in which a methylene bridge is created between two decorated 
phlorisobutyrophenone molecules (Crispin et al., 2013).  No transcript or enzyme has yet been 
154 
 
found that catalyzes this reaction in any species.  However, three enzymes with known sequences 
form a methylene bridge analogous to what is observed in diacylphloroglucinol biosynthesis: 
(S)-reticuline oxidase (Winkler et al., 2009), canadine synthase (Dang and Facchini, 2014), and 
berbamunine synthase (Gesell et al., 2009).  Of these, the (S)-reticuline oxidase reaction is most 
similar, because it biosynthesizes a C-C methylene bridge where as the other two enzymes form 
a C-O methylene bridge (Crispin et al., 2013).  No unigenes represented in the H. gentianoides 
expression library have significant homology to canadine oxidase.  One unigene is homologous 
to berbamunine synthase.  (S)-reticuline oxidase is a non-cytochrome P450 oxygen 
oxidoreductase in Eschscholtzia californica Cham. (California poppy) that converts (S)-
reticuline to (S)-scoulerine (Kutchan and Dittrich, 1995).  But 12 unigenes from H. gentianoides 
have homology to (S)-reticuline oxidase.  Twelve of these 30 unigenes had 0 FPKM throughout 
the experimental samples after examining the transcriptomic library for unigenes homologous to 
reticuline oxidase.  Using the reticuline oxidase protein from E. californica 
(http://www.ncbi.nlm.nih.gov/protein/P30986.1) as the standard for a reticuline oxidase, the 
predicted proteins from the 18 H. gentianoides unigenes homologous to reticuline oxidase were 
arranged into a phylogenetic tree using ClustalW2 (www.ebi.ac.uk/Tools/msa/clustalw2).  It is 
also important to illustrate that the unigenes used for alignment from H. gentianoides are not full 
length transcripts, but the unigenes generated by the sequencing.  Of these, 4 clustered most 
closely to the E. californica reticuline oxidase, unigenes 20737, 103430, 109915, 116738.  An 
approximately 75 amino acid region is common to these unigenes but not found in the other 
unigenes that were identified as reticuline oxidase homologs.  This region is conserved in several 
reticuline oxidase proteins from both bacteria and plants (Figures 5, 6).  Of these four, unigenes 
103430 and 109915 are up-regulated following UV-B stress, but only unigene 109915 is up-
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regulated to a statistically significant degree (q<0.05).  Neither of these reticuline oxidase like 
unigenes were up-regulated (q<0.05) when comparing the two different accessions (data not 
shown).  Based on these observations, we predict that the difference in acylphloroglucinol 
accumulation levels in the different accessions are due to factors other than transcriptional and 
translational abundances of the biosynthetic machinery such as different levels of biosynthetic 
intermediates available for the predicted enzymatic machinery. 
 
Filtering of differential expression matrix to reveal unigenes altered by UV-B irradiation 
 Given that the primary focus of this study has been to understand acylphloroglucinol 
biosynthesis, we focused our differential expression analysis on transcripts that are altered only 
because UV-B light.  With this in mind, the dataset of 92,407 unigenes that were identified were 
filtered to retain unigenes that were significantly different (q<0.05) with respect to control at 30 
min and UV treatment at 8 h, UV treatment at 30 min and UV treatment at 8 h, and control at 8 h 
and UV treatment at 8 h, while simultaneously not being significantly different (q<0.05) with 
respect to control at 30 min and UV treatment at 30 min, control at 30 min and control at 8 h, and 
control at 8 h and UV treatment at 30 min.  Of the original 93,407 unigenes used for the 
differential expression analysis, we found 2,604 had differential expression after 8 hours of UV-
B irradiation.  Of those 2,604, 2,104 were up-regulated and 500 were down-regulated. 
Of the up-regulated unigenes, nearly 650 have no functional annotation through any of the four 
protein databases, while in the down-regulated unigenes, 170 do not have annotation.  Table S1 
gives a list of the functional annotations of up- and down-regulated unigenes, while Table 3 
shows 46 pathways that are significantly enriched. 
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 To validate the unigenes that were isolated from this analysis, the list was examined for 
genes that corresponded to anthocyanin production, as this metabolic process is also increased 
during UV exposure of Ames 27657 seedlings (Figure 1).  The list of differentially expressed 
unigenes shows that 83 of the 2,104 are related to the flavonoid biosynthetic pathway.  Many 
flavonoid and anthocyanidin biosynthesis transcripts were up-regulated, as well as transcripts 
involved in earlier steps, such as those in chorismate and phenylalanine biosynthesis (Table S3; 
Figure 7).  The pathway enrichment analysis also in agreement with this analysis, with 9 of the 
46 enriched pathways corresponding to anthocyanidin biosynthesis (Table 3). 
 With the observation of a detectable up-regulation of anthocyanidin biosynthetic genes 
that is also correlated with a qualitative change in anthocyanins, we assume that the shift in 
acylphloroglucinols should also correspond to an up-regulation of genes involved in the 
production of these compounds. 
 There are four steps in acylphloroglucinol biosynthesis that would need to be up-
regulated in order to cause an increase in the accumulation of these metabolites: a polyketide 
synthase (most specifically the currently unidentified phlorisobutyrophenone synthase), a 
methyltransferase, a prenyltransferase, and the enzyme responsible for phlorisobutyrophenone 
dimerization.  We previously postulated in Crispin et al. (2013) that the enzyme that dimerizes 
phlorisobutyrophenone would be similar to reticuline oxidase, the enzyme that catalyzes (S)-
scoulerine from (S)-reticuline (Winkler et al., 2008).  Unigenes with sequence homologs to each 
of these activities are included among the genes that are differentially expressed genes, including 
several polyketide synthases and methyltransferases, as well as two prenyltransferases, and three 
unigenes that are homologous to reticuline oxidase.  Most of these unigenes are up-regulated 
following UV exposure; however, both prenyltransferases are down-regulated.     
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Discussion 
 Currently much of the information we have obtained pertaining to specialized metabolic 
pathways in Hypericum have been gained from identification based on homology from model 
organisms such as Arabidopsis or from cDNA libraries (Bais et al., 2003, Karppinen and 
Hohtola, 2008).  However, with the advent of a more global analysis method through next 
generation sequencing technologies, groups have begun to take a different approach for 
idenfying genes involved in specialized metabolism. 
(http://medicinalplantgenomics.msu.edu/final_version_release_info.shtml, 
http://uic.edu/pharmacy/MedPlTranscriptome/index.html).  Efforts to gather H. perforatum next 
generation sequencing expression libraries have already shown many of the genes that should be 
present and have been identified by homology based approaches (He et al., 2012).  Outputs from 
COG, GO, KEGG, NR, and Swiss-PR from the expression library of H. perforatum (He et al., 
2012) resemble those of our H. gentianoides library (Table 3; Figure 4, S1).  The H. gentianoides 
expression matrix differs from that in He et al. (2012) in the number of unigenes, which is 
double that of what was observed in H. perforatum.  A likely explaination for this observation 
could lie in the allelic variation inherent with using different accessions of plants as well as using 
plants from the same accession that are not isogenic lines as would be seen in model organisms 
such as Arabidopsis.  If there are numerous SNPs among plants within and between accessions, 
we would expect to see short unigenes, and a larger number of unigenes corresponding to an 
individual enzymatic step than has been observed in other plants.  This is what we observed 
when comparing the many enzymatic steps in anthocyanin biosynthesis to efforts examining 
anthocyanin biosynthesis in other plants (Figure S4; Tanase et al., 2012).  Even with smaller 
unigenes, we were still able to examine our library for homology to enzymatic steps involved in 
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polyketide biosynthesis, a goal similar to that of He et al. (2012).  Along with this, others goals 
of this research were 1) to understand how stressors affect the accumulation of 
acylphloroglucinols in H. gentianoides, 2) to identify previously unidentified genes that may be 
involved with acylphloroglucinols, 3) to develop a means to later aid in understanding the 
regulation of acylphloroglucinol biosynthesis.  Our collection method focused on identifying a 
set of tissues that were actively and significantly accumulating the nine acylphloroglucinols of 
interest.  In the case of H. gentianoides, UV-B irradiation increased the amount of 
acylphloroglucinols significantly after 24 h (Figure 3).  We assume that UV-B is causing this 
effect because acylphloroglucinols serve as antioxidants in the glands.  The rationale is that 
because flavonoids such as quercetin and quercetin glycosides accumulate everywhere but the 
glands (Chapter 4), but there must be a way to quench radical oxygen species in the glandular 
tissues.  In turn, acylphloroglucinol content in Ames 27657 is raised to a possible threshold level.  
We said it is a threshold level because after UV-B exposure Ames 27657 accumulates at a level 
similar to that observed in PI 664838.  PI 664838 being at a threshold accumulation level without 
treatment with stressors would explain why we saw no change in acylphloroglucinol content in 
these seedlings treated with UV-B for as much as 72 hours.   
 Because a significant change of acylphloroglucinol and flavonoid concentrations in Ames 
27657 seedlings was observed after UV-B exposure, this yielded a set of tissues that should have 
displayed increased numbers of the transcripts coding for machinery involved with 
acylphloroglucinol and flavonoid metabolism.  Although identification of putative transcripts 
was based mainly on homology, or homology based on putative activity, we were also able to 
lower the number of possible candidates through a differential gene expression analysis. 
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Through computational annotations, we identified 13 transcripts with up to 80% identity and 
96% similarity with Hyp-1 (Figure S3).  Hyp-1 protein (isolated from H. perforatum, 
andexpressed in E. coli) has been reported to convert emodin to hypericin in vitro (Bais et al., 
2003).  However, this report has not been accepted by some.  If this gene were directly 
responsible for hypericin biosynthesis, we might expect to detect hypericin in H. gentianoides; 
however, we do not detect hypericin, nor are glandular nodules that hypericins accumulate in 
found in H. gentianoides (Karppinen et al., 2008).  In addition, other Hypericum species also 
accumulate Hyp-1 like transcripts but do not accumulate hypericin (Košuth et al., 2011).  In St. 
John's wort, roots accumulate the highest levels of Hyp-1, yet hypericins accumulate at very low 
or undetectable levels in the roots, suggesting a different role for this transcript.   
 Along with the hypericins biosynthetic pathway, we examined flavonoid biosynthesis as 
well, because this pathway was important for two reasons: 1) the color change between plants 
treated and not treated with UV may be useful as a simple phenotypic screen predictive of 
acylphloroglucinol accumulations (Figure 1); 2) analysis of changes in the flavonoid biosynthetic 
genes is a means of validating the use of the differential gene expression analysis in identifying 
genes involved in acylphloroglucinol metabolism in this system.  Three percent of the genes that 
are differentially up-regulated after exposure to UV-B were assigned to the flavonoid pathway 
by comparing the computational annotations given to these genes to enzymatic steps of the 
flavonoid pathway (www.metacyc.com/META/NEW-
IMAGE?type=PATHWAY&object=PWY1F-FLAVSYN).  These genes encode enzymes 
catalyzing steps as early as the biosynthesis of phosphoenolpyruvate and 4-erythrose phosphate 
(Figure 6).   
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 Acyphloroglucinols and flavonoids are increased during exposure of H. gentianoides 
plants to UV-B.  If UV-B induces the acylphloroglucinol biosynthesis genes as it does the 
flavonoid transcripts and metabolite abundances increased, giving us evidence that the genes 
involved in acylphloroglucinol biosynthesis should be increased as well.  Although not all these 
enzymes are characterized, based on the reactions involved, all can be postulated. 
Biosynthesis of diacylphloroglucinol likely involves at its early stage the genes of the non-
mevalonate pathway and the genes encoding enzymes for biosynthesis of isobutyryl-CoA from 
valine (Adam et al., 2002; Karppinen et al., 2007; Chapter 4).  The latter steps of 
diacylphloroglucinol biosynthesis likely require a polyketide synthase, most specifically 
phlorisobutyrophenone synthase, to produce phlorisobutyrophenone (Klingauf et al., 2005).  
Phlorisobutyrophenone would be modified to form the monomer pool described by Crispin et al. 
(2013), through various prenyl and methyltransferases.  We hypothesize that the dimerization of 
these acylphloroglucinol monomers we hypothesize proceeds via an enzyme homologous to the 
non-cytochrome P450 oxidoreductase, reticuline oxidase (Crispin et al., 2013). 
 UV-B induces up-regulation of genes with homology to polyketide synthase, 
methyltransferases, prenyltransferases and one of the four genes with homology to reticuline 
oxidase (Figure 5).  The domain described in Figure 5 does not include the 3 histidine residues 
that are essential for reticuline oxidase‘s activity (Winkler et al., 2008), so it is also possible that 
these RTO-like genes are involved in acylphloroglucinol dimerization.  
 Transcripts corresponding to the two biosynthetic pathways for dimethylallyl 
diphosphate, the mevalonate and non-mevalonate pathways, and to isobutyryl-CoA biosynthesis 
were not found to be differentially expressed in our analysis.  The explanation for this is that 
entire aerial portions of plants were used for RNA sequencing.  It is likely that 
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acylphloroglucinol biosynthesis takes place exclusively in the glands, but it is possible that an 
increase in dimethylallyl diphosphate and isobutyryl-CoA biosynthesis in the translucent glands 
may be obscured by the countervailing or overwhelming expression of these two pathways in 
non-glandular tissues. 
 
Conclusion 
 Understanding the biosynthesis of specialized metabolites in Hypericum species has been 
difficult given the lack of information about intermediate steps and/or the localization of 
intermediate metabolites.  However, next generation sequencing has recently accelerated the 
information gathering and gleaning process.  We used UV-B stress to induce changes in 
acylphloroglucinol and flavonoid biosynthesis and their biosynthetic transcripts.  From this we 
identified unigenes corresponding to flavonoid biosynthesis and identified 2,600 transcripts that 
were differentially expressed following UV-B irradiation.  Of these, several corresponded to 
transcripts previously identified as involved in flavonoid biosynthesis.  Perhaps not surprisingly, 
many of the pathways corresponding to these steps are also enriched (Table 3).  Given the extent 
of evidence we observed indicating that the flavonoid biosynthetic pathway is up-regulated, we 
have evidence to suggest that acylphloroglucinol biosynthetic transcripts should also be 
significantly up-regulated.  We identified several transcripts that were up-regulated, and 
annotated as polyketide synthases, methyltransferase, prenyltransferases, and a reticuline 
oxidase-like gene; we believe these genes are be involved in acylphloroglucinol biosynthesis in 
Hypericum gentianoides. 
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Materials and Methods 
 
Plant Material 
               Hypericum gentianoides germplasm, accessioned in the US National Germplasm 
system as Ames 27657 and PI 664838, were obtained as seeds from the USDA North Central 
Regional Plant Introduction Station, Ames, Iowa.  Seeds were planted in a growing medium 
(Sunshine LC1 SUN-COIR, Sun Gro Horticulture, Canada) in a greenhouse with natural light 
supplemented by an 8/16 hr photoperiod at 120 μmol m-2 s-1, in temperatures between 19-25 
degrees Celsius, and plants were watered as necessary.  Plant samples were placed in a 1.5 mL 
Eppendorf tubes, and immediately stored in liquid nitrogen to minimize degradation of 
polyketides. Samples were kept in liquid nitrogen until they were extracted.  
 
Application of Stressors 
 
UV-B Treatment 
 Three pots containing multiple H. gentianoides plants were put under a lighting apparatus 
with UV-B lights, and three more pots were placed under a lighting apparatus with fluorescent 
lights as a control.  Two days prior to incubation with different lights, we surrounded the 
apparatuses with saran wrap to equalize the air currents and temperatures.  Immediately before 
the experiment, the UV-B apparatus was also wrapped in tin foil to ensure that UV-B light would 
not bleed into the fluorescent light control.  After the lights were turned on (fluorescent for the 
control, UV-B for the treatment), samples were taken at 0, 6, 12, and 24 h to analyze with 
HPLC-UV where samples were taken at 30 min and 8 h to be sequenced. 
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Metabolite Extraction 
 Before extraction, plant material was removed from liquid nitrogen, quickly weighed 
before thawing and placed in a liquid nitrogen cooled mortar. 10 µL of apigenin in methanol at a 
concentration of 1 mg/mL was added to each sample of plant material as an internal standard.  
More liquid nitrogen was added to prevent thawing, and the plant material was finely ground 
with a pestle.  2 mL of methanol were added, the extract was further ground, and then vortexed 
for 30 s, and centrifuged at 13,000 rpm for 2 min.  The supernatant was decanted, filtered 
through a 0.45 micron nylon syringe filter, and stored in a -80°C freezer.  
 
RNA Extraction 
 Before extraction, plant material was removed from liquid nitrogen, and quickly placed 
into a liquid nitrogen filled mortar.  Ground plant material was extracted by using a Spectrum
TM 
Plant Total RNA kit from Sigma Aldrich (St. Louis, MO). 
 
Acylphloroglucinol Identification and Quantification 
 The nine acylphloroglucinols of interest were identified and quantified using methods 
described by our lab previously (Crispin et al., 2013). 
 
Differential Expression Analysis 
 As a requirement for this type of analysis, the experiment was done as a randomized 
experiment.  To retain a unigene from the initial list of 125,571 generated from the de novo 
transcriptome assembly, it was necessary for at least two non-zero read counts across samples 
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within the combinations to be tested for differential expression.  After applying this stipulation, 
92,407 were tested for differential expression with the R package QuasiSeq (http://cran.r-
project.org/web/packages/QuasiSeq).  Six tests of differential expression for each gene were 
computed: difference between control and treatmentafter 30 min, difference between control and 
treatmentafter 8 h, difference between the control at 30 min and 8 h, difference between the UV 
treatment at 30 min and 8 h, difference between the control at 30 min and UV treatment at 8 h, 
and the difference between the control at 8 h and UV treatment at 30 min. 
 P-values for each gene and comparison were computed using the negative binomial 
QLSpline method implemented in the QuasiSeq package of R as described by Lund et al. (2012).  
The log of each count mean was modeled as the sum of an intercept term, treatment 
effects(control at 8 h minus control at 30 min, UV at 30 min minus control at 30 min, UV at 8 h 
minus control at 30 min) and an offset normalization factor, determined for each sample by the 
weighted trimmed mean of M-values described in Robinson and Oshlack (2010).  Estimates of 
the log base 2 fold change between the difference in treatment effects were computed by 
evaluating the exponential function at estimates of treatment effect differences and then 
evaluating the corresponding results using the log base 2 function.  Using the p-values for each 
comparison, the approach of Nettleton et al. (2006) was applied to estimate the number of genes 
with true null hypotheses among all genes tested. This estimate was used to convert the p-values 
to q-values (Storey, 2002).  To obtain approximate control of the false discovery rate at 5%, 
genes with q-values no larger than 0.05 were declared to be significantly different with respect to 
any specific comparison.  
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Table 1- Summary of sequence assembly
a
 from H. gentianoides. 
Total number of reads 68,993,210 
Total number of nucleotides (nt) 6,899,321,000 
Q20 percentage 89.25% 
GC percentage 50.87% 
Assembly  
Total number of contigs 428,447 
Average contig length (bp) 155 
Total number of unigenes 125,571 
Total nucleotides (nt) in unigenes 40,802,343 
Average unigene length (bp) 325 
a.
 Assembly is derived from sequences of a pool of tissues collected from Ames 27657 untreated 
and UV-B treated plants and from PI 664838 plants  
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Table 2- Summary of functional annotations for H. gentianoides unigenes based on public 
protein databases. Based on 125,571 unigenes in the assembled transcriptome. 
Public Protein Database Number of Unigene Hits Percent of all Unigenes (%) 
COG 
(www.ncbi.nlm.nih.gov/COG/) 
14,748 11 
KEGG (www.genome.jp/kegg/) 25,653 20 
NR 
(www.ncbi.nlm.nih.gov/refseq/) 
65,730 52 
Swiss-Prot (www.uniprot.org/) 40,928 33 
Total hits to public databases 66,140 53 
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Table 3- Pathway enrichment analysis.   
Pathway Name P-value  Corrected 
P-value  
Differentially 
expressed 
genes in 
pathway 
Genes In 
Background 
esculetin biosynthesis 1.17E-10 1.17E-10 7 7 
o-diquinones biosynthesis 1.17E-10 1.17E-10 7 7 
betanidin degradation 7.28E-07 7.28E-07 16 97 
superpathway of lipoxygenase 9.84E-07 9.84E-07 21 163 
9-lipoxygenase and 9-hydroperoxide lyase pathway 1.45E-06 1.45E-06 11 48 
divinyl ether biosynthesis I 1.45E-06 1.45E-06 11 48 
9-lipoxygenase and 9-allene oxide synthase pathway 1.45E-06 1.45E-06 11 48 
epoxy fatty acid biosynthesis 1.45E-06 1.45E-06 11 48 
flavonol glucosylation I 2.81E-06 2.81E-06 9 33 
trans-cinnamoyl-CoA biosynthesis 1.00E-05 1.00E-05 9 38 
pyruvate fermentation to lactate 1.05E-05 1.05E-05 4 5 
phenylpropanoid biosynthesis, initial reactions 5.16E-05 5.16E-05 9 46 
homogalacturonan degradation 5.23E-05 5.23E-05 20 194 
sucrose degradation I 0.000120 0.000120 9 51 
suberin biosynthesis 0.000121 0.000121 13 101 
stachyose biosynthesis 0.000220 0.000220 9 55 
superpathway of anthocyanin biosynthesis (from 
delphinidin 3-O-glucoside) 0.000252 0.000252 5 16 
glutathione-mediated detoxification II 0.000756 0.000756 8 52 
gentiodelphin biosynthesis 0.000836 0.000836 4 12 
methyl indole-3-acetate interconversion 0.00225 0.00210 18 221 
glutamate degradation X 0.00400 0.00400 3 9 
glutamate biosynthesis II 0.00400 0.00400 3 9 
chorismate biosynthesis from 3-dehydroquinate 0.00529 0.00529 5 30 
mannitol degradation II 0.00555 0.00555 3 10 
thioredoxin pathway 0.00555 0.00555 3 10 
superpathway of glyoxylate cycle and fatty acid 
degradation 0.00809 0.00711 14 174 
D-mannose degradation 0.00843 0.00843 2 4 
proline degradation 0.00843 0.00843 2 4 
4-hydroxybenzoate biosynthesis V 0.00912 0.00912 4 22 
coumarin biosynthesis (via 2-coumarate) 0.0109 0.0109 10 112 
chitin degradation II 0.0116 0.0116 5 36 
jasmonic acid biosynthesis 0.0130 0.0130 10 115 
ethylene biosynthesis I (plants) 0.0185 0.0185 6 55 
phenylpropanoid biosynthesis 0.0249 0.0249 7 75 
ascorbate glutathione cycle 0.0269 0.0269 4 30 
UDP-D-glucuronate biosynthesis (from myo-inositol) 0.0273 0.0273 2 7 
methylquercetin biosynthesis 0.0273 0.0273 2 7 
DIMBOA-glucoside biosynthesis 0.0300 0.0300 4 31 
174 
 
Table 3. Continued 
xylose degradation I 0.0355 0.0355 2 8 
linear furanocoumarin biosynthesis 0.0385 0.0385 1 1 
fructan degradation 0.0385 0.0385 1 1 
chorismate biosynthesis I 0.0393 0.0393 5 49 
sesquiterpenoid phytoalexins biosynthesis 0.0445 0.0445 2 9 
TCA cycle II (eukaryotic) 0.0616 0.0446 8 103 
flavin biosynthesis I (bacteria and plants) 0.0451 0.0451 3 21 
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Supplemental Tables 
Table S1- H. gentianoides expression matrix. 
Table S2- Unigenes that are differentially expressed when exposed to UV-B irradiation for 8 h. 
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Table S3- Unigenes that are significantly up-regulated after UV-B irradiation for 8 h, with 
annotations corresponding to the flavonoid biosynthetic pathway. 
Flavonoid Gene Name Corresponding Up-regulated Hypericum 
gentianoides Unigene(s) 
3-Dehydroquinate Dehydratase Unigene20824 
Shikimate Dehydrogenase Unigene23530 
Shikimate Kinase Unigene18969, 105820 
Chorismate Synthase Unigene97762, 103928  
Phenylalanine Ammonia Lyase Unigene1, 13, 3492, 21203, 23509, 82508, 
87635, 87888, 117991 
4-Coumaroyl-CoA Ligase Unigene1895, 12604, 15032, 51657, 
87537, 92332 
Chalcone Synthase Unigene1058, 3096, 4002, 5583, 7925, 
8604, 9363, 13969, 15832, 16288, 18263, 
60545, 63064, 68228, 81768, 91220, 
92344, 94884, 116099, 121244  
Flavonol Synthase Unigene12080, 116282, 124743 
Flavonoid 3'-Monooxygenase Unigene419, 1038 
Dihydroflavonol 4-Reductase Unigene309, 1205, 118230  
2-Oxoglutarate Dependent Dioxygenase Unigene1764, 20428, 21589, 23596, 
59685, 118801 
Anthocyanidin 3-O-Glucosyltransferase Unigene8174, 114164 
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Figure 1- Effect of stressors on the total relative acylphloroglucinol content in 2 accessions of H. 
gentianoides.  Using several stressors that have been reported to modulate the abundance of 
specialized metabolites in Hypericum spp, we determined that only UV-B in the Ames 27657 has 
significantly up-accumulated ((p<0.05) denoted by the '*').  Statistical significance for each of 
the nine major acylphlorogluinols over the UV-B treatment is shown in Figure 3. 
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Figure 2- Effects of UV-B exposure on flavonoid accumulation in H. gentianoides (Ames 27657 
accession). Plants were treated with UV-B for 24 h. A) Plants treated with UV-B show leaves 
that are slightly purple, and much darker than the plants that have not been treated with UV-B.  0 
h UV-B stress- left, 24 h UV-B irradiation- right.  B) Insoluble pellet after methanol extraction 
and centrifugation of shoots.  The pellet illustrates the change in color after 24 h of UV-B 
irradiation.   
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Figure 3- Accumulation of acylphloroglucinols after exposure of H. gentianoides plants to UV-
B irradiation.  Thirty day old H. gentianoides plants (accession Ames 27657) were kept in the 
dark for 12 h prior to experiment, then harvested at 0 h, 6 h,12 h, and 24 h.  These samples were 
ground, extracted and analyzed using HPLC-UV. Acylphloroglucinol content is normalized with 
an apigenin internal standard.  A) Untreated plant seedlings, B) UV-B treated Ames 27657 
seedlings.  n =3 
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Figure 4- Quality of de novo transcript assembly in H. gentianoides.  A) Length and B) Gap 
distribution of unigenes.  There appear to be many on average smaller unigenes which are likely 
due to the use of two different populations not to mention the use of many small vegetative phase 
plants from the same accession that would also have allelic diversity. 
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Figure 5- Alignment of amino acid sequences of reticuline oxidase from Eschscholzia 
californica (California poppy) to translations of the 18 H. gentianoidesunigenes with homology 
to this protein.  We did not include 12 of the 30 unigenes because their expression was 0 RPKM 
in the 8 h UV-B treatment.  It is highly unlikely these unigenes would be involved with 
diacylphlooglucinol biosynthesis, given the negative correlation between these unigene FPKM 
and diacylphloroglucinol accumulation.  RTO, reticuline oxidase from Eschscholzia californica. 
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Figure 6- Sequence comparison of H. gentianoides reticuline oxidase-like protein to reticuline 
oxidase (RTO) proteins, and putative RTO proteins,in bacteria and plants.  Reticuline oxidase 
proteins of bacteria, plants, compared to four H. gentianoides unigenes.  Only four of the 30 
unigenes of H. gentianoides have regions homologous to this region of reticuline oxidase.  The 
domain does not include 3 histidine residues required for reticuline oxidase activity.  Similar and 
identical regions are shown in red, slight similarity is shown in blue.  SaRTO (Sulfobacillus 
acidophilus reticuline oxidase), green font represents amino acidsthat are different from those of 
plant reticuline oxidase proteins.  Figure abbreviations: 103430, 109915, 20737, 116738- 
translated unigenes from H. gentianoides, At1g30760- reticuline oxidase-like protein from A. 
thaliana, At1g11770- putative reticuline oxidase, MtRTO- Medicago truncatula reticuline 
oxidase, EcRTO- Eschscholzia californica reticuline oxidase, SaRTO- Sulfobacillus acidophilus 
reticuline oxidase 
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Figure 7- UV-B irradiation up-regulates the genes of the anthocyanin biosynthetic pathway and 
pathways of the phenylalanine precursor in H. gentianoides.  The latter steps of anthocyanidin 
biosynthesis are up-regulated, as well as many steps much earlier in the process.  The red 
highlights represent unigenes in the anthocyanin biosynthetic pathway that are up-regulated 
under UV-B irradiation.  See Table S3 for enzyme names and other unigenes corresponding to 
that step.  
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Figure S1- COG (http://www.ncbi.nlm.nih.gov/COG/) and GO analysis of unigenes from H. 
gentianoides. COG functional classification of H. gentianoides unigenes.  14,748 (11.74%) of 
the unigenes are encompassed through the 26 COG terms with an e-value greater than or equal to 
1x10
-5
. GO terms assigned to H. gentianoides unigenes.  32,299 (25.72%) of the unigenes were 
assigned to the three independent GO functions.  Cellular processes and metabolic processes 
were most often assigned in the biological process; cell and cell part were most frequent in 
cellular components, and catalytic activity and binding were most prevalent in molecular 
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function.  These two methods for examining function yield similar results to that found in H. 
perforatum (He et al., 2012).  
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Figure S2-Gene ontology analysis in H. gentianoides.  The GO analysis in Figure S1 is a more 
generic analysis, so a GO analysis that delved deeper into the hierarchy of GO terms was 
performed.  A) Biological processes, B) cellular component, C) molecular function 
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Figure S3- Alignment of unigene22184 to the Hyp-1 protein from Hypericum perforatum.  The 
Hyp-1 protein has been shown to directly catalyze emodin to hypericin in H. perforatum (Bais et 
al., 2003).  However, H. gentanoides does not produce any detectable hypericin or the glands by 
which hypericin accumulates in.  Other Hypericum species beside H. gentianoides that do not 
produce hypericin or the glandular nodules produce this Hyp-1 protein as well (Košuth et al., 
2011). 
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Figure S4- Visualizing the flavonoid biosynthetic pathway using H. gentianoides unigenes.  
Given our goal to identify genes involved in the production of specialized metabolism, we 
examined the known flavonoid biosynthesis.  After inserting unigene annotations into Plantcyc 
pathway tools, it is observable that there are unigenes that correspond to every step of this 
pathway beginning at phenylalanine.  The step between leucocyanidin and cyanidin does not 
have any unigenes assigned to it because the reaction in Plantcyc corresponds to a general 
reaction.  
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Abstract 
 Hypericum perforatum is an herbaceous perennial plant that has been used since Ancient 
Greek times for its bioactive properties.  Many of the molecules that evoke these bioactivities 
have been identified.  However, there is still relatively little information about genes and 
chemical intermediates involved with polyketide metabolism in Hypericum species.  Here, we 
used laser desorption ionization mass spectroscopy to visualize regions of accumulation of 
polyketides in situ.  This analysis revealed that much of the hypericin biosynthetic pathway as 
well as the metabolites quercitrin, isoquercitrin and miquelianin accumulate only in the glandular 
nodules.  We hypothesize the quercetin glycosides accumulate on the outer layer of the glandular 
nodules and act to protect the plant from the photo-reactive hypericins.  Additionally, fifteen 
tissues at varied stages of development were dissected from H. perforatum, analyzed for 
polyketides content, and sequenced and assembled into a de novo transcriptome.  Through 
functional annotations, we identified a polyketide synthase highly correlated to hyperforin, this 
gene, PKS1 was hypothesized to be the PKS, phlorisobutyrophenone synthase.  This protein was 
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expresssed in bacteria, purified, and incubated with malonyl-CoA and isobutyryl-CoA.  This 
assay demonstrated that PKS1 is capable of producing phlorisobutyrophenone, indicating 
another unidentified PKS is responsible for this activity.    
 
Introduction 
 According to fossil records, humans have used plants with medicinal properties as far 
back as 60,000 years ago (Fabricant and Farnsworth, 2001).  Not only are these plants useful to 
humans past and present, but they are used by other primates as anti-parasitic agents (Huffman et 
al., 1997). The transition to modern drugs from medicinal plants began around 1770, when 
digoxin, a terpene alkaloid from Digitalis purpurea L., was shown to be useful in the treatment 
of heart failure (Fowler, 2006).  There has been a recent surge in use of herbal remedies, so much 
so that more people use these ―alternative‖ medicines than modern pharmaceuticals (Tachjian et 
al., 2010).  Considering the wide medicinal applications for these bioactive compounds, many 
researchers have worked to understand their biosynthesis (Schmidt and Beerhues, 1997; 
Karppinen et al., 2007).  Many of these studies have found that these compounds are sequestered 
in specialized organelles and structures (Onelli et al., 2002; Soelberg et al., 2007; Karppinen et 
al., 2008). 
 Even though a great deal of information has been complied on the accumulation of 
bioactive compounds in these plants, there is still relatively little information pertaining to the 
enzymatic and regulatory mechanisms underlying the biosynthesis of these compounds in 
Hypericum species beyond of the type III polyketide synthases (Liu et al., 2003; Karppinen et al., 
2008a).  In Hypericum perforatum, there are four predicted PKS enzymes involved with 
specialized metabolism: chalcone synthase, benzophenone synthase, emodin synthase, and 
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phlorisobutyrophenone synthase, responsible for the synthesis of flavonoids, xanthones, 
dianthrones, and acylphloroglucinols respectively (Liu et al., 2003; Karppinen and Hohtola, 
2008; Karppinen et al., 2008).  The chalcone and benzophenone synthase have been identified 
and validated in H. perforatum, and catalyze by adding variable numbers of malonyl-CoA 
molecules to an activated CoA molecules, such as acetyl-CoA (Košuth et al., 2011).  With the 
exception of the xanthones and the flavonoids, which are present in other species of plants, and 
PKSs, only one other gene, Hyp-1, has been shown to be involved in the processing of 
specialized metabolites in H. perforatum (Bais et al., 2003; Yonekura-Sakakibara and Saito, 
2009). 
 With the introduction of next generation sequencing, rapid and meaningful sequencing of 
the full genome/transcriptome of medicinal species can be performed.  Through the efforts of the 
Medicinal Plant Consortium (http://medicinalplantgenomics.msu.edu/), material was collected 
and sequenced from 13 medicinal plant species, including H. perforatum.  This analysis was 
quite useful, given that the entire transcriptome should include all the transcripts in the plant, 
including those involved in bioactive compound biosynthesis.  Many steps involved in the 
processing of specialized metabolites are unknown, thereby making approaches based on 
homology problematic.  In order to gain useful information about to the polyketide biosynthetic 
genes, it is necessary to compare the abundance of transcripts, also referred to as unigenes, 
abundance to the metabolite abundance.  The goal of this type of metabolomic/transcriptomic 
correlation experiments is to identify a set of tissues that possess transcriptomes that differ, as 
much as possible, only with respect to the biosynthetic and regulatory genes of the biosynthetic 
process of interest.  In order for such an experiment to be useful, according to Crispin and 
Wurtele (2013) two assumptions must be met: 1) the tissue location of a metabolite must also be 
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the location of the expression of the corresponding biosynthetic gene, and 2) that tissue needs to 
be actively biosynthesizing the metabolite of interest.  Additionally, the change between 
expression abundance and metabolite abundance must be directly proportional. 
 In this study, we used LDI-MS to identify how several specialized polyketides and their 
intermediates accumulate across the leaves, sepals, petals, and anthers of H. perforatum.  Based 
on this, we identified a set of tissues with diverse levels of bioactive compounds across the 
flowers, leaves, and roots.  Aliquots of the collected tissues were analyzed by liquid 
chromatography and sequenced by using Illumina GAII.  We compared the accumulation of 
eleven specialized polyketides to the expresssion patterns of all the unigenes from our 
transcriptomic library.  Through this comparison we found several unigenes of interest, but 
focused on single unigene with homology to a polyketide synthase and abundance that was 
strongly correlated to the acylphloroglucinol, hyperforin.  Cloning in E. coli and subsequent in 
vitro biochemical assays with the purified recombinant protein established that this gene is not 
capable of producing phlorisobutyrophenone at any level, revealing that a true gene possessing 
this activity has yet to be identified.         
 
Results 
 
Visualization of Quercetins, Hypericins, and Hyperforin by using Laser Desorption Ionization 
Mass Spectroscopy (LDI-MS) 
 To determine more effectively which tissues would be examined for a 
metabolomic/transcriptomic evaluation, we used LDI-MS.  The advantages of this approach are 
1) we can examine metabolites by using intact fresh tissue instead of ground tissue, and 2) we 
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can examine metabolic precursors to the metabolites of interest to gain a better understanding of 
where biosynthesis occurs.  Via this approach, we examined hyperforin, hypericins, and several 
flavonoids in the leaves, petals, anthers, and sepals.  In Figure 1, we illustrate that the 
acylphloroglucinol, hyperforin, accumulates only in translucent glands, on both the abaxial and 
adaxial sides of the leaf.  This observation is identical to acylphloroglucinol accumulation in the 
translucent glands of H. gentianoides (Chapter 4). 
 Next we examined how metabolites in the hypericin biosynthetic pathway accumulate in 
the four types of tissues.  Specifically, we examined emodin anthrone, emodin, emodin 
dianthrone, protohypericin, hypericin, protopseudohypericin, and pseudohypericin.  In all 
examined tissues, the emodin dianthrones, protohypericin, hypericin, protopseudohypericin, and 
pseudohypericin always corresponded to the presence of a glandular nodule (Figures 2-5).  As 
seen with hyperforin, hypericin accumulation follows what has been previously reported 
(Kornfeld et al., 2007; Karppinen et al., 2008).  If the glandular nodules are the site of hypericin 
biosynthesis as is predicted by Kornfeld et al. (2007), then emodin anthrone, emodin, and 
emodin dianthrone should be detectable in the glandular nodules as well.  For emodin dianthrone 
this is exactly what we observed (Figures 2D, 3D, and 4D).  However, emodin anthrone was 
difficult to detect except in the anthers; in that tissue, it seems to accumulate in the glandular 
nodules.  In contrast, emodin appears to be negatively correlated with the glandular nodules in 
the anthers and the leaves (Figures 2C, 4C), but seems to more closely associated with the 
nodules in petals (Figure 3C).  Although metabolites putatively involved with the early steps of 
dianthrone biosynthesis were slightly unexpected, based on the localization of all the polyketides 
of interest analyzed using LDI-MS, we believed focusing on tissues with and without glandular 
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nodules for the metabolomic/transcriptomic correlation analysis would yield information about 
the biosynthesis of dianthrones. 
 The last polyketide class analyzed was the quercetins.  Much more information is 
available in the literature pertaining to the biosynthesis of quercetin and quercetin glycosides, 
since these compounds accumulate in model organisms like Arabidopsis, and in some 
agriculturally relevant plants like soybeans (Naim et al., 1976; Yonekura-Sakakibara and Saito, 
2009).  These compounds accumulate in plants that produce neither glandular nodules nor 
translucent glands; therefore, we expected that they would accumulate throughout the aerial 
portions of the plants with the exception of the glands.  We observed this for quercetin and its 
precursor, kampferol; however, quercitrin, isoquercetin, and miquelianin preferentially 
accumulated in the glandular nodules in the leaves, petals, and anthers, the three tissues analyzed 
for quercetin accumulation (Figures 7E-G, 8E-G).      
 
Profiling of metabolites using HPLC-UV 
 LDI-MS and other metabolic analyses not shown in paper were used to identify the 15 
candidate tissue types used for generating the transcriptomic and metabolomic profiles that we 
hypothesized would be most likely to identify new polyketide biosynthetic genes.  The H. 
perforatum tissues types that were collected focused on different developmental stages and on 
tissues where translucent glands and glandular nodules could be separated.  We collected 12 
different aerial portions of the plant: open flowers, petals from open flowers, petal region with 
glandular nodules from an open flower, petal region without glandular nodules from an open 
flower, flower buds, pistil, stamen, and sepal from flower buds, young leaves, old leaves, and 
young, mid-aged and old leaves without light glands. 
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 Along with aerial portions of the plant, we collected and analyzed root tissues 
representing three different stages of growth.  The advantage of using including these tissues was 
that their low or undetectable polyketide levels gave us a baseline for a wide spectrum of 
polyketide abundances.  The absolute and relative concentration of 11 polyketides in the roots 
compared to the average of all 12 aerial tissues collected are shown in Table 1. 
 We observed many results from this analysis that were directly in line with observations 
made using LDI-MS.  All of the accumulations levels over all the tissues described can be found 
on the Plant & Microbial Metabolomics Resource (www.metnetdb.org/PMR/). 
 
Analysis of transcriptomic profiles 
 To identify transcripts involved with polyketide biosynthesis in H. perforatum, next 
generation sequencing was utilized.  At the time this experiment was performed there was no 
existing genome/transcriptome for H. perforatum, so it was necessary to generate a reference 
genome from a pooled sample of H. perforatum meant to encompass as much of the 
transcriptome as possible.  Extraction and processing of RNA prior to sequencing, as well as 
assembly and quantification of the de novo transcriptome was performed as described in 
Góngora-Castillo et al. (2012).  The expression matrix for all the analyzed tissues and unigene 
sequences can be found in Tables S1 and S2. 
 After annotating the expression matrix, we identified several enzymatic processes that 
have previously been identified as being involved or putatively involved in the metabolism of 
specialized polyketides in Hypericum spp (Table 2).  Many of these annotations were observed 
in another de novo assembly of H. perforatum done by He et al. (2012).  However, the goal of 
this study was to use the de novo transcriptome to identify new biosynthetic genes.   
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Because of the anti-depressant activity of hyperforin, we focused on identifying the polyketide 
synthase involved with biosynthesis of this compound.  Previous efforts found two cDNA in H. 
perforatum homologous to a polyketide synthase (PKS1 and PKS2).  PKS1 in that study was 
correlated to hyperforin accumulation while PKS2 was correlated to hypericin accumulation.  
PKS2 was found to be an octaketide synthase in vitro that accumulated highest in the glandular 
nodules (Karppenin et al., 2008).  No other studies into PKS1 have been conducted; therefore, 
we examined our transcriptomic library to determine whether PKS1 was present.  After 
translating this unigene into all translational reading frames, we observed one reading frame that 
contained the entire CDS of PKS1 (Figure 10).  We observe that the accumulation of hyperforin 
does indeed correlate well with the expression of PKS1 over the collected H. perforatum tissues 
(Figure 11).    
 
Enzymatic activity of recombinant PKS1 protein in vitro 
 To study the enzymatic activity of PKS1 in vitro, we performed Gateway transformation 
in E. coli and expressed a GST-PKS1 fusion protein in the protein expression bacteria BL21-AI 
(see methods, Figure 12A-C).  After testing for phlorisobutyrophenone synthase activity by 
adding isobutyryl-CoA and malonyl-CoA to the bacteria culture and to crude protein extracts 
(data not shown), we were unable to detect phlorisobutyrophenone.  We hypothesized the GST 
protein fused to the PKS1 protein was somehow inhibiting activity.  Therefore, we purified the 
GST-PKS1 fusion protein and cut with factor Xa, which cut at the N-terminus of PKS1 (see 
methods).  Protein gel confirmed the presence of a band at 42 kD (the predicted molecular 
weight of PKS1) corresponding to cleavage of the GST protein and amino acids from the 5‘ 
primer (Figure 12D).  We testedforphlorisobutyrophenone synthase activity after incubating the 
199 
 
purified PKS1 protein with malonyl-CoA and isobutyryl-CoA similar to Klingauf et al. (2005).  
We also compared this to a GST-GUS control also incubated with malonyl-CoA and isobutyryl-
CoA.  FTICR-MS was used to identify an ion, in negative ion mode, corresponding to the 
molecular weight of phlorisobutyrophenone ((195.1 m/z), Figure 13A).  MS/MS was performed, 
from this, the primary fragmentation ions were found to have m/z of 158.9 and 176.9, which 
corresponds to the loss of one and two hydroxyl group, respectively (Figure 13B).  However, this 
spectra was not consistent with that found from what was putatively identified as 
phlorisobutyrophenone in H. gentianoides by Crispin et al. (2013).  Using a synthetic scheme 
shown by Kraus and Liu (2012), we synthesized phlorisobutyrophenone and developed an 
MS/MS profile.  This profile definitively showed that the 195.1 m/z ion detected in the PKS1 
assay was not phlorisobutyrophenone and this gene may be homologous to a PKS but it does not 
appear to have the expected PKS activity.      
 
Discussion 
 Hypericum perforatum is a medicinal plant species that biosynthesizes several classes of 
specialized metabolites including: acylphloroglucinols, dianthrones, and flavonoids (Ganzera et 
al., 2002; Soelberg et al., 2007; Karppinen et al., 2008).  Due to the established bioactivities of 
each of these classes of polyketides (Thiede and Walper, 1994; Brenner et al., 2000; Butterweck 
et al., 2000), a considerable effort has been devoted to understanding the means by which 
specialized polyketides unique to H. perforatum are generated (Bais et al., 2003; Karppinen et 
al., 2007; Karppinen et al., 2008). 
 Part of the issue that has previously hindered identification of biosynthetic machinery has 
been a lack of sequencing data available; however, with next generation sequencing, de novo 
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transcriptomes are relatively easy to generate.  The first effort to sequence H. perforatum in 
which the primary goal of the study was to use next generation sequencing and RT-PCR as a 
means to identify and validate the presence of previously identified biosynthetic genes was 
performed by He et al. (2012).  The goal of our research was to identify and validate a previously 
unidentified genes/enzymatic activities involved with specialized polyketide biosynthesis. 
 To accomplish this, we did not use only one sample, but we used a large array of tissues 
that accumulate differing amounts of the polyketides of interest.  As described in Crispin and 
Wurtele (2013) this allowed us the ability to correlate shifts in metabolite abundance to shifts in 
transcript abundance, assuming two things are happening: 1) a metabolite is biosynthesized in 
the same place it is accumulating and 2) a metabolite is being actively biosynthesized at that 
time.  Additionally, with these experiments, we assume that translation and transcription rates of 
a specific gene are directly proportional. 
 Prior to collection of tissues, LDI-MSI and HPLC-UV were used to identify tissues with 
the greatest difference with respect to the polyketides of interest.  After examining the leaves, 
anthers, petals, and sepals with LDI-MSI, we established that the glandular nodules and 
translucent glands were the locations of the hypericins and the acylphloroglucinol hyperforin 
respectively.  This finding is in agreement with other studies on the accumulation sites of 
dianthrones and acylphloroglucinols in H. perforatum (Soelberg et al., 2007; Karppinen et al., 
2008).  After examination of the accumulation of the quercetins with LDI-MSI and HPLC-UV, 
we observed that three quercetin glycosides accumulation preferentially within the glandular 
nodules (Figures 6-8).  This is unusual given these compounds aren't found exclusively in the 
genus Hypericum, but they accumulate preferentially in a structure unique to the genus (Onelli et 
al., 2002).  We hypothesize that these quercetin glycosides are protecting the plant from photo-
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reactive damage inherent with hypericin by two means: 1) in Onelli et al. (2002), researchers 
observed that the outer layer of the glands is composed of dark colored material that are not the 
hypericins and are likely flavonoids, and 2) quercitrin, isoquercitrin and miquelianin all possess 
anti-oxidant properties (Hasan et al., 2006; Kirmizibekmez et al., 2009; Jung et al., 2010), likely 
assisting in buffering any self photo-oxidation as a result of the hypericins. 
 Using information gleaned from the LDI-MSI analysis, 15 tissues were collected, half of 
each sample was analyzed with HPLC-UV while the other half was sequenced using Illumina 
sequencing.  After assembling the qualities of both metabolites and transcripts, we began to 
identify unigenes that corresponding to many of the genes that have been predicted to be 
involved in polyketide metabolism (Table 2).  Of those genes/processes involved, we observed a 
unigene of interest that was strongly correlated with hyperforin and contained the entire coding 
region of a previously identified protein homologous to a polyketide synthase (Figures 10, 11).   
Because of 1) its strong correlation to hyperforin, and 2) its strong homology to other polyketide 
synthases, we hypothesized that this polyketide synthase could be the enzyme responsible for 
phlorisobutyrophenone biosynthesis.  PCR validation of 3‘ rapid amplication of cDNA ends 
(RACE) was performed.  The band of ~1200 bp on the agarose gel was the correct size to be 
PKS1 (Figure 12A).  This sequence was transformed into the protein expression bacteria BL21-
AI using Gateway cloning.  PCR validation revealed the presence of the PKS1 gene in the 
bacteria, and a protein gel shows that the GST-PKS1 is expressed and under the control of the 
arabinose promoter (Figure 12B, C).  Protein (PKS1 and GUS for the FTICR-MS control) 
produced from the protein expression cultures were induced using ITPG, the protein was 
extracted and purified by means of the GST tag.  The purified protein was cut with factor Xa, 
yielding the native PKS1 protein (see methods).  After incubating with the putative 
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phlorisobutyrophenone substrates, and analyzing a sample with the PKS1 protein compared to a 
GST-GUS control, we identified an ion corresponding to phlorisobutyrophenone in negative ion 
mode (195.1 m/z) (Figure 13A).  This ion was only present at detectable levels within the PKS1 
sample, however, validation that this ion was phlorisobutyrophenone was needed.  
 FTICR-MS/MS of this ion showed two fragments, which could correspond to the lost of 
one and two hydroxyl groups (Figure 13B).  However, this is different from the MS/MS spectra 
obtained from an ion predicted to be phlorisobutyrophenone by Crispin et al. (2013), and from 
our phlorisobutyrophenone chemical standard (Figure 14).  This indicates that the protein 
produced from this gene could be 1) functionally inactived in some way in our assay, 2) a PKS 
that does not possess phlorisobutyrophenone activity, or 3) a gene that based on homology 
appears to be a PKS but has a different function in vivo.  The first of these is highly unlikely 
given the methods we followed for purification and functional analysis has been more or less 
standardized with PKSs across species (Karppinen et al., 2008; Crosby et al., Nualkaew et al., 
2012).  It is likely though this gene, although strongly correlated with hyperforin, is not 
phlorisobutyrophenone synthase.  We have come this conclusion in part after finding through 
transcriptomic efforts that PKS1 is not present at any detectable levels using PCR or Illumina 
sequencing in another species of Hypericum, H. gentianoides (data not shown).  This is quite 
important because this species produces a wide array of acylphloroglucinols at relatively high 
levels (Crispin et al., 2013), and therefore should produce a large quality of PKS1 if it were 
involved in phlorisobutyrophenone synthesis.  What currently remains a mystery is whether 
PKS1 is a different polyketide synthase that lacks phlorisobutyrophenone synthase, or if it has a 
different function entirely.  Additionally, this indicates at present, the gene involved with 
phlorisobutyrophenone biosynthesis has yet to be identified by any group.        
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Materials and Methods 
 
Plant material and tissue collections 
 Hypericum perforatum germplasm (as seeds), maintained as PI 649080 in the US 
National Germplasm System, was obtained from the USDA North Central Regional Plant 
Introduction Station in Ames, Iowa.  Because preliminary studies revealed the presence of 
relatively high amounts of the 11 metabolites of interest, this accession was deemed appropriate 
for use in this experiment.  Seeds were grown in soil (Sunshine LC1 SUN-COIR, Sun Gro 
Horticulture, Canada)  
 To ensure that there was no diurnal variation that would confound our analysis, all tissues 
used for this research were collected between 11 am and 12 pm.  Approximately 1 g of each of 
the tissues was collected by removing or dissecting it from the plant and immediately placingit 
into liquid nitrogen to ensure there was no degradation of RNAs. 
 
Metabolite extract preparation   
 Aliquots from H. perforatum fresh plant material under liquid nitrogen, 0.1 g, were 
ground into fine particulates, dissolved in 2 mL of methanol, vortexed for 30 s, and centrifuged 
at 13,000 rpm for 2 min.  Supernatants from centrifuged samples were removed into a syringe, 
and put into a 2 mL glass vial with a 0.45 micron filter, where they were analyzed. 
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High pressure liquid chromatography (HPLC) 
 HPLC conditions are the same as used by Crispin et al. (2013).  Metabolite abundance 
was determined using a Beckman Coulter (Fullerton, CA) HPLC equipped with a Detector 168 
diode array  
 
Quantification of metabolites based on chemical standards 
 The absolute concentrations and relative concentration in the case of protohypericin 
protopsuedohypericin and pseudohypericin, were quantified based on chemical standards for 
each compound.  Apigenin was added prior to the extraction process as an internal standard.  
Methanolic extracts of each sample were analyzed, normalized using the apigenin internal 
standard and converted to nmol based on the chemical standards, and standardized to a per gram 
fresh weight basis (nmol g
-1
 FW). 
 
Laser desorption ionization mass spectroscopy (LDI-MS)  
 H. perforatum was grown at 25°C, 16 h daylight, with a light intensity of                      
110 µE m
-2
s
-1
 and at ambient relative humidity.  Collected fresh plant material was immobilized 
on stainless steel sample plates with conductive double-sided tape (3M, St. Paul, MN). A 
MALDI linear ion trap-Orbitrap hybrid mass spectrometer (MALDI LTQ Orbitrap-Discovery; 
Thermo Fisher Scientific, San Jose, CA, USA) with an external Nd:YAG laser (UVFQ; 
Elforlight Ltd., Daventry, UK) was used to obtain the mass spectra. Optimal laser conditions 
were found for individual experiments. The laser was set in negative ion mode with a 25 μm 
raster step size.  The final spectra obtained was based on 10 laser shots and the average of 2 
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spectra per pixel.  Heat map images were generated using Thermo ImageQuest software (Thermo 
Scientific).  These images were manually overlaid with its corresponding optical image.   
 
RNA extraction preparation and de novo transcriptome assembly 
 Aliquots of the collected samples were taken for RNA extraction and subsequent 
sequencing.  RNA was extracted using a Spectrum Plant Total RNA kit from Sigma-Aldrich (St. 
Louis, MI).   
 Assembly of the transcriptome was performed according to the method described in 
Góngora-Castillo et al. (2012). 
 
Construction of expression plasmid 
 The coding sequence of PKS1 (with Gateway cloning adaptors) was amplified from 3‘ 
RACE cDNA from H. perforatum leaves using the forward primer 5‘-
GGGGACAAGTTTGTACAAAAAAGCAGGCT 
TCATCGAAGGTCGTATGTCGTTTAGAAAAGTAGAGAAGA-3‘ (Start codon is in bold, 
Factor Xa protease site underlined), and the reverse primer 5‘-
GGGGACCACTTTGTACAAGAAA 
GCTGGGTCTTAGTAATTAGGGAAGTGTTTGCG-3‘ (termination codon in bold).  The PCR 
was performed using Platinum PFX DNA polymerase (Life Technologies, Carlsbad, CA) using 
the conditions as follows: denaturation for 5 min at 94 °C, followed by 30 cycles of amplification 
at 94 °C for 20s, 55 °C for 30s,  68 °C for 1.5 min with a final extension at 68 °C for 5 min.  1 μl 
of the resulting product was re-amplified using the same protocol and this product was purified 
by electrophoresis on a 1.2% (w/v) ethidium bromide agarose gel.  The PCR product (~1.2 kb) 
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was excised and purified using a Qiaquick Kit (Qiagen, Venlo, Limberg).  The product was then 
cloned into the expression vector pDest15 using a one-step Gateway reaction.   
 
Expression of recombinant PKS1 
 The pDest15-PKS1 plasmid was transformed into the E. coli strain BL21-AI (Life 
Technologies).  Transformed cells were subsequently grown in Luria-Bertani liquid media with 
100 μg/ml ampicillin at 37°C until the O.D600 reached 0.5.  20% L-arabinose was added to the 
culture to a final concentration of 0.2%.  After this the culture was induced for 20 h at 16°C. 
 
Enzyme purification 
 E. coli cells were harvested by centrifugation at 5,000 rpm for 20 min and resuspended in 
a lysis buffer consisting of 20 mM Tris-HCl, 100 mM NaCl, 2 mm CalCl2, and 5% glycerol, pH 
8.0, with 1 mM DTT, 1 mM EDTA, and 1 mM PMSF and plant tissue protease inhibitor cocktail 
(Sigma Aldrich, St. Louis, MO) added immediately prior to use.  The cells were lysed with 
lysozyme for >1 h on ice and brief sonication.  DNAseI was added to 1 μg/ml with MgCl2 added 
to 2 mM and incubated on ice for 15 min.   The lysate was then centrifuged at 14,000 rpm for 20 
min and the supernatant was collected for purification.  Purification was performed using a GST 
batch purification method in an Eppendorf tube using a wash buffer of PBS (140 mM NaCl, 2.7 
KCl, 10 mM Na2HPO4, 1.8 KH2PO4) and an elution buffer containing 10 mM reduced 
glutathione, 50mM Tris-HCl ph 8.0, and 5% glycerol and 10 μm DTT added right before use.  
 Before elution, the washed beads containing bound fusion protein we diluted to a 50% 
slurry with PBS.  Half of the elution solution was used for protease cleavage. 
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Protease cleavage was done by spinning down the bead mixture so that the PBS could be 
removed.  After washing once with Factor Xa buffer (20 mM Tris-HCl, 100 mM NaCl, 2 mM 
CalCl2, pH 8.0), the beads were incubated in the same buffer with 20 μg/ml Factor Xa added at 
room temperature for 12 h.  The reaction was terminated with 1 mM PMSF. 
 
Enzyme assay 
 For the enzyme assay, approximately 30 μg of purified PKS1 was added with 20 μm 
malonyl-CoA and 15 μm isobutyryl-CoA in 0.1 M potassium phosphate buffer, pH 7.4, to a 
volume of 250 μL, and incubated at 30°C overnight.  Control reactions were conducted using 
heat-denatured enzyme.  The reaction mixtures were extracted in 250 μl of ethyl acetate twice 
and dried under N2 gas.  The extracts were suspended in 1:1 methanol:0.1% ammonium acetate 
in water (v:v) before being analyzed using FTICR-MS. 
 
FT-ICR analysis 
 Protein extracts from the in vitro biochemical assays were analyzed using a FTICR-MS 
from Bruker Solarix (Billerica, MA).  This extract was directly infused into the machine, 
analyzed using negative ion mode, and yielded the mass spectra shown in Figure 13A.  Specific 
ions were then isolated and fragmented to using MS/MS to yield the mass spectra shown in 
Figures 13B and 14. 
 
Phlorisobutyrophenone chemical synthesis 
 Phlorisobutyrophenone was synthesized using the synthesis scheme previously described 
by Kraus and Liu (2012).  In our scheme, 400 µL (4 equiv) of baron triflouride diethyl etherate 
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(Sigma, St. Louis MO) was added to a mixture of 600 µL (8 equiv) of isobutyric acid and 100 
mg (1 equiv) of phloroglucinol (Sigma, St. Louis MO).    
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Table 1- Concentration of polyketides in sections of the root compared to the averages over the 
aerial portions.  The root were split into 3 sections, the taproot (Figure 9; PO:0004542), mid aged 
root (Figure 9; PO:0009005), and root with elongation zone (Figure 9; PO:0025181) 
Compound Average 
of Aerial 
Portions 
(AA) 
Taproot 
(T)  
Fold 
Change 
(AA/T) 
Mid-
Aged 
Root 
(MR) 
Fold 
Change 
(AA/MR) 
Root With 
Elongation 
Zone 
(REZ) 
Fold 
Change 
(AA/REZ) 
Rutin 1986.16 0.49 4022 0.88 2250 0.20 9722 
Hyperoside 1979.73 45.62 43 0.82 2426 0.19 10481 
Isoquercitrin 153.07 3.03 50 0.09 1678 0.02 7247 
Quercitrin 1823.98 17.67 103 1.09 1675 0.25 7235 
Quercetin 1209.56 77.23 16 1.87 646 0.43 2792 
Amentoflavone 291.10 0.17 1695 0.30 948 0.07 4097 
Protopseudohypericin 1345.75 107.80 12 111.37 12 34.67 39 
Pseudohypericin 3670.09 343.48 11 596.97 6 195.89 19 
Protohypericin 343.53 121.13 3 150.68 2 139.12 2 
Hypericin 172.47 0.56 307 5.71 30 56.48 3 
Hyperforin 20257.89 815.92 25 744.07 27 405.62 50 
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Table 2- Enzymatic steps that are currently known/hypothesized to be involved in the 
biosynthesis of specialized polyketides in H. perforatum. 
Enzyme Name Pathway Involved In Number Of Unigenes 
4-Coumaroyl-CoA Ligase Flavonoids 4 
Chalcone Synthase Flavonoids 3 
Chalcone Isomerase Flavonoids 4 
Flavonol Synthase Flavonoids 17 
Quercetin 3-O-Glycosyltransferase Flavonoids 7 
Rhamnosyltransferase Flavonoids 3 
1-Deoxyxylulose 5-Phosphate Synthase Acylphloroglucinols 4 
1-Deoxyxylulose 5-Phosphate 
Reductoisomerase 
Acylphloroglucinols 1 
4-Diphosphocytidyl-2-C-Methylerythritol 
Kinase 
Acylphloroglucinols 1 
2-C-Methyl-D-Erythritol 2,4-
Cyclodiphosphate Synthase 
Acylphloroglucinols 1 
Isopentenyl Pyrophosphate: Dimethylallyl 
Pyrophosphate Isomerase 
Acylphloroglucinols 1 
PKS1 Acylphloroglucinols 1 
Prenyltransferase Acylphloroglucinols 16 
Hyp-1 Dianthrones 12 
 Total 71 
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Supplemental Tables 
Table S1- FASTA file containing a list of all unigenes as well as the isoforms for those unigenes 
 
Table S2- Expression matrix expressed in log 2 FPKM.  This matrix contains only one isoform 
for each unigene.  This is the unigene that either the most prevalent or the largest of the isoforms.   
 
 
 
 
 
 
 
 
 
216 
 
 
Figure 1- Visualizing hyperforin in H. perforatum leaves.  Previous work done by Soelberg et al. 
(2007) ascertained that hyperforin accumulated in the translucent glands by dissecting and 
analyzing tissue with translucent glands and tissue without any of these glands.  This data is in 
agreement with this previous work. A) optical image of adaxial side of H. perforatum leaf, B) 
LDI spectra of hyperforin on adaxial side of leaf, C) optical image of abaxial side of leaf, D) LDI 
spectra of hyperforin on abaxial side of leaf.  Scale bar=0.2 cm, white arrow=translucent glands, 
black arrow=glandular nodules. 
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Figure 2- Visualizing metabolites in the hypericin biosynthetic pathway in H. perforatum leaves.  
As is expected and has been previously shown, pseudoprotohypericin, pseudohypericin, 
protohypericin, and hypericin (E, F, G, and H respectively) accumulate highly in the glandular 
nodules while almost completely undetectable in the non-glandular tissues.  The hypericin 
precursor, emodin dianthrone (D), also accumulates prevalently in the glandular nodules.  The 
supposed hypericin precursor emodin (C) accumulates in all non-glandular tissue.  Scale bar=0.2 
cm, white arrow=translucent glands, black arrow=glandular nodules. 
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Figure 3- Visualization of hypericin biosynthetic metabolites in H. perforatum petals.  The LDI 
spectra for petals were examined at molecular weights corresponding to the hypericin 
biosynthetic pathway as it is currently understood.  The dianthrones (D-H) follow the same 
accumulation pattern as seen in the leaves.  A) Optical image of H. perforatum petals, B) emodin 
anthrone, C) emodin, D) emodin dianthrone, E) protohypericin, F) protopseudohypericin, G) 
hypericin, H) pseudohypericin.  Scale bar=0.2 cm, black arrow=glandular nodules 
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Figure 4- Visualization metabolites of the hypericin biosynthetic pathway in the anthers.  A) 
Optical image of anther with visible glandular nodule on the left side, B) emodin anthrone, C) 
emodin, D) emodin dianthrone, E) protohypericin, F) protopseudohypericin, G) hypericin, H) 
pseudohypericin.  Scale bar=0.2 cm  
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Figure 5- LDI imaging of hypericin biosynthetic metabolite on the sepal.  As in the other 
figures, these metabolites are based on molecular weight.  A) Optical image of H. perforatum 
sepal, B) protohypericin, C) protopseudohypericin, D) pseudohypericin, E) hypericin.  Scale 
bar=0.2 cm, black arrow=glandular nodules. 
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Figure 6- Visualizing quercetins and amentoflavone in H. perforatum leaves.  A) optical image 
of H. perforatum leaf, the black arrow is pointing to a glandular nodule, while the translucent 
glands are indicted by the white arrow.  B) kampferol, C) quercetin, D) isorhamnetin, E) 
quercitrin, F) isoquercitrin, G) miquelianin, H) amentoflavone, I) rutin. Scale bar=0.2 cm, white 
arrow=translucent glands, black arrow=glandular nodules. 
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Figure 7- Visualization of quercetins and amentoflavone in petals.  A) optical image of petal, B) 
kampferol, C) quercetin, D) isorhamnetin, E) quercitrin, F) isoquercitrin, G) miquelianin, H) 
amentoflavone, I) rutin. Scale bar=0.2 cm, black arrows=glandular nodules. 
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Figure 8- Visualization of quercetins and amentoflavone in anther.  A) optical image of anther 
with visible glandular nodule on the left side, B) kampferol, C) quercetin, D) isorhamnetin, E) 
quercitrin, F) isoquercitrin, G) miquelianin, H) amentoflavone, I) rutin. Scale bar=0.2 cm. 
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Figure 9- H. perforatum tissues collected for metabolomic/transcriptomic analysis.  This 
analysis focused on two types of tissue: different developmental stages of the same tissues, and 
tissues in which glands can be separated, the site of acylphloroglucinols and dianthrones 
accumulation (Figures 1-5; Soelberg et al., 2007; Karppinen et al., 2008).  A) Open flower, the 
tissues collected from this tissue were the whole open flower (in white), whole petals (in red), 
petals with glandular nodules (in black), and the same petals without any glandular nodules (in 
blue).  B) Flower buds, from this the whole bud was taken (in white), whole petals from the bud 
(in red), and the pistil, stamen and sepal (partially illustrated in black).  C) Developmental stages 
of leaves.  For the leaves, three different stages of development were collected: leaves near the 
shoot meristematic tissue (abbreviated young leaf, PO:0001051, illustrated in red), leaves on 
primary branches near shoot meristematic tissue (abbreviated mid-aged leaf, PO:0001052, 
illustrated in white).  Leaves on primary branches near the center of the plant (abbreviated old 
leaves, PO:0001053). D) Root developmental stages, collected to obtain as much information 
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about the transcriptome as possible and to provide a tissue with very little polyketides of interest 
(see Table 1).  Three tissues were collected, the rhizome (PO:0004542, illustrated in white), mid-
aged root (root tissue inbetween the rhizome and the young root with elongation zone, in red), 
and the young root with elongation zone (PO:0001031, in yellow). 
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Figure 10-Alignment of a large translated region of the unigene 
hpa_locus_4881_iso_3_len_1552 compared to that of the previously identified polyketide 
synthase 1 (PKS1) (Karppinen et al., 2007).  This alignment shows that unigene 4881 covers 
100% of the PKS1 protein with 97.9% homology. 
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Figure 11- Correlating the metabolite hyperforin and the unigene 4881 (referred to as PKS1 see 
Figure 10).  A) The accumulation pattern of hyperforin, in blue, and the accumulation pattern of 
PKS1, in red, across different tissues show that there is a strong trend between them across 
diverse tissues including flowers, leaves, and roots.  B) A linear regression between hyperforin 
and PKS1 shows that there is a strong positive correlation, R
2
=0.98, a similar result to that in 
Karppenin et al. (2007). 
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Figure 12- Confirmation of PKS1 transcript and protein. A) Electrophoretic gel confirming the 
amplication of PKS1 from H. perforatum 3‘ RACE cDNA.  1) Hind III ladder, 2) negative 
control with just water, 3) negative control with all pcr reagents excluding template, PKS1) 
PKS1 amplication product, 5) 1 Kb Plus ladder.  B) Electrophoretic gel confirming the presence 
of PKS1 in LR vector.  1 Kb+) 1 Kb Plus ladder, Hind III) Hind III ladder, 1-6) individual cells 
selected from Ampicillin plates, +) positive control, -) negative control.  C)  Protein gel 
confirming both the presence of the GST-PKS1 fusion protein (predicted molecule weight 68 
kD) and whether it can be induced with ITPG.  The uninduced and induced GUS positive 
controls (Ucon and Icon respectively) do not show the 68 kD band that corresponds to the GUS-
PKS1 fusion protein.  Colonies not induced with ITPG (U1, U2, and U3) show no fusion protein 
band, however, the same colonies induced with ITPG show a strong band at approximately 68 
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kD (I1, I2, and I3, indicated by the arrows) showing the protein is produced and under the 
control of ITPG.  D) Protein gel confirming the factor Xa protease cleaves the GST-PKS1 at the 
N-terminus of the PKS1 protein, yielding the native PKS1 protein.  L) Precision Dual Color 
protein ladder, CP) crude protein extraction, 1) first elution after putting supernatant through 
GST binding column, 2) second elution from the binding column, Xa) elution after cutting with 
factor Xa, the black arrow is indicating a band at approximately 42 kD, the predicted molecular 
weight of the PKS1 protein, 1Xa) first elution after factor Xa cutting.  
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Figure 13-FTICR-MS analysis confirms PKS1 possesses phlorisobutyrophenone synthase 
activity in vitro.  A) To determine if PKS1 is capable of biosynthesizing phlorisobutyrophenone 
in vitro, we examined 2 conditions 1) PKS1 protein purified from induced BL21-AI culture 
(shown in red), 2) GST-GUS control from a different BL21-AI culture induced with ITPG and 
incubated with the enzymatic substrates (shown in green).  Protein extracts were incubated with 
isobutyryl-CoA and malonyl-CoA for 14 hours prior to extraction (see methods).  B) FTICR-
MS/MS was done on the ion at 195.1 m/z (corresponding to the molecular weight of 
phlorisobutyrophenone in negative ion mode).  This ion fragments at two positions 
corresponding to the loss of one or two water molecules, however, this MS/MS profile indicates 
this ion is not phlorisobutyrophenone, and also corresponds to the peak indicated at 194.9 m/z. 
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Figure 14- FTICR-MS/MS profile of phlorisobutyrophenone chemical standard in negative ion 
mode.  Fragmentation of phlorisobutyrophenone (195.1 m/z) shows 3 distinct peaks 
corresponding to the fragmentation of the entire acyl tail (125.0 m/z), fragmentation of isobutane 
from the acyl tail (151.1 m/z) and the fragmentation of a single hydroxyl group (177.1 m/z).  This 
fragmentation patterning is also consistent with findings in H. gentianoides performed by Crispin 
et al. (2013)    
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CHAPTER 7. GENERAL CONCLUSIONS 
 The research presented in this dissertation has shown that in H. gentianoides 
acylphloroglucinols are likely biosynthesized by decorating phlorisobutyrophenone molecules 
prior to ligation of two of these decorated molecules, and this entire process takes place only in 
the translucent glands (Chapters 3 and 4).  This dissertation also describes methods and 
assumptions needed to correlate metabolites to transcripts in order to identify novel polyketide 
biosynthetic genes (Chapter 2).  This dissertation also describes efforts using these methods to 
identify putative polyketide related transcripts in H. gentianoides and H. perforatum (Chapters 5 
and 6). 
 
Acylphloroglucinols in H. gentianoides are generated from a decorated 
phlorisobutyrophenone pool 
 Two findings that were the initial basis for the diacylphloroglucinol biosynthesis pathway 
in H. gentianoides had previously emerged from our lab: 1) NMR spectra established that 3 of 
the 9 major accumulating metabolites were saroaspidin A, uliginosin A, and hyperbrasilol C 
(Hillwig, 2008), and 2) comparing the UV spectra of these 3 compounds with the 6 other 
unknown compounds revealed all nine of these peaks were in fact acylphloroglucinols (Hillwig 
et al., 2008).  Given the difficulty of purifying enough of these unknown acylphloroglucinol in 
order to perform NMR analysis, we examined the MS/MS spectra of all these compounds.  Our 
analysis indicted 8 of the 9 compounds were diacylphloroglucinols utilizing a set of common 
monomers that are ligated by a methylene bridge, while the first compound that eluted in our 
liquid chromatographic separation was a monoacylphloroglucinol composed of a further 
prenylated monomer from the pool used to make diacylphloroglucinols.  From this, we 
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hypothesized and gave evidence to suggest the presence of a monomer pool is sufficient for the 
biosynthesis of the observed acylphloroglucinols in H. gentianoides (Chapter 3). 
 
Acylphloroglucinol biosynthesis is completely sequestered within the translucent glands of H. 
gentianoides 
 Next, using a combination of LC/ESI-MS, FTICR-MS and LDI-MS, I demonstrated that 
not only do the 9 major acylphloroglucinols observed by using our LC separation method in H. 
gentianoides accumulate preferentially within the translucent glands of the leaf, but so does 
phlorisobutyrophenone and the pool of decorated phlorisobutyrophenone molecules. 
 This suggests that acylphloroglucinol biosynthesis is sequestered within the translucent 
glands.  If this is the case, several classes of organelles would need to be present there.  The first 
are mitochondria, given that isobutyryl-CoA and malonyl-CoA are generated through a 
mitochondria specific dehydrogenase (Wynn et al., 1992).  Plastids would also be needed 
because the dimethylallyl diphosphate is transferred to phlorisobutyrophenone molecules are 
likely derived the same way in H. gentianoides as in H. perforatum, through the plastidic 
methylerythritol pathway (Adam et al., 2002).  In order to produce any proteins within a 
structure such as a translucent glands, ribosomes would be completely necessary.  After analysis 
using electron microscopy, we determined that all three of these organelles are present.  The 
results provide very strong evidence that acylphloroglucinol metabolism occurs only in the 
translucent glands. 
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Metabolites shifts can be correlated to transcript shifts by using several different tissue 
collection methods in Hypericum 
 Previous efforts using a small sample of tissues and cDNA library have revealed very 
little new information about the biosynthesis of polyketides in Hypericum, but with next 
generation sequencing, many more distinct tissues can be collected and sequenced quickly and 
efficiently (Chapter 2).  In this section of the dissertation, I discuss four means of tissue 
collection that yield high and low polyketide abundance that can be correlated to shifts in 
transcript abundance.  The first is by using different parts of the same organ, for example, H. 
perforatum leaves only produce glandular nodules on the periphery of the leaf.  Therefore 
separation of leaf tissue with glandular nodules will yield a transcriptome generally resembling 
leaf tissue without these glands, but will be very distinct with respect to transcripts involving 
with metabolism occurring inside the glands. 
 The second method is using the same tissues, but during different developmental stages; 
for example, collecting flower buds and mature flowers.  The third method was to collect from 
different accessions of H. gentianoides which yielded a 2-5 fold difference in acylphloroglucinol 
content (Chapter 2).  This could correspond to different levels of biosynthetic transcripts if the 
change of metabolites is due to transcriptional regulation, and not some other factor such as 
translational modification or different isozymes. 
 The last method discussed use of environmental stressors to induce shifts in metabolite 
abundance.  Researchers have long used environmental stressors to alter levels of specialized 
metabolites and transcripts involved in their biosynthesis (Chapter 2; Chapter 5; Glombitza et al., 
2004). 
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UV-B stress increases the abundance of several polyketides as well as polyketide related 
transcripts 
 After identifying UV-B irradiation induced flavonoid production in H. gentianoides, I 
established that use of environmental stressors (described in Chapter 2) can be used to identify 
many of the biosynthetic genes involved in flavonoid biosynthesis.  Additionally, I identified a 
set of 2,600 transcripts that are differentially expressed in H. gentianoides under UV-B 
irradiation, of which several correspond to polyketide synthases, methyltransferases, 
prenyltransferases, and reticuline oxidase which may be involved in acylphloroglucinol 
biosynthesis in H. gentianoides (Chapter 5).  Based on the information in this dissertation and 
other primary literature discussing acylphloroglucinol metabolism, future experiments should 
focus on finding transcripts homologous to these steps that accumulate in the translucent glands 
(Chapter 2-5, Soelberg et al., 2007) 
 
Discrete accumulation sites of polyketides in H. perforatum revealed PKS1 is strongly 
correlated with hyperforin, but no catalytic functioning as phlorisobutyrophenone synthase  
 Finally, I focused on identifying novel accumulation sites for polyketides in H. 
perforatum as well as confirming that the polyketide synthase PKS1 has phlorisobutyrophenone 
synthase activity in vitro (Chapter 6).  LDI-MS identified several novel results about the 
accumulation of polyketides in H. perforatum.  In the leaves, emodin accumulates everywhere 
except in the glandular nodules indicating that it may not be directly involved in hypericin 
biosynthesis as it has been previously shown in vitro biochemical assays (Bais et al., 2003).  
 Emodin dianthrone accumulates in the glandular nodules in every tissue that accumulates 
glandular nodules, which indicates that emodin dianthrone, protohypericin, and hypericin are 
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likely biosynthesized in the glandular nodules.  The last novel finding from LDI-MS was that 
quercitrin, isoquercitrin, and miquelianin accumulate in the glandular nodules.  This is the first 
observation of this phenomenon in H. perforatum, but it had been previously predicted to occur 
by Onelli et al. (2002).  Based on Onelli et al. (2002) and the nature of flavonoids and these 
quercetin glycosides, we predicted that these flavonoids make up a portion of the outer layer of 
cells that comprise the glandular nodules, and they function to: 1) form a light barrier to prevent 
photoactivation of the hypericins in the glandular nodules and 2) to prevent oxidative damage in 
the case of photoactivation of the hypericins. 
 In addition to identifying novel accumulation sites for polyketides in H. perforatum, LDI-
MS identified several tissues with high and low polyketide accumulation. We used these to 
correlate metabolite shifts to transcript shifts.  Through this approach, I found that a unigene 
corresponding to PKS1 (homologous to a polyketide synthase) correlated with an R
2
=0.98 with 
hyperforin accumulation over tissues, a finding noted by others (Chapter 6, Karppinen et al., 
2007).  I predicted this unigene to be phlorisobutyrophenone synthase.  The cDNA from this 
transcript was transformed into a protein expression strain of E. coli (BL21-AI); the crude extract 
was collected, purified, and cut with factor Xa protease to yield the native PKS1 protein.  After 
adding the substrates necessary for phlorisobutyrophenone synthase activity and incubating for 
14 h, PKS1 was found to not possess the capabilities to generate phlorisobutyrophenone in vitro.  
Future studies could focus on 1) identifying the true function of PKS1, and 2) identifying the true 
phlorisobutyrophenone synthase gene in H. gentianoides and H. perforatum 3) perform in vivo 
assays determining the function of any hyperforin related genes.  Difficulties for these 
experiments are 1) H. perforatum is a very slow maturing plant relative to many other plants 
used for transformational experiments, therefore in vivo experiments would be quite time 
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consuming and 2) many of the prenyl- and geranyltransferases in H. perforatum could be 
correlated to acylphloroglucinol accumulation but actually be involved with other metabolic 
processes. 
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APPENDIX. MODIFIED SEMI-PREPARATIVE HPLC METHOD 
FOR ISOLATING ACYLPHLOROGLUCINOLS FROM HYPERICUM 
GENTIANOIDES L. 
 
Abstract 
 Hypericum gentianoides produces 9 distinct acylphloroglucinols which may become 
important in pharmaceuticals because of their wide range of bioactivities (Hillwig et al., 2008).   
The goals of modifying the semi-preparative HPLC method used by Hillwig et al. (2008) were 
to: 1) to produce extracts that were stable and consisted mostly of the acylphloroglucinols of 
interest, and 2) to modify the HPLC method in such a way that all 9 acylphloroglucinols elute 
after the mobile phase shifts to 100% non-polar phase, which can then be easily purified and 
dried under nitrogen gas. 
 Here, I show that not only are I was able to produce extracts with almost all 
acylphloroglucinol content, but I was able to modify the existing semi-prep HPLC method to 
cause all the nine acylphloroglucinols to elute in a mobile phase that can be easily dried under 
nitrogen gas.  This method can be used to purify large amounts of the acylphloroglucinols, which 
can be used for both in vitro and in vivo studies to expand our knowledge of these compounds 
and their bioactivity. 
 
Introduction- 
 Hypericum gentianoides is an herbaceous annual plant that grows natively throughout the 
United States and Canada. This species has been shown to be pharmacologically relevant 
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because of its translucent glands, which produce bioactive metabolites (Hillwig et al., 2008; 
Babka, 2009; Crispin et al., 2013). 
 Efforts to identify possible new bioactivities have been recently explored however, pre-
existing methods for isolating these compounds are historically expensive and time-consuming.  
In order to streamline this process, we sought to adapt pre-existing methods in order to quickly 
and efficiently obtain sufficient quantities of acylphloroglucinols to perform in vitro and in vivo 
bioassays.  Here, we describe our modified method for obtaining methanolic extracts that are 
stable for long durations at -80°C, as well as a modified semi-preparative HPLC purification 
method. 
 
Methods/Results and Discussion- 
Gathering Extracts with High Concentrations of Acylphloroglucinols 
 We collected material from vegetative phase H. gentianoides plants (Ames, IA, accession 
PI 664838).  Fresh plant material was ground thoroughly in methanol, placed into aliquots and 
vortexed.  Each aliquot was pelleted by centrifugation for 2 min at 13,000 rpm.  Following the 
methods of Hillwig et al. (2008) and Crispin et al. (2013) the supernatant was removed by 
syringe and filtered with a 0.45 micron filter. 
 The additional step taken in my modified protocol involves dehydrating this product up 
to 10 fold under nitrogen gas.  This step causes much of what are most likely chlorophylls and 
tannins to precipitate out of solution (Figure 1B).  The liquid is removed from this vial, and 
filtered again into a new vial.  This extract product presumably consists mostly of 
acylphloroglucinols, given that the color of the refined extract loses the dark green color of the 
initial extract, then resembling that of purified acylphloroglucinols (Figures 1A, 1B; 2).  
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Additional advantages to this method are that extracts can be stored in -80°C without contents 
coming out of solution requiring additional filtering, and that these extracts are less harsh on the 
HPLC system and column/guard column than those that have not been so refined. 
 
Modifying the Previous Semi-Preparative HPLC Method 
 The semi-preparative HPLC method used by Hillwig et al. (2008) is sufficient for 
purification of several of the acylphloroglucinols in 100% 9:1 acetonitrile:methanol; however, all 
9 do not elute in this part of the mobile phase.  Therefore, we set out to alter the method so it did 
not interfere with the amount of product we obtained, but allowed for us to obtain all nine 
acylphloroglucinols in 100% non-polar phase.  After several strategies, such as alterating of the 
non-polar phase to 4:1 acetonitrile:methanol, and altering the length of time of the linear gradient 
from 83%A to 0%A, we found that lowering the 2.5 mL/min flow rate by 40% allowed for all 
nine acylphloroglucinols to elute after 30 min which is when the linear shift to 100%B is 
complete (Figure 3).  Our lab‘s previous analyses used max spectrum plots; however, for this 
analysis, 350 nm was used.  This is primarily because 350 nm gives a flat baseline corresponding 
to the 350 nm baseline of one of the three UV maxima for all the acylphloroglucinols. 
 
Obtaining Purified Acylphloroglucinols 
 Aliquots of the extract, 50 μL, were injected into the HPLC per run.  Given the high flow 
rate (2.5 mL/min), and the near instaneous time between detector and where waste is deposited, 
it was ascertained that when a peak corresponding to an acylphloroglucinol is observed through 
the user interface, it should be collected from the end of the tubing.  At the time of collection, the 
compounds are in 100% 9:1 acetonitrile:methanol.  Each compound is collected in the same 
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glass vial during every run for 2 reasons: 1) to ensure there is no loss of material, given we are 
collecting microgram amounts of compound and 2) to ensure that acetonitrile doesn‘t degrade 
any part of the container, giving a contaminated sample.  After acylphloroglucinol/9:1 
acetonitrile:methanol mixtures were collected for the 7 of the diacylphloroglucinols, they were 
immediately dried to completion under nitrogen gas.  The dried product is shown in Figure 2.  
Because of its abundance, the acylphloroglucinols appear as a yellow powder on the vial. 
 
Assessing Quality and Weight of Acylphloroglucinols 
 After extracting processed aerial portions of 5 g (fresh weight) of H. gentianoides into 
methanolic extract and running 50 times on the HPLC, we needed to ascertain the weight and 
quality of the purified compounds.  Purified acylphloroglucinols were dissolved in 1 mL 100% 
acetonitrile, and 1 μL of this was put into a 2 mL of 1:1 (v/v) acetonitrile/0.1% ammonium 
acetate in water.  This was then directly injected into a Bruker Solarix FTICR-MS set on 
negative ion mode.  This analysis revealed that the saroaspidin A, uliginosin A, and hyperbrasilol 
C samples that were collected were pure (data not shown).   
 The rest of the purified acylphloroglucinols were placed into a vial of known weight, 
dried to completion under nitrogen gas and weighed again to determine absolute abundance.  We 
determined that there was 5-6 mg of purified saroaspidin A, uliginosin A, and hyperbrasilol C 
from this analysis.  This also gave us the means to determine an approximate abundance based 
on signals of saroaspidin A, uliginosin A, and hyperbrasilol C in our UV spectra. 
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Conclusions 
 Here, we describe a method for preparing stable extracts of H. gentianoides as well as a 
semi-preparative HPLC method that yields easily separated and quantified acylphloroglucinols.  
This provides enough purified compound for in vitro assays; however, in order to perform in vivo 
assays, we need at least 100 mg.  Fortunately, this method can be easily converted to a 
preparative HPLC method, resulting in nearly the same retention times and ease of separation. 
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Figure 1-Hypericum gentianoides methanolic extracts before and after drying with gaseous 
nitrogen.  A) methanolic extract of H. gentianoides after grinding, extraction, and filtration.  B) 
On the left is the methanolic extract after drying under nitrogen gas and refiltering.  The yellow 
color is similar to the color observed when several milligrams of purified acylphloroglucinols 
dissolved in methanol.  On the right represents what I suspect to be chlorophylls and tannins and 
other particulates that precipitate out of the solution in A) after addition of nitrogen gas. 
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Figure 2- Purified acylphloroglucinols after drying under gaseous nitrogen.  Each vial 
corresponds to one of the six diacylphloroglucinols collected using the modified semi-prep 
HPLC method.  Further verification via FTICR-MS (not shown) showed every vial (except 
number 5) contained only one acylphloroglucinol.  This arrangement is identical to the order of 
elution, and as shown in figure 3, the absolute abundance corresponds well with the relative 
abundance shown using a UV detector at 350 nm.  In order from left to right: saroaspidin A, 
saroaspidin B, [3‘mePIB]-[1‘pren3‘me4‘oxoPIB], uliginosin A, (uliginosin A, 
[3‘3‘4me4‘oxoPIB]-[3‘prenPIB], hyperbrasilol C), hyperbrasilol C. 
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Figure 3-Output from modified semi-prep HPLC method at 350 nm.  We show the location of 
all the nine major accumulating acylphloroglucinols; however, we did not collect 
1‘3‘pren45‘me4‘oxoPIB, uliginosin B, or [3‘prenPIB]-[1‘pren3‘4me4‘oxoPIB] because of their 
low concentrations. 
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